| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.752 | 0.002 | 0.915 | Succinate dehydrogenase inhibitor | 0.648 0.002 DBMET00060 0.879 0.002 DBMET00061 0.569 0.003 DBMET00062 0.514 0.003 DBMET00063 0.22 0.035 DBMET00064 0.592 0.003 DBMET00065 0.561 0.003 DBMET00066 0.561 0.003 DBMET00067 0.618 0.002 DBMET01106 0.744 0.002 DBMET01109 0.659 0.002 DBMET01110 0.915 0.002 DBMET01107 0.913 0.002 DBMET01108 | DBMET01107 | |
| 0.717 | 0.006 | 0.785 | 5 Hydroxytryptamine release stimulant | 0.604 0.014 DBMET00060 0.558 0.019 DBMET00061 0.769 0.004 DBMET00062 0.785 0.004 DBMET00063 0.64 0.011 DBMET00064 0.49 0.029 DBMET00065 0.662 0.009 DBMET00066 0.662 0.009 DBMET00067 0.474 0.032 DBMET01106 0.628 0.012 DBMET01109 0.745 0.005 DBMET01110 0.62 0.013 DBMET01107 0.628 0.012 DBMET01108 | DBMET00063 | |
| 0.704 | 0.008 | 0.736 | Aldehyde oxidase inhibitor | 0.366 0.052 DBMET00060 0.682 0.01 DBMET00061 0.693 0.009 DBMET00062 0.724 0.007 DBMET00063 0.599 0.019 DBMET00065 0.525 0.029 DBMET00066 0.525 0.029 DBMET00067 0.397 0.047 DBMET01106 0.623 0.016 DBMET01109 0.736 0.006 DBMET01110 0.615 0.017 DBMET01107 0.623 0.016 DBMET01108 | DBMET01110 | |
| 0.687 | 0.004 | 0.719 | Anesthetic general | 0.651 0.004 DBMET00060 0.698 0.003 DBMET00061 0.508 0.007 DBMET00062 0.677 0.004 DBMET00063 0.625 0.004 DBMET00064 0.335 0.026 DBMET00065 0.539 0.006 DBMET00066 0.539 0.006 DBMET00067 0.388 0.018 DBMET01106 0.701 0.003 DBMET01109 0.69 0.004 DBMET01110 0.719 0.003 DBMET01107 0.65 0.004 DBMET01108 | DBMET01107 | |
| 0.653 | 0.003 | 0.722 | Alpha-N-acetylglucosaminidase inhibitor | 0.357 0.011 DBMET00060 0.628 0.004 DBMET00061 0.668 0.003 DBMET00062 0.622 0.004 DBMET00063 0.722 0.003 DBMET00064 0.571 0.004 DBMET00065 0.443 0.007 DBMET00066 0.443 0.007 DBMET00067 0.428 0.008 DBMET01106 0.558 0.004 DBMET01109 0.461 0.006 DBMET01110 0.415 0.008 DBMET01107 0.558 0.004 DBMET01108 | DBMET00064 | |
| 0.653 | 0.012 | 0.776 | Cholesterol antagonist | 0.609 0.018 DBMET00060 0.666 0.011 DBMET00061 0.635 0.014 DBMET00062 0.643 0.013 DBMET00063 0.776 0.004 DBMET00064 0.696 0.008 DBMET00065 0.63 0.015 DBMET00066 0.63 0.015 DBMET00067 0.608 0.018 DBMET01106 0.685 0.009 DBMET01109 0.589 0.02 DBMET01110 0.543 0.026 DBMET01107 0.638 0.014 DBMET01108 | DBMET00064 | |
| 0.644 | 0.006 | 0.644 | 5 Hydroxytryptamine release inhibitor | 0.439 0.056 DBMET00060 0.644 0.006 DBMET00061 0.6 0.011 DBMET00062 0.612 0.009 DBMET00063 0.598 0.011 DBMET00064 0.491 0.035 DBMET00065 0.511 0.029 DBMET00066 0.511 0.029 DBMET00067 0.384 0.088 DBMET01106 0.577 0.014 DBMET01109 0.551 0.019 DBMET01110 0.516 0.028 DBMET01107 0.577 0.014 DBMET01108 | ||
| 0.611 | 0.002 | 0.686 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.224 0.003 DBMET00060 0.333 0.002 DBMET00061 0.074 0.003 DBMET00062 0.293 0.002 DBMET00063 0.072 0.004 DBMET00066 0.072 0.004 DBMET00067 0.686 0.001 DBMET01109 0.087 0.003 DBMET01110 0.27 0.003 DBMET01107 0.638 0.002 DBMET01108 | DBMET01109 | |
| 0.594 | 0.003 | 0.783 | Alcohol oxidase inhibitor | 0.135 0.012 DBMET00060 0.512 0.004 DBMET00061 0.783 0.003 DBMET00062 0.428 0.004 DBMET00063 0.068 0.03 DBMET00064 0.429 0.004 DBMET00065 0.204 0.006 DBMET00066 0.204 0.006 DBMET00067 0.19 0.007 DBMET01106 0.359 0.004 DBMET01109 0.263 0.005 DBMET01110 0.207 0.006 DBMET01107 0.359 0.004 DBMET01108 | DBMET00062 | |
| 0.591 | 0.001 | 0.819 | Aconitate hydratase inhibitor | 0.329 0.002 DBMET00060 0.362 0.002 DBMET00061 0.441 0.002 DBMET00062 0.506 0.001 DBMET00063 0.078 0.014 DBMET00064 0.332 0.002 DBMET00065 0.33 0.002 DBMET00066 0.33 0.002 DBMET00067 0.222 0.003 DBMET01106 0.806 0.001 DBMET01109 0.38 0.002 DBMET01110 0.442 0.002 DBMET01107 0.819 0.001 DBMET01108 | DBMET01108 | |
| 0.594 | 0.028 | 0.785 | Cyclophilin D inhibitor | 0.352 0.121 DBMET00060 0.565 0.034 DBMET00061 0.62 0.024 DBMET00062 0.585 0.03 DBMET00063 0.785 0.008 DBMET00064 0.778 0.008 DBMET00065 0.781 0.008 DBMET00066 0.781 0.008 DBMET00067 0.479 0.057 DBMET01106 0.629 0.023 DBMET01109 0.43 0.075 DBMET01107 0.64 0.021 DBMET01108 | DBMET00064 | |
| 0.564 | 0.003 | 0.636 | GABA C receptor agonist | 0.382 0.005 DBMET00060 0.348 0.007 DBMET00061 0.348 0.007 DBMET00062 0.307 0.009 DBMET00063 0.107 0.06 DBMET00064 0.529 0.003 DBMET00065 0.47 0.004 DBMET00066 0.47 0.004 DBMET00067 0.398 0.005 DBMET01106 0.636 0.002 DBMET01109 0.428 0.005 DBMET01110 0.383 0.005 DBMET01107 0.561 0.003 DBMET01108 | DBMET01109 | |
| 0.573 | 0.013 | 0.653 | Histamine release inhibitor | 0.46 0.045 DBMET00060 0.567 0.014 DBMET00061 0.543 0.018 DBMET00062 0.559 0.015 DBMET00063 0.653 0.006 DBMET00064 0.57 0.013 DBMET00065 0.476 0.038 DBMET00066 0.476 0.038 DBMET00067 0.525 0.021 DBMET01106 0.596 0.01 DBMET01109 0.482 0.035 DBMET01110 0.451 0.049 DBMET01107 0.547 0.017 DBMET01108 | DBMET00064 | |
| 0.559 | 0.004 | 0.569 | Thrombolytic | 0.382 0.013 DBMET00060 0.48 0.005 DBMET00061 0.363 0.015 DBMET00062 0.434 0.009 DBMET00063 0.445 0.008 DBMET00064 0.45 0.007 DBMET00065 0.325 0.02 DBMET00066 0.325 0.02 DBMET00067 0.371 0.014 DBMET01106 0.568 0.004 DBMET01109 0.373 0.014 DBMET01110 0.527 0.005 DBMET01107 0.569 0.004 DBMET01108 | DBMET01108 | |
| 0.559 | 0.009 | 0.689 | Hypolipemic | 0.511 0.012 DBMET00060 0.532 0.01 DBMET00061 0.558 0.009 DBMET00062 0.556 0.009 DBMET00063 0.555 0.009 DBMET00064 0.689 0.005 DBMET00065 0.583 0.007 DBMET00066 0.583 0.007 DBMET00067 0.526 0.01 DBMET01106 0.556 0.009 DBMET01109 0.355 0.034 DBMET01110 0.351 0.035 DBMET01107 0.574 0.008 DBMET01108 | DBMET00065 | |
| 0.555 | 0.006 | 0.555 | Peroxidase inhibitor | 0.305 0.036 DBMET00060 0.484 0.011 DBMET00061 0.534 0.007 DBMET00062 0.495 0.01 DBMET00063 0.385 0.023 DBMET00065 0.401 0.02 DBMET00066 0.401 0.02 DBMET00067 0.229 0.052 DBMET01106 0.477 0.012 DBMET01109 0.449 0.014 DBMET01110 0.406 0.02 DBMET01107 0.477 0.012 DBMET01108 | ||
| 0.556 | 0.009 | 0.673 | Anticonvulsant | 0.497 0.012 DBMET00060 0.408 0.021 DBMET00061 0.153 0.125 DBMET00062 0.284 0.045 DBMET00063 0.448 0.016 DBMET00065 0.163 0.114 DBMET00066 0.163 0.114 DBMET00067 0.169 0.108 DBMET01106 0.588 0.008 DBMET01109 0.169 0.108 DBMET01110 0.469 0.014 DBMET01107 0.673 0.005 DBMET01108 | DBMET01108 | |
| 0.583 | 0.039 | 0.793 | Caspase 9 stimulant | 0.536 0.048 DBMET00060 0.549 0.045 DBMET00061 0.488 0.065 DBMET00062 0.48 0.068 DBMET00063 0.793 0.012 DBMET00064 0.592 0.037 DBMET00065 0.463 0.076 DBMET00066 0.463 0.076 DBMET00067 0.519 0.053 DBMET01106 0.643 0.031 DBMET01109 0.522 0.052 DBMET01110 0.579 0.039 DBMET01107 0.526 0.051 DBMET01108 | DBMET00064 | |
| 0.547 | 0.009 | 0.547 | Superoxide dismutase inhibitor | 0.409 0.025 DBMET00060 0.547 0.009 DBMET00061 0.379 0.03 DBMET00062 0.374 0.031 DBMET00063 0.503 0.013 DBMET00065 0.417 0.024 DBMET00066 0.417 0.024 DBMET00067 0.446 0.019 DBMET01106 0.441 0.02 DBMET01109 0.485 0.014 DBMET01110 0.437 0.021 DBMET01107 0.441 0.02 DBMET01108 | ||
| 0.545 | 0.01 | 0.709 | Platelet antagonist | 0.192 0.107 DBMET01015 0.342 0.04 DBMET00060 0.51 0.013 DBMET00061 0.523 0.012 DBMET00062 0.485 0.015 DBMET00063 0.45 0.019 DBMET00064 0.507 0.013 DBMET00065 0.414 0.024 DBMET00066 0.414 0.024 DBMET00067 0.215 0.091 DBMET01106 0.709 0.005 DBMET01109 0.444 0.02 DBMET01110 0.389 0.029 DBMET01107 0.622 0.006 DBMET01108 | DBMET01109 | |
| 0.533 | 0.009 | 0.604 | Psychostimulant | 0.381 0.026 DBMET00060 0.585 0.006 DBMET00061 0.437 0.017 DBMET00062 0.442 0.017 DBMET00063 0.38 0.026 DBMET00064 0.166 0.103 DBMET00065 0.331 0.035 DBMET00066 0.331 0.035 DBMET00067 0.145 0.121 DBMET01106 0.604 0.006 DBMET01109 0.312 0.04 DBMET01110 0.365 0.029 DBMET01107 0.506 0.01 DBMET01108 | DBMET01109 | |
| 0.545 | 0.021 | 0.64 | Vasodilator, peripheral | 0.316 0.089 DBMET01015 0.427 0.047 DBMET00060 0.532 0.023 DBMET00061 0.532 0.023 DBMET00062 0.64 0.012 DBMET00063 0.55 0.021 DBMET00064 0.413 0.051 DBMET00065 0.399 0.055 DBMET00066 0.399 0.055 DBMET00067 0.405 0.054 DBMET01106 0.621 0.014 DBMET01109 0.465 0.036 DBMET01110 0.626 0.013 DBMET01107 0.512 0.026 DBMET01108 | DBMET00063 | |
| 0.528 | 0.013 | 0.711 | Hypoglycemic | 0.423 0.024 DBMET00060 0.491 0.016 DBMET00061 0.347 0.038 DBMET00062 0.518 0.014 DBMET00063 0.711 0.005 DBMET00064 0.61 0.008 DBMET00065 0.39 0.029 DBMET00066 0.39 0.029 DBMET00067 0.475 0.018 DBMET01106 0.552 0.011 DBMET01109 0.308 0.05 DBMET01110 0.428 0.023 DBMET01107 0.566 0.01 DBMET01108 | DBMET00064 | |
| 0.531 | 0.018 | 0.622 | GABA C receptor rho-3 antagonist | 0.568 0.012 DBMET00060 0.418 0.054 DBMET00061 0.363 0.079 DBMET00062 0.325 0.1 DBMET00063 0.556 0.013 DBMET00065 0.461 0.038 DBMET00066 0.461 0.038 DBMET00067 0.622 0.005 DBMET01106 0.47 0.035 DBMET01109 0.431 0.049 DBMET01110 0.395 0.064 DBMET01107 0.47 0.035 DBMET01108 | DBMET01106 | |
| 0.517 | 0.004 | 0.582 | Tyrosine 3 hydroxylase inhibitor | 0.374 0.011 DBMET00060 0.404 0.008 DBMET00061 0.362 0.013 DBMET00062 0.339 0.019 DBMET00063 0.452 0.005 DBMET00065 0.582 0.003 DBMET00066 0.582 0.003 DBMET00067 0.367 0.013 DBMET01106 0.506 0.004 DBMET01109 0.419 0.006 DBMET01110 0.391 0.009 DBMET01107 0.506 0.004 DBMET01108 | DBMET00067 | |
| 0.53 | 0.025 | 0.743 | Antithrombotic | 0.435 0.041 DBMET01015 0.469 0.034 DBMET00060 0.54 0.024 DBMET00061 0.548 0.023 DBMET00062 0.631 0.013 DBMET00063 0.743 0.006 DBMET00064 0.616 0.015 DBMET00065 0.448 0.038 DBMET00066 0.448 0.038 DBMET00067 0.542 0.023 DBMET01106 0.591 0.017 DBMET01109 0.515 0.027 DBMET01110 0.544 0.023 DBMET01107 0.577 0.019 DBMET01108 | DBMET00064 | |
| 0.52 | 0.028 | 0.644 | Immunosuppressant | 0.434 0.052 DBMET01015 0.644 0.008 DBMET00060 0.535 0.024 DBMET00061 0.512 0.03 DBMET00062 0.527 0.026 DBMET00063 0.633 0.009 DBMET00064 0.359 0.082 DBMET00065 0.589 0.014 DBMET00066 0.589 0.014 DBMET00067 0.536 0.024 DBMET01106 0.533 0.025 DBMET01109 0.546 0.021 DBMET01110 0.608 0.012 DBMET01107 0.557 0.019 DBMET01108 | DBMET00060 | |
| 0.472 | 0.005 | 0.522 | Protein kinase stimulant | 0.482 0.004 DBMET00060 0.512 0.004 DBMET00061 0.345 0.012 DBMET00062 0.396 0.008 DBMET00063 0.522 0.004 DBMET00064 0.303 0.016 DBMET00065 0.434 0.006 DBMET00066 0.434 0.006 DBMET00067 0.214 0.037 DBMET01106 0.495 0.004 DBMET01109 0.32 0.014 DBMET01110 0.362 0.011 DBMET01107 0.498 0.004 DBMET01108 | DBMET00064 | |
| 0.468 | 0.001 | 0.542 | Glutamate (mGluR6) antagonist | 0.214 0.003 DBMET00060 0.329 0.002 DBMET00061 0.186 0.003 DBMET00062 0.213 0.003 DBMET00063 0.108 0.008 DBMET00064 0.126 0.005 DBMET00065 0.18 0.003 DBMET00066 0.18 0.003 DBMET00067 0.11 0.007 DBMET01106 0.542 0.001 DBMET01109 0.2 0.003 DBMET01110 0.233 0.002 DBMET01107 0.439 0.002 DBMET01108 | DBMET01109 | |
| 0.467 | 0.003 | 0.589 | GABA aminotransferase inhibitor | 0.517 0.002 DBMET00060 0.242 0.004 DBMET00061 0.181 0.005 DBMET00062 0.211 0.004 DBMET00063 0.286 0.004 DBMET00064 0.171 0.005 DBMET00065 0.194 0.004 DBMET00066 0.194 0.004 DBMET00067 0.24 0.004 DBMET01106 0.57 0.002 DBMET01109 0.175 0.005 DBMET01110 0.202 0.004 DBMET01107 0.589 0.002 DBMET01108 | DBMET01108 | |
| 0.462 | 0.003 | 0.96 | Macrophage elastase inhibitor | 0.311 0.004 DBMET00060 0.235 0.004 DBMET00061 0.96 0.001 DBMET00062 0.258 0.004 DBMET00063 0.042 0.031 DBMET00064 0.079 0.012 DBMET00066 0.079 0.012 DBMET00067 0.513 0.003 DBMET01109 0.095 0.01 DBMET01110 0.197 0.005 DBMET01107 0.603 0.003 DBMET01108 | DBMET00062 | |
| 0.459 | 0.003 | 0.459 | Ferrochelatase inhibitor | 0.384 0.004 DBMET00060 0.314 0.006 DBMET00061 0.341 0.005 DBMET00062 0.311 0.007 DBMET00063 0.429 0.003 DBMET00065 0.344 0.005 DBMET00066 0.344 0.005 DBMET00067 0.44 0.003 DBMET01106 0.455 0.003 DBMET01109 0.343 0.005 DBMET01110 0.314 0.006 DBMET01107 0.455 0.003 DBMET01108 | ||
| 0.459 | 0.006 | 0.494 | 5 Hydroxytryptamine uptake stimulant | 0.375 0.019 DBMET00060 0.32 0.036 DBMET00061 0.346 0.027 DBMET00062 0.316 0.037 DBMET00063 0.406 0.013 DBMET00065 0.343 0.028 DBMET00066 0.343 0.028 DBMET00067 0.408 0.013 DBMET01106 0.494 0.005 DBMET01109 0.374 0.019 DBMET01110 0.343 0.028 DBMET01107 0.444 0.008 DBMET01108 | DBMET01109 | |
| 0.464 | 0.025 | 0.623 | Apoptosis antagonist | 0.362 0.051 DBMET00060 0.395 0.04 DBMET00061 0.327 0.068 DBMET00062 0.347 0.057 DBMET00063 0.623 0.007 DBMET00064 0.6 0.01 DBMET00065 0.503 0.02 DBMET00066 0.503 0.02 DBMET00067 0.375 0.046 DBMET01106 0.582 0.012 DBMET01109 0.37 0.048 DBMET01110 0.521 0.018 DBMET01107 0.484 0.023 DBMET01108 | DBMET00064 | |
| 0.458 | 0.035 | 0.703 | Immunostimulant | 0.703 0.008 DBMET01015 0.488 0.03 DBMET00060 0.501 0.029 DBMET00061 0.409 0.047 DBMET00062 0.527 0.025 DBMET00063 0.701 0.008 DBMET00064 0.4 0.049 DBMET00065 0.437 0.04 DBMET00066 0.437 0.04 DBMET00067 0.389 0.053 DBMET01106 0.493 0.03 DBMET01109 0.361 0.061 DBMET01110 0.465 0.034 DBMET01107 0.491 0.03 DBMET01108 | DBMET01015 | |
| 0.452 | 0.03 | 0.622 | Spasmolytic | 0.318 0.063 DBMET00060 0.492 0.024 DBMET00061 0.327 0.06 DBMET00062 0.498 0.023 DBMET00063 0.622 0.011 DBMET00064 0.331 0.059 DBMET00065 0.373 0.046 DBMET00066 0.373 0.046 DBMET00067 0.174 0.142 DBMET01106 0.459 0.029 DBMET01109 0.284 0.076 DBMET01110 0.395 0.041 DBMET01107 0.478 0.026 DBMET01108 | DBMET00064 | |
| 0.421 | 0.003 | 0.928 | Phosphofructokinase-1 inhibitor | 0.928 0 DBMET01015 0.36 0.004 DBMET00060 0.405 0.003 DBMET00061 0.505 0.002 DBMET00062 0.402 0.003 DBMET00063 0.495 0.002 DBMET00064 0.343 0.004 DBMET00065 0.335 0.004 DBMET00066 0.335 0.004 DBMET00067 0.344 0.004 DBMET01106 0.483 0.002 DBMET01109 0.376 0.004 DBMET01110 0.35 0.004 DBMET01107 0.487 0.002 DBMET01108 | DBMET01015 | |
| 0.417 | 0.009 | 0.591 | Phospholipase C inhibitor | 0.306 0.018 DBMET01015 0.382 0.012 DBMET00060 0.444 0.008 DBMET00061 0.361 0.013 DBMET00062 0.304 0.018 DBMET00063 0.298 0.018 DBMET00064 0.459 0.007 DBMET00065 0.273 0.021 DBMET00066 0.273 0.021 DBMET00067 0.591 0.004 DBMET01106 0.468 0.007 DBMET01109 0.301 0.018 DBMET01110 0.253 0.024 DBMET01107 0.386 0.011 DBMET01108 | DBMET01106 | |
| 0.41 | 0.014 | 0.445 | Sodium/bile acid cotransporter inhibitor | 0.419 0.012 DBMET00060 0.384 0.022 DBMET00061 0.39 0.02 DBMET00062 0.379 0.024 DBMET00063 0.294 0.085 DBMET00064 0.369 0.029 DBMET00065 0.445 0.008 DBMET00066 0.445 0.008 DBMET00067 0.325 0.058 DBMET01106 0.425 0.011 DBMET01109 0.372 0.028 DBMET01110 0.359 0.034 DBMET01107 0.407 0.015 DBMET01108 | DBMET00067 | |
| 0.418 | 0.022 | 0.566 | Interleukin 2 agonist | 0.515 0.006 DBMET00060 0.428 0.02 DBMET00061 0.388 0.031 DBMET00062 0.37 0.037 DBMET00063 0.556 0.004 DBMET00064 0.359 0.042 DBMET00065 0.566 0.004 DBMET00066 0.566 0.004 DBMET00067 0.304 0.071 DBMET01106 0.457 0.014 DBMET01109 0.351 0.045 DBMET01110 0.334 0.053 DBMET01107 0.426 0.021 DBMET01108 | DBMET00067 | |
| 0.393 | 0.004 | 0.551 | Glutamate dehydrogenase inhibitor | 0.551 0.003 DBMET01015 0.295 0.006 DBMET00060 0.238 0.008 DBMET00061 0.484 0.003 DBMET00062 0.339 0.005 DBMET00063 0.141 0.017 DBMET00064 0.218 0.009 DBMET00065 0.261 0.007 DBMET00066 0.261 0.007 DBMET00067 0.215 0.009 DBMET01106 0.482 0.003 DBMET01109 0.331 0.005 DBMET01110 0.378 0.004 DBMET01107 0.485 0.003 DBMET01108 | DBMET01015 | |
| 0.386 | 0.003 | 0.387 | Argininosuccinate synthase inhibitor | 0.319 0.004 DBMET01015 0.231 0.006 DBMET00060 0.284 0.004 DBMET00061 0.292 0.004 DBMET00062 0.269 0.005 DBMET00063 0.198 0.008 DBMET00064 0.229 0.006 DBMET00065 0.278 0.004 DBMET00066 0.278 0.004 DBMET00067 0.162 0.01 DBMET01106 0.381 0.003 DBMET01109 0.361 0.003 DBMET01110 0.387 0.003 DBMET01107 0.381 0.003 DBMET01108 | DBMET01107 | |
| 0.442 | 0.06 | 0.7 | Antibacterial | 0.36 0.096 DBMET01015 0.481 0.046 DBMET00060 0.414 0.07 DBMET00061 0.51 0.038 DBMET00062 0.441 0.06 DBMET00063 0.7 0.009 DBMET00064 0.462 0.053 DBMET00065 0.479 0.047 DBMET00066 0.479 0.047 DBMET00067 0.486 0.045 DBMET01106 0.422 0.067 DBMET01109 0.395 0.079 DBMET01110 0.45 0.057 DBMET01107 0.457 0.054 DBMET01108 | DBMET00064 | |
| 0.377 | 0.004 | 0.417 | Catalase inhibitor | 0.23 0.011 DBMET00060 0.395 0.004 DBMET00061 0.353 0.004 DBMET00062 0.37 0.004 DBMET00063 0.092 0.041 DBMET00064 0.245 0.009 DBMET00065 0.279 0.007 DBMET00066 0.279 0.007 DBMET00067 0.185 0.018 DBMET01106 0.417 0.003 DBMET01109 0.344 0.005 DBMET01110 0.373 0.004 DBMET01107 0.374 0.004 DBMET01108 | DBMET01109 | |
| 0.368 | 0.005 | 0.414 | Neurotrophic factor | 0.414 0.005 DBMET00060 0.411 0.005 DBMET00061 0.128 0.083 DBMET00062 0.227 0.017 DBMET00063 0.198 0.029 DBMET00064 0.196 0.029 DBMET00065 0.192 0.031 DBMET00066 0.192 0.031 DBMET00067 0.162 0.049 DBMET01106 0.323 0.007 DBMET01109 0.276 0.009 DBMET01110 0.293 0.008 DBMET01107 0.367 0.005 DBMET01108 | DBMET00060 | |
| 0.365 | 0.008 | 0.396 | Gastrin inhibitor | 0.351 0.01 DBMET00060 0.379 0.006 DBMET00061 0.341 0.013 DBMET00062 0.324 0.019 DBMET00063 0.298 0.034 DBMET00064 0.358 0.009 DBMET00065 0.318 0.022 DBMET00066 0.318 0.022 DBMET00067 0.308 0.028 DBMET01106 0.396 0.005 DBMET01109 0.335 0.015 DBMET01110 0.317 0.023 DBMET01107 0.359 0.009 DBMET01108 | DBMET01109 | |
| 0.369 | 0.024 | 0.506 | Interleukin agonist | 0.305 0.045 DBMET00060 0.362 0.026 DBMET00061 0.334 0.034 DBMET00062 0.351 0.029 DBMET00063 0.506 0.008 DBMET00064 0.314 0.041 DBMET00065 0.396 0.019 DBMET00066 0.396 0.019 DBMET00067 0.253 0.076 DBMET01106 0.403 0.018 DBMET01109 0.278 0.06 DBMET01110 0.25 0.079 DBMET01107 0.355 0.028 DBMET01108 | DBMET00064 | |
| 0.339 | 0.002 | 0.339 | Glutamate (mGluR3) antagonist | 0.109 0.004 DBMET00060 0.305 0.003 DBMET00061 0.132 0.004 DBMET00062 0.254 0.003 DBMET00063 0.043 0.018 DBMET00064 0.053 0.011 DBMET00065 0.11 0.004 DBMET00066 0.11 0.004 DBMET00067 0.325 0.002 DBMET01109 0.142 0.004 DBMET01110 0.216 0.003 DBMET01107 0.312 0.002 DBMET01108 | ||
| 0.345 | 0.008 | 0.475 | Cell wall synthesis inhibitor | 0.358 0.008 DBMET00060 0.311 0.009 DBMET00061 0.251 0.015 DBMET00062 0.275 0.012 DBMET00063 0.475 0.004 DBMET00064 0.267 0.013 DBMET00065 0.303 0.01 DBMET00066 0.303 0.01 DBMET00067 0.219 0.023 DBMET01106 0.351 0.008 DBMET01109 0.26 0.014 DBMET01110 0.255 0.015 DBMET01107 0.348 0.008 DBMET01108 | DBMET00064 | |
| 0.399 | 0.064 | 0.824 | Transcription factor NF kappa B inhibitor | 0.436 0.056 DBMET00060 0.395 0.065 DBMET00061 0.345 0.078 DBMET00062 0.302 0.093 DBMET00063 0.824 0.011 DBMET00064 0.48 0.047 DBMET00065 0.454 0.052 DBMET00066 0.454 0.052 DBMET00067 0.424 0.058 DBMET01106 0.398 0.064 DBMET01109 0.269 0.114 DBMET01110 0.434 0.056 DBMET01107 0.415 0.06 DBMET01108 | DBMET00064 | |
| 0.335 | 0.002 | 0.335 | Kainate receptor 3 antagonist | 0.236 0.003 DBMET00060 0.165 0.003 DBMET00061 0.026 0.006 DBMET00062 0.127 0.003 DBMET00063 0.155 0.003 DBMET00065 0.031 0.005 DBMET00066 0.031 0.005 DBMET00067 0.109 0.004 DBMET01106 0.283 0.002 DBMET01109 0.031 0.005 DBMET01110 0.15 0.003 DBMET01107 0.263 0.002 DBMET01108 | ||
| 0.333 | 0.005 | 0.478 | Porphobilinogen synthase inhibitor | 0.206 0.011 DBMET00060 0.171 0.016 DBMET00061 0.152 0.02 DBMET00062 0.126 0.027 DBMET00063 0.285 0.006 DBMET00065 0.18 0.015 DBMET00066 0.18 0.015 DBMET00067 0.279 0.006 DBMET01106 0.44 0.004 DBMET01109 0.292 0.005 DBMET01110 0.478 0.004 DBMET01107 0.326 0.005 DBMET01108 | DBMET01107 | |
| 0.356 | 0.029 | 0.731 | DNA synthesis inhibitor | 0.731 0.004 DBMET01015 0.305 0.042 DBMET00060 0.376 0.025 DBMET00061 0.365 0.027 DBMET00062 0.327 0.035 DBMET00063 0.486 0.014 DBMET00064 0.304 0.042 DBMET00065 0.396 0.022 DBMET00066 0.396 0.022 DBMET00067 0.261 0.06 DBMET01106 0.374 0.025 DBMET01109 0.398 0.022 DBMET01110 0.345 0.031 DBMET01107 0.378 0.025 DBMET01108 | DBMET01015 | |
| 0.331 | 0.005 | 0.879 | Adenylate kinase inhibitor | 0.879 0 DBMET01015 0.289 0.007 DBMET00060 0.301 0.007 DBMET00061 0.323 0.006 DBMET00062 0.301 0.007 DBMET00063 0.212 0.013 DBMET00064 0.311 0.006 DBMET00065 0.26 0.009 DBMET00066 0.26 0.009 DBMET00067 0.314 0.006 DBMET01106 0.357 0.004 DBMET01109 0.303 0.007 DBMET01110 0.325 0.005 DBMET01107 0.323 0.006 DBMET01108 | DBMET01015 | |
| 0.324 | 0.004 | 0.324 | Peroxisome proliferator-activated receptor gamma agonist | 0.186 0.008 DBMET00060 0.254 0.005 DBMET00061 0.272 0.005 DBMET00062 0.233 0.005 DBMET00063 0.314 0.004 DBMET00065 0.257 0.005 DBMET00066 0.257 0.005 DBMET00067 0.186 0.008 DBMET01106 0.316 0.004 DBMET01109 0.184 0.008 DBMET01110 0.193 0.007 DBMET01107 0.269 0.005 DBMET01108 | ||
| 0.325 | 0.012 | 0.37 | Insulin sensitizer | 0.284 0.02 DBMET00060 0.317 0.013 DBMET00061 0.323 0.012 DBMET00062 0.346 0.009 DBMET00063 0.246 0.037 DBMET00064 0.37 0.008 DBMET00065 0.337 0.01 DBMET00066 0.337 0.01 DBMET00067 0.285 0.019 DBMET01106 0.358 0.009 DBMET01109 0.26 0.029 DBMET01110 0.241 0.04 DBMET01107 0.307 0.014 DBMET01108 | DBMET00065 | |
| 0.307 | 0.003 | 0.457 | Fumarate hydratase inhibitor | 0.201 0.003 DBMET01015 0.124 0.004 DBMET00060 0.12 0.004 DBMET00061 0.457 0.002 DBMET00062 0.268 0.003 DBMET00063 0.065 0.009 DBMET00064 0.356 0.002 DBMET00065 0.187 0.003 DBMET00066 0.187 0.003 DBMET00067 0.179 0.003 DBMET01106 0.424 0.002 DBMET01109 0.216 0.003 DBMET01110 0.275 0.003 DBMET01107 0.429 0.002 DBMET01108 | DBMET00062 | |
| 0.304 | 0.004 | 0.337 | GABA C receptor antagonist | 0.296 0.004 DBMET00060 0.203 0.012 DBMET00061 0.233 0.008 DBMET00062 0.207 0.011 DBMET00063 0.281 0.005 DBMET00065 0.219 0.01 DBMET00066 0.219 0.01 DBMET00067 0.337 0.004 DBMET01106 0.239 0.007 DBMET01109 0.2 0.013 DBMET01110 0.178 0.018 DBMET01107 0.239 0.007 DBMET01108 | DBMET01106 | |
| 0.301 | 0.005 | 0.394 | Triose-phosphate isomerase inhibitor | 0.206 0.01 DBMET00060 0.291 0.005 DBMET00061 0.303 0.005 DBMET00062 0.268 0.006 DBMET00063 0.394 0.003 DBMET00064 0.244 0.007 DBMET00065 0.179 0.014 DBMET00066 0.179 0.014 DBMET00067 0.248 0.007 DBMET01106 0.361 0.004 DBMET01109 0.26 0.006 DBMET01110 0.228 0.008 DBMET01107 0.295 0.005 DBMET01108 | DBMET00064 | |
| 0.304 | 0.012 | 0.555 | Insulin secretagoues | 0.166 0.059 DBMET00060 0.289 0.014 DBMET00061 0.301 0.012 DBMET00062 0.555 0.004 DBMET00063 0.271 0.016 DBMET00064 0.438 0.005 DBMET00065 0.169 0.057 DBMET00066 0.169 0.057 DBMET00067 0.222 0.026 DBMET01106 0.372 0.007 DBMET01109 0.179 0.049 DBMET01110 0.142 0.082 DBMET01107 0.302 0.012 DBMET01108 | DBMET00063 | |
| 0.296 | 0.009 | 0.312 | Aminopeptidase B inhibitor | 0.205 0.02 DBMET00060 0.285 0.01 DBMET00061 0.28 0.01 DBMET00062 0.264 0.011 DBMET00063 0.082 0.08 DBMET00064 0.2 0.021 DBMET00065 0.232 0.015 DBMET00066 0.232 0.015 DBMET00067 0.162 0.033 DBMET01106 0.279 0.01 DBMET01109 0.272 0.011 DBMET01110 0.288 0.009 DBMET01107 0.312 0.008 DBMET01108 | DBMET01108 | |
| 0.298 | 0.012 | 0.329 | Cholesterol synthesis inhibitor | 0.302 0.011 DBMET00060 0.292 0.012 DBMET00061 0.285 0.013 DBMET00062 0.287 0.013 DBMET00063 0.267 0.015 DBMET00064 0.329 0.009 DBMET00065 0.23 0.021 DBMET00066 0.23 0.021 DBMET00067 0.285 0.013 DBMET01106 0.301 0.011 DBMET01109 0.252 0.017 DBMET01110 0.223 0.022 DBMET01107 0.328 0.009 DBMET01108 | DBMET00065 | |
| 0.291 | 0.005 | 0.322 | Toll-Like receptor 2 antagonist | 0.301 0.005 DBMET00060 0.31 0.004 DBMET00061 0.274 0.006 DBMET00062 0.275 0.006 DBMET00063 0.156 0.048 DBMET00064 0.196 0.025 DBMET00065 0.235 0.012 DBMET00066 0.235 0.012 DBMET00067 0.206 0.021 DBMET01106 0.322 0.004 DBMET01109 0.241 0.011 DBMET01110 0.226 0.014 DBMET01107 0.279 0.006 DBMET01108 | DBMET01109 | |
| 0.328 | 0.043 | 0.352 | Insulysin inhibitor | 0.293 0.063 DBMET00060 0.268 0.081 DBMET00061 0.276 0.075 DBMET00062 0.251 0.095 DBMET00063 0.276 0.075 DBMET00065 0.265 0.083 DBMET00066 0.265 0.083 DBMET00067 0.28 0.071 DBMET01106 0.352 0.033 DBMET01109 0.293 0.063 DBMET01110 0.307 0.054 DBMET01107 0.322 0.046 DBMET01108 | DBMET01109 | |
| 0.285 | 0.007 | 0.314 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.183 0.019 DBMET00060 0.2 0.016 DBMET00061 0.255 0.009 DBMET00062 0.279 0.007 DBMET00063 0.269 0.008 DBMET00064 0.212 0.014 DBMET00065 0.167 0.022 DBMET00066 0.167 0.022 DBMET00067 0.2 0.016 DBMET01106 0.314 0.005 DBMET01109 0.251 0.01 DBMET01110 0.221 0.013 DBMET01107 0.265 0.008 DBMET01108 | DBMET01109 | |
| 0.338 | 0.061 | 0.605 | Vasodilator, coronary | 0.41 0.032 DBMET01015 0.258 0.126 DBMET00060 0.389 0.039 DBMET00061 0.325 0.069 DBMET00062 0.332 0.065 DBMET00063 0.605 0.007 DBMET00064 0.265 0.119 DBMET00065 0.287 0.099 DBMET00066 0.287 0.099 DBMET00067 0.293 0.093 DBMET01106 0.315 0.076 DBMET01109 0.248 0.137 DBMET01110 0.209 0.174 DBMET01107 0.295 0.091 DBMET01108 | DBMET00064 | |
| 0.29 | 0.015 | 0.434 | Phospholipase A2 inhibitor | 0.224 0.032 DBMET00060 0.339 0.009 DBMET00061 0.226 0.031 DBMET00062 0.216 0.035 DBMET00063 0.255 0.022 DBMET00064 0.434 0.004 DBMET00065 0.33 0.01 DBMET00066 0.33 0.01 DBMET00067 0.331 0.01 DBMET01106 0.336 0.009 DBMET01109 0.259 0.021 DBMET01110 0.289 0.015 DBMET01107 0.312 0.012 DBMET01108 | DBMET00065 | |
| 0.283 | 0.011 | 0.422 | Cell adhesion inhibitor | 0.211 0.022 DBMET00060 0.201 0.024 DBMET00061 0.141 0.052 DBMET00062 0.127 0.06 DBMET00063 0.385 0.005 DBMET00064 0.171 0.035 DBMET00065 0.185 0.029 DBMET00066 0.185 0.029 DBMET00067 0.257 0.014 DBMET01106 0.348 0.007 DBMET01109 0.145 0.05 DBMET01110 0.144 0.05 DBMET01107 0.422 0.005 DBMET01108 | DBMET01108 | |
| 0.297 | 0.032 | 0.625 | RNA-directed DNA polymerase inhibitor | 0.625 0.004 DBMET01015 0.21 0.085 DBMET00060 0.242 0.054 DBMET00061 0.236 0.059 DBMET00062 0.243 0.054 DBMET00063 0.253 0.047 DBMET00064 0.23 0.064 DBMET00065 0.221 0.073 DBMET00066 0.221 0.073 DBMET00067 0.202 0.097 DBMET01106 0.27 0.04 DBMET01109 0.221 0.072 DBMET01110 0.204 0.094 DBMET01107 0.244 0.053 DBMET01108 | DBMET01015 | |
| 0.268 | 0.003 | 0.411 | Kainate receptor antagonist | 0.411 0.002 DBMET00060 0.166 0.004 DBMET00061 0.064 0.014 DBMET00062 0.084 0.009 DBMET00063 0.257 0.003 DBMET00065 0.284 0.003 DBMET00066 0.284 0.003 DBMET00067 0.215 0.004 DBMET01106 0.234 0.004 DBMET01109 0.093 0.008 DBMET01110 0.165 0.004 DBMET01107 0.216 0.004 DBMET01108 | DBMET00060 | |
| 0.267 | 0.002 | 0.491 | Kainate receptor 2 antagonist | 0.491 0.002 DBMET00060 0.164 0.003 DBMET00061 0.08 0.006 DBMET00062 0.095 0.005 DBMET00063 0.176 0.003 DBMET00065 0.303 0.002 DBMET00066 0.303 0.002 DBMET00067 0.156 0.003 DBMET01106 0.24 0.003 DBMET01109 0.1 0.005 DBMET01110 0.118 0.004 DBMET01107 0.21 0.003 DBMET01108 | DBMET00060 | |
| 0.286 | 0.022 | 0.433 | Interferon gamma antagonist | 0.253 0.028 DBMET00060 0.271 0.025 DBMET00061 0.261 0.026 DBMET00062 0.306 0.019 DBMET00063 0.433 0.009 DBMET00064 0.205 0.039 DBMET00065 0.341 0.015 DBMET00066 0.341 0.015 DBMET00067 0.261 0.026 DBMET01106 0.313 0.018 DBMET01109 0.213 0.036 DBMET01110 0.192 0.044 DBMET01107 0.273 0.024 DBMET01108 | DBMET00064 | |
| 0.288 | 0.025 | 0.368 | Diuretic | 0.163 0.067 DBMET00060 0.288 0.024 DBMET00061 0.185 0.051 DBMET00062 0.231 0.034 DBMET00063 0.295 0.023 DBMET00064 0.122 0.102 DBMET00065 0.297 0.023 DBMET00066 0.297 0.023 DBMET00067 0.316 0.02 DBMET01109 0.164 0.066 DBMET01110 0.237 0.033 DBMET01107 0.368 0.015 DBMET01108 | DBMET01108 | |
| 0.267 | 0.005 | 0.32 | Photosensitizer | 0.217 0.01 DBMET00060 0.302 0.004 DBMET00061 0.177 0.019 DBMET00062 0.159 0.026 DBMET00063 0.298 0.004 DBMET00064 0.185 0.016 DBMET00065 0.189 0.015 DBMET00066 0.189 0.015 DBMET00067 0.229 0.008 DBMET01106 0.316 0.004 DBMET01109 0.237 0.007 DBMET01110 0.213 0.01 DBMET01107 0.32 0.004 DBMET01108 | DBMET01108 | |
| 0.278 | 0.025 | 0.32 | Lipocortins synthesis antagonist | 0.174 0.077 DBMET00060 0.268 0.028 DBMET00061 0.211 0.05 DBMET00062 0.195 0.06 DBMET00063 0.182 0.069 DBMET00064 0.229 0.041 DBMET00065 0.204 0.054 DBMET00066 0.204 0.054 DBMET00067 0.179 0.072 DBMET01106 0.32 0.018 DBMET01109 0.286 0.024 DBMET01110 0.269 0.028 DBMET01107 0.278 0.025 DBMET01108 | DBMET01109 | |
| 0.257 | 0.004 | 0.259 | Arachidonic acid antagonist | 0.246 0.006 DBMET00060 0.258 0.004 DBMET00061 0.239 0.008 DBMET00062 0.238 0.009 DBMET00063 0.213 0.022 DBMET00064 0.259 0.004 DBMET00065 0.252 0.005 DBMET00066 0.252 0.005 DBMET00067 0.258 0.004 DBMET01106 0.259 0.004 DBMET01109 0.259 0.004 DBMET01110 0.252 0.005 DBMET01107 0.249 0.006 DBMET01108 | DBMET01110 | |
| 0.277 | 0.025 | 0.323 | Neurotrophic factor enhancer | 0.2 0.077 DBMET00060 0.272 0.028 DBMET00061 0.236 0.047 DBMET00062 0.232 0.05 DBMET00063 0.289 0.021 DBMET00064 0.323 0.013 DBMET00065 0.224 0.056 DBMET00066 0.224 0.056 DBMET00067 0.275 0.026 DBMET01106 0.256 0.035 DBMET01109 0.246 0.041 DBMET01110 0.258 0.034 DBMET01107 0.238 0.046 DBMET01108 | DBMET00065 | |
| 0.276 | 0.025 | 0.418 | Melanin inhibitor | 0.418 0.011 DBMET00060 0.212 0.036 DBMET00061 0.231 0.032 DBMET00062 0.223 0.033 DBMET00063 0.388 0.013 DBMET00064 0.284 0.024 DBMET00065 0.265 0.026 DBMET00066 0.265 0.026 DBMET00067 0.258 0.027 DBMET01106 0.278 0.025 DBMET01109 0.231 0.032 DBMET01110 0.331 0.018 DBMET01107 0.237 0.031 DBMET01108 | DBMET00060 | |
| 0.266 | 0.015 | 0.509 | DNA polymerase I inhibitor | 0.509 0.004 DBMET01015 0.16 0.044 DBMET00060 0.226 0.021 DBMET00061 0.211 0.025 DBMET00062 0.208 0.026 DBMET00063 0.282 0.013 DBMET00064 0.267 0.014 DBMET00065 0.273 0.014 DBMET00066 0.273 0.014 DBMET00067 0.21 0.025 DBMET01106 0.287 0.012 DBMET01109 0.227 0.021 DBMET01110 0.207 0.026 DBMET01107 0.25 0.017 DBMET01108 | DBMET01015 | |
| 0.255 | 0.005 | 0.481 | Ornithine carbamoyltransferase inhibitor | 0.481 0.003 DBMET01015 0.28 0.005 DBMET00060 0.354 0.004 DBMET00061 0.225 0.006 DBMET00062 0.197 0.007 DBMET00063 0.102 0.016 DBMET00064 0.163 0.009 DBMET00065 0.16 0.009 DBMET00066 0.16 0.009 DBMET00067 0.195 0.007 DBMET01106 0.196 0.007 DBMET01109 0.156 0.009 DBMET01110 0.137 0.011 DBMET01107 0.196 0.007 DBMET01108 | DBMET01015 | |
| 0.392 | 0.144 | 0.835 | Antiinflammatory | 0.616 0.049 DBMET00060 0.384 0.149 DBMET00061 0.38 0.152 DBMET00062 0.395 0.142 DBMET00063 0.832 0.011 DBMET00064 0.835 0.011 DBMET00065 0.422 0.126 DBMET00066 0.422 0.126 DBMET00067 0.724 0.027 DBMET01106 0.442 0.114 DBMET01109 0.525 0.078 DBMET01107 0.431 0.121 DBMET01108 | DBMET00065 | |
| 0.263 | 0.016 | 0.371 | Aldehyde dehydrogenase inhibitor | 0.367 0.007 DBMET01015 0.245 0.019 DBMET00060 0.371 0.006 DBMET00061 0.201 0.027 DBMET00062 0.219 0.024 DBMET00063 0.166 0.039 DBMET00064 0.213 0.025 DBMET00065 0.158 0.043 DBMET00066 0.158 0.043 DBMET00067 0.273 0.015 DBMET01106 0.301 0.012 DBMET01109 0.212 0.025 DBMET01110 0.243 0.019 DBMET01107 0.236 0.02 DBMET01108 | DBMET00061 | |
| 0.268 | 0.024 | 0.272 | Growth factor agonist | 0.272 0.023 DBMET00061 0.202 0.06 DBMET00063 0.176 0.092 DBMET00064 0.252 0.031 DBMET01109 0.224 0.045 DBMET01107 0.214 0.051 DBMET01108 | DBMET00061 | |
| 0.26 | 0.019 | 0.26 | Neurotensin receptor agonist | 0.195 0.037 DBMET00060 0.207 0.031 DBMET00061 0.185 0.045 DBMET00062 0.176 0.055 DBMET00063 0.18 0.05 DBMET00065 0.201 0.034 DBMET00066 0.201 0.034 DBMET00067 0.164 0.072 DBMET01106 0.252 0.021 DBMET01109 0.209 0.03 DBMET01110 0.195 0.037 DBMET01107 0.241 0.023 DBMET01108 | ||
| 0.244 | 0.006 | 0.244 | Creatine kinase inhibitor | 0.131 0.034 DBMET00060 0.214 0.009 DBMET00061 0.157 0.021 DBMET00062 0.141 0.028 DBMET00063 0.224 0.008 DBMET00065 0.163 0.019 DBMET00066 0.163 0.019 DBMET00067 0.164 0.019 DBMET01106 0.199 0.011 DBMET01109 0.185 0.013 DBMET01110 0.167 0.018 DBMET01107 0.199 0.011 DBMET01108 | ||
| 0.26 | 0.023 | 0.338 | Bone formation stimulant | 0.12 0.085 DBMET00060 0.338 0.014 DBMET00061 0.211 0.033 DBMET00062 0.174 0.044 DBMET00063 0.153 0.057 DBMET00064 0.214 0.032 DBMET00065 0.176 0.043 DBMET00066 0.176 0.043 DBMET00067 0.113 0.092 DBMET01106 0.287 0.019 DBMET01109 0.237 0.027 DBMET01110 0.143 0.064 DBMET01107 0.268 0.021 DBMET01108 | DBMET00061 | |
| 0.29 | 0.053 | 0.835 | Angiogenesis stimulant | 0.23 0.079 DBMET00060 0.368 0.028 DBMET00061 0.221 0.084 DBMET00062 0.205 0.092 DBMET00063 0.835 0.003 DBMET00064 0.27 0.061 DBMET00065 0.202 0.093 DBMET00066 0.202 0.093 DBMET00067 0.209 0.09 DBMET01106 0.361 0.029 DBMET01109 0.185 0.102 DBMET01110 0.149 0.123 DBMET01107 0.3 0.049 DBMET01108 | DBMET00064 | |
| 0.313 | 0.079 | 0.313 | Calcium channel activator | 0.221 0.183 DBMET00060 0.278 0.115 DBMET00061 0.23 0.171 DBMET00062 0.244 0.154 DBMET00063 0.262 0.134 DBMET00065 0.208 0.201 DBMET00066 0.208 0.201 DBMET00067 0.243 0.155 DBMET01106 0.257 0.139 DBMET01109 0.231 0.171 DBMET01110 0.257 0.139 DBMET01108 | ||
| 0.26 | 0.028 | 0.625 | Protein-tyrosine phosphatase inhibitor | 0.244 0.032 DBMET00060 0.208 0.044 DBMET00061 0.257 0.029 DBMET00062 0.183 0.054 DBMET00063 0.159 0.07 DBMET00064 0.415 0.008 DBMET00065 0.625 0.004 DBMET00066 0.625 0.004 DBMET00067 0.301 0.019 DBMET01106 0.278 0.024 DBMET01109 0.218 0.04 DBMET01110 0.219 0.04 DBMET01107 0.252 0.03 DBMET01108 | DBMET00067 | |
| 0.235 | 0.003 | 0.245 | Glycine receptor agonist | 0.192 0.004 DBMET00060 0.239 0.003 DBMET00061 0.162 0.005 DBMET00062 0.143 0.008 DBMET00063 0.203 0.004 DBMET00064 0.22 0.004 DBMET00065 0.169 0.005 DBMET00066 0.169 0.005 DBMET00067 0.182 0.005 DBMET01106 0.245 0.003 DBMET01109 0.169 0.005 DBMET01110 0.149 0.007 DBMET01107 0.224 0.004 DBMET01108 | DBMET01109 | |
| 0.236 | 0.005 | 0.238 | Aminopeptidase I inhibitor | 0.147 0.013 DBMET00060 0.213 0.006 DBMET00061 0.238 0.005 DBMET00062 0.221 0.005 DBMET00063 0.066 0.059 DBMET00064 0.142 0.014 DBMET00065 0.172 0.009 DBMET00066 0.172 0.009 DBMET00067 0.11 0.023 DBMET01106 0.23 0.005 DBMET01109 0.21 0.006 DBMET01110 0.195 0.007 DBMET01107 0.23 0.005 DBMET01108 | DBMET00062 | |
| 0.23 | 0.003 | 0.39 | Kainate receptor 1 antagonist | 0.39 0.002 DBMET00060 0.099 0.004 DBMET00061 0.043 0.006 DBMET00062 0.06 0.005 DBMET00063 0.222 0.003 DBMET00065 0.257 0.002 DBMET00066 0.257 0.002 DBMET00067 0.169 0.003 DBMET01106 0.2 0.003 DBMET01109 0.052 0.005 DBMET01110 0.071 0.004 DBMET01107 0.178 0.003 DBMET01108 | DBMET00060 | |
| 0.322 | 0.097 | 0.756 | Toll-Like receptor agonist | 0.388 0.065 DBMET00061 0.756 0.006 DBMET00062 0.369 0.073 DBMET01109 0.388 0.065 DBMET01108 | DBMET00062 | |
| 0.231 | 0.006 | 0.576 | Carbamoyl phosphate synthetase inhibitor | 0.576 0.002 DBMET01015 0.115 0.017 DBMET00060 0.22 0.006 DBMET00061 0.231 0.006 DBMET00062 0.207 0.007 DBMET00063 0.099 0.021 DBMET00064 0.175 0.009 DBMET00065 0.143 0.012 DBMET00066 0.143 0.012 DBMET00067 0.128 0.014 DBMET01106 0.289 0.004 DBMET01109 0.199 0.007 DBMET01110 0.18 0.009 DBMET01107 0.23 0.006 DBMET01108 | DBMET01015 | |
| 0.229 | 0.005 | 0.251 | Prolactin inhibitor | 0.199 0.009 DBMET00060 0.172 0.015 DBMET00061 0.175 0.014 DBMET00062 0.157 0.019 DBMET00063 0.187 0.011 DBMET00065 0.18 0.013 DBMET00066 0.18 0.013 DBMET00067 0.187 0.011 DBMET01106 0.251 0.004 DBMET01109 0.172 0.015 DBMET01110 0.154 0.02 DBMET01107 0.218 0.006 DBMET01108 | DBMET01109 | |
| 0.228 | 0.005 | 0.228 | CDC25A inhibitor | 0.173 0.009 DBMET00060 0.186 0.008 DBMET00061 0.156 0.012 DBMET00062 0.136 0.015 DBMET00063 0.08 0.043 DBMET00064 0.183 0.008 DBMET00065 0.198 0.007 DBMET00066 0.198 0.007 DBMET00067 0.103 0.026 DBMET01106 0.228 0.005 DBMET01109 0.167 0.01 DBMET01110 0.146 0.013 DBMET01107 0.21 0.006 DBMET01108 | ||
| 0.226 | 0.004 | 0.261 | NMDA receptor agonist | 0.143 0.009 DBMET00060 0.156 0.007 DBMET00061 0.089 0.024 DBMET00062 0.117 0.014 DBMET00063 0.101 0.019 DBMET00065 0.183 0.005 DBMET00066 0.183 0.005 DBMET00067 0.06 0.047 DBMET01106 0.261 0.004 DBMET01109 0.107 0.017 DBMET01110 0.123 0.013 DBMET01107 0.214 0.004 DBMET01108 | DBMET01109 | |
| 0.224 | 0.004 | 0.623 | Acyl-CoA dehydrogenase inhibitor | 0.623 0 DBMET01015 0.19 0.006 DBMET00060 0.194 0.005 DBMET00061 0.223 0.004 DBMET00062 0.211 0.005 DBMET00063 0.115 0.013 DBMET00064 0.213 0.004 DBMET00065 0.232 0.004 DBMET00066 0.232 0.004 DBMET00067 0.208 0.005 DBMET01106 0.198 0.005 DBMET01109 0.191 0.006 DBMET01110 0.175 0.007 DBMET01107 0.198 0.005 DBMET01108 | DBMET01015 | |
| 0.22 | 0.001 | 0.396 | Kainate receptor agonist | 0.396 0.001 DBMET00060 0.118 0.002 DBMET00061 0.102 0.003 DBMET00062 0.113 0.002 DBMET00063 0.059 0.008 DBMET00064 0.204 0.001 DBMET00065 0.268 0.001 DBMET00066 0.268 0.001 DBMET00067 0.265 0.001 DBMET01106 0.166 0.002 DBMET01109 0.111 0.003 DBMET01110 0.125 0.002 DBMET01107 0.166 0.002 DBMET01108 | DBMET00060 | |
| 0.259 | 0.041 | 0.584 | Hepatoprotectant | 0.269 0.038 DBMET00060 0.237 0.047 DBMET00061 0.242 0.045 DBMET00062 0.311 0.027 DBMET00063 0.584 0.005 DBMET00064 0.338 0.021 DBMET00065 0.307 0.028 DBMET00066 0.307 0.028 DBMET00067 0.287 0.033 DBMET01106 0.289 0.033 DBMET01109 0.217 0.056 DBMET01110 0.327 0.023 DBMET01107 0.276 0.036 DBMET01108 | DBMET00064 | |
| 0.359 | 0.141 | 0.359 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.315 0.193 DBMET00065 0.303 0.208 DBMET01109 0.303 0.208 DBMET01108 | ||
| 0.222 | 0.005 | 0.273 | GABA C receptor rho-1 antagonist | 0.227 0.005 DBMET00060 0.149 0.022 DBMET00061 0.184 0.011 DBMET00062 0.165 0.016 DBMET00063 0.231 0.005 DBMET00065 0.17 0.014 DBMET00066 0.17 0.014 DBMET00067 0.273 0.004 DBMET01106 0.18 0.012 DBMET01109 0.152 0.021 DBMET01110 0.136 0.029 DBMET01107 0.18 0.012 DBMET01108 | DBMET01106 | |
| 0.216 | 0.001 | 0.248 | Glucose-6-phosphate isomerase inhibitor | 0.146 0.003 DBMET00060 0.219 0.001 DBMET00061 0.227 0.001 DBMET00062 0.209 0.001 DBMET00063 0.224 0.001 DBMET00064 0.13 0.003 DBMET00065 0.171 0.002 DBMET00066 0.171 0.002 DBMET00067 0.104 0.004 DBMET01106 0.248 0.001 DBMET01109 0.198 0.002 DBMET01110 0.183 0.002 DBMET01107 0.215 0.001 DBMET01108 | DBMET01109 | |
| 0.219 | 0.005 | 0.221 | Sphingosine 1-phosphate receptor 5 antagonist | 0.159 0.048 DBMET00060 0.221 0.005 DBMET00061 0.18 0.024 DBMET00062 0.174 0.03 DBMET00063 0.184 0.02 DBMET00065 0.182 0.022 DBMET00066 0.182 0.022 DBMET00067 0.148 0.064 DBMET01106 0.2 0.011 DBMET01109 0.193 0.015 DBMET01110 0.182 0.022 DBMET01107 0.2 0.011 DBMET01108 | DBMET00061 | |
| 0.218 | 0.008 | 0.23 | Adenylate cyclase stimulant | 0.225 0.006 DBMET00060 0.205 0.011 DBMET00061 0.203 0.012 DBMET00062 0.193 0.017 DBMET00063 0.173 0.032 DBMET00064 0.195 0.016 DBMET00065 0.21 0.01 DBMET00066 0.21 0.01 DBMET00067 0.22 0.007 DBMET01106 0.23 0.005 DBMET01109 0.188 0.02 DBMET01110 0.179 0.027 DBMET01107 0.212 0.009 DBMET01108 | DBMET01109 | |
| 0.217 | 0.007 | 0.241 | Thioredoxin inhibitor | 0.162 0.014 DBMET00060 0.171 0.012 DBMET00061 0.117 0.033 DBMET00063 0.169 0.012 DBMET00064 0.135 0.023 DBMET00065 0.087 0.066 DBMET00066 0.087 0.066 DBMET00067 0.114 0.035 DBMET01106 0.241 0.005 DBMET01109 0.107 0.041 DBMET01110 0.202 0.008 DBMET01107 0.192 0.009 DBMET01108 | DBMET01109 | |
| 0.251 | 0.042 | 0.383 | Non-steroidal antiinflammatory agent | 0.246 0.044 DBMET00060 0.271 0.035 DBMET00061 0.22 0.057 DBMET00062 0.231 0.051 DBMET00063 0.383 0.015 DBMET00064 0.334 0.022 DBMET00065 0.315 0.025 DBMET00066 0.315 0.025 DBMET00067 0.189 0.08 DBMET01106 0.275 0.034 DBMET01109 0.18 0.087 DBMET01110 0.267 0.036 DBMET01107 0.286 0.031 DBMET01108 | DBMET00064 | |
| 0.25 | 0.043 | 0.491 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.491 0.004 DBMET01015 0.188 0.083 DBMET00061 0.176 0.098 DBMET00062 0.178 0.095 DBMET00063 0.183 0.089 DBMET00064 0.211 0.064 DBMET00065 0.168 0.112 DBMET00066 0.168 0.112 DBMET00067 0.153 0.142 DBMET01106 0.251 0.042 DBMET01109 0.221 0.057 DBMET01110 0.195 0.076 DBMET01107 0.216 0.06 DBMET01108 | DBMET01015 | |
| 0.209 | 0.003 | 0.222 | Ca2+-transporting ATPase inhibitor | 0.186 0.005 DBMET00060 0.2 0.004 DBMET00061 0.19 0.004 DBMET00062 0.185 0.005 DBMET00063 0.222 0.002 DBMET00064 0.206 0.003 DBMET00065 0.208 0.003 DBMET00066 0.208 0.003 DBMET00067 0.189 0.004 DBMET01106 0.209 0.003 DBMET01109 0.189 0.005 DBMET01110 0.184 0.005 DBMET01107 0.198 0.004 DBMET01108 | DBMET00064 | |
| 0.212 | 0.007 | 0.244 | Carbonic anhydrase stimulant | 0.095 0.02 DBMET00060 0.12 0.014 DBMET00061 0.106 0.017 DBMET00062 0.12 0.014 DBMET00063 0.081 0.025 DBMET00065 0.096 0.02 DBMET00066 0.096 0.02 DBMET00067 0.055 0.047 DBMET01106 0.196 0.008 DBMET01109 0.103 0.018 DBMET01110 0.117 0.015 DBMET01107 0.244 0.005 DBMET01108 | DBMET01108 | |
| 0.237 | 0.032 | 0.451 | Amylase inhibitor | 0.149 0.064 DBMET00060 0.252 0.027 DBMET00061 0.231 0.034 DBMET00062 0.3 0.018 DBMET00063 0.451 0.007 DBMET00064 0.4 0.009 DBMET00065 0.15 0.064 DBMET00066 0.15 0.064 DBMET00067 0.292 0.019 DBMET01106 0.231 0.034 DBMET01109 0.168 0.056 DBMET01110 0.135 0.072 DBMET01107 0.21 0.041 DBMET01108 | DBMET00064 | |
| 0.212 | 0.009 | 0.309 | Vanilloid 1 agonist | 0.214 0.009 DBMET00060 0.254 0.005 DBMET00061 0.182 0.018 DBMET00062 0.17 0.023 DBMET00063 0.189 0.015 DBMET00064 0.182 0.018 DBMET00065 0.309 0.004 DBMET00066 0.309 0.004 DBMET00067 0.18 0.018 DBMET01106 0.229 0.007 DBMET01109 0.196 0.013 DBMET01110 0.183 0.017 DBMET01107 0.201 0.012 DBMET01108 | DBMET00067 | |
| 0.213 | 0.011 | 0.231 | Mucolytic | 0.166 0.024 DBMET00060 0.231 0.008 DBMET00061 0.202 0.013 DBMET00062 0.193 0.015 DBMET00063 0.188 0.016 DBMET00064 0.149 0.033 DBMET00065 0.157 0.029 DBMET00066 0.157 0.029 DBMET00067 0.144 0.036 DBMET01106 0.225 0.009 DBMET01109 0.183 0.018 DBMET01110 0.167 0.024 DBMET01107 0.199 0.014 DBMET01108 | DBMET00061 | |
| 0.242 | 0.043 | 0.242 | Dual specificity phosphatase 3 inhibitor | 0.135 0.11 DBMET00061 0.164 0.085 DBMET00062 0.156 0.091 DBMET00063 0.158 0.089 DBMET00065 0.217 0.052 DBMET01109 0.126 0.121 DBMET01110 0.19 0.067 DBMET01108 | ||
| 0.207 | 0.007 | 0.209 | Electrolyte absorption antagonist | 0.181 0.011 DBMET00060 0.152 0.018 DBMET00061 0.177 0.012 DBMET00062 0.158 0.017 DBMET00063 0.18 0.011 DBMET00065 0.139 0.024 DBMET00066 0.139 0.024 DBMET00067 0.209 0.007 DBMET01106 0.205 0.008 DBMET01109 0.14 0.024 DBMET01110 0.124 0.033 DBMET01107 0.181 0.011 DBMET01108 | DBMET01106 | |
| 0.203 | 0.007 | 0.247 | Glutamate decarboxylase inhibitor | 0.154 0.012 DBMET00060 0.159 0.011 DBMET00061 0.186 0.008 DBMET00062 0.166 0.01 DBMET00063 0.24 0.005 DBMET00065 0.142 0.015 DBMET00066 0.142 0.015 DBMET00067 0.234 0.005 DBMET01106 0.247 0.004 DBMET01109 0.183 0.008 DBMET01110 0.164 0.011 DBMET01107 0.202 0.007 DBMET01108 | DBMET01109 | |
| 0.237 | 0.041 | 0.237 | Dual specificity phosphatase inhibitor | 0.147 0.097 DBMET00061 0.154 0.09 DBMET00062 0.146 0.099 DBMET00063 0.164 0.08 DBMET00065 0.229 0.043 DBMET01109 0.132 0.118 DBMET01110 0.192 0.059 DBMET01108 | ||
| 0.204 | 0.009 | 0.366 | Cell adhesion molecule inhibitor | 0.074 0.063 DBMET00060 0.137 0.018 DBMET00061 0.089 0.043 DBMET00062 0.081 0.052 DBMET00063 0.242 0.007 DBMET00064 0.115 0.026 DBMET00065 0.127 0.021 DBMET00066 0.127 0.021 DBMET00067 0.269 0.005 DBMET01109 0.086 0.046 DBMET01110 0.079 0.055 DBMET01107 0.366 0.005 DBMET01108 | DBMET01108 | |
| 0.219 | 0.024 | 0.631 | Protein-tyrosine phosphatase 1B inhibitor | 0.227 0.022 DBMET00060 0.173 0.037 DBMET00061 0.199 0.029 DBMET00062 0.167 0.039 DBMET00063 0.159 0.042 DBMET00064 0.38 0.006 DBMET00065 0.631 0.004 DBMET00066 0.631 0.004 DBMET00067 0.273 0.013 DBMET01106 0.23 0.021 DBMET01109 0.14 0.05 DBMET01110 0.189 0.032 DBMET01107 0.216 0.025 DBMET01108 | DBMET00067 | |
| 0.202 | 0.007 | 0.203 | Sphingosine 1-phosphate receptor 2 antagonist | 0.15 0.041 DBMET00060 0.202 0.007 DBMET00061 0.166 0.024 DBMET00062 0.159 0.031 DBMET00063 0.164 0.026 DBMET00065 0.16 0.03 DBMET00066 0.16 0.03 DBMET00067 0.142 0.052 DBMET01106 0.203 0.007 DBMET01109 0.172 0.02 DBMET01110 0.16 0.029 DBMET01107 0.19 0.01 DBMET01108 | DBMET01109 | |
| 0.216 | 0.022 | 0.276 | GABA C receptor rho-2 antagonist | 0.23 0.017 DBMET00060 0.164 0.057 DBMET00061 0.138 0.092 DBMET00062 0.125 0.116 DBMET00063 0.228 0.017 DBMET00065 0.174 0.047 DBMET00066 0.174 0.047 DBMET00067 0.276 0.008 DBMET01106 0.182 0.041 DBMET01109 0.161 0.06 DBMET01110 0.147 0.078 DBMET01107 0.182 0.041 DBMET01108 | DBMET01106 | |
| 0.24 | 0.046 | 0.398 | Growth hormone agonist | 0.222 0.051 DBMET00060 0.185 0.065 DBMET00061 0.199 0.059 DBMET00062 0.219 0.052 DBMET00063 0.146 0.09 DBMET00065 0.132 0.104 DBMET00066 0.132 0.104 DBMET00067 0.219 0.052 DBMET01106 0.398 0.016 DBMET01109 0.152 0.086 DBMET01110 0.133 0.103 DBMET01107 0.295 0.033 DBMET01108 | DBMET01109 | |
| 0.213 | 0.022 | 0.213 | Glutamate receptor antagonist | 0.201 0.025 DBMET00060 0.125 0.069 DBMET00061 0.117 0.078 DBMET00063 0.177 0.034 DBMET00065 0.105 0.091 DBMET01106 0.17 0.038 DBMET01109 0.153 0.049 DBMET01108 | ||
| 0.263 | 0.074 | 0.275 | Transcription factor STAT3 inhibitor | 0.25 0.083 DBMET00060 0.18 0.164 DBMET00061 0.219 0.112 DBMET00063 0.231 0.1 DBMET00064 0.219 0.112 DBMET00065 0.275 0.066 DBMET00066 0.275 0.066 DBMET00067 0.183 0.159 DBMET01106 0.231 0.1 DBMET01109 0.248 0.085 DBMET01108 | DBMET00067 | |
| 0.193 | 0.005 | 0.205 | Ornithine decarboxylase inhibitor | 0.168 0.007 DBMET00060 0.176 0.006 DBMET00061 0.163 0.008 DBMET00062 0.15 0.011 DBMET00063 0.12 0.026 DBMET00064 0.161 0.008 DBMET00065 0.154 0.01 DBMET00066 0.154 0.01 DBMET00067 0.17 0.007 DBMET01106 0.205 0.005 DBMET01109 0.16 0.009 DBMET01110 0.157 0.009 DBMET01107 0.174 0.006 DBMET01108 | DBMET01109 | |
| 0.231 | 0.043 | 0.302 | Anticoagulant | 0.175 0.063 DBMET00061 0.156 0.075 DBMET00062 0.12 0.111 DBMET00063 0.302 0.028 DBMET00064 0.272 0.034 DBMET01109 0.2 0.053 DBMET01110 0.225 0.045 DBMET01107 0.264 0.035 DBMET01108 | DBMET00064 | |
| 0.219 | 0.031 | 0.315 | Interleukin 6 antagonist | 0.148 0.092 DBMET00060 0.223 0.03 DBMET00061 0.191 0.046 DBMET00062 0.18 0.055 DBMET00063 0.167 0.067 DBMET00064 0.315 0.013 DBMET00065 0.211 0.035 DBMET00066 0.211 0.035 DBMET00067 0.222 0.03 DBMET01106 0.217 0.032 DBMET01109 0.134 0.116 DBMET01110 0.172 0.062 DBMET01108 | DBMET00065 | |
| 0.192 | 0.006 | 0.414 | Biliverdin reductase inhibitor | 0.414 0.002 DBMET01015 0.143 0.01 DBMET00060 0.124 0.013 DBMET00061 0.177 0.007 DBMET00062 0.156 0.009 DBMET00063 0.082 0.025 DBMET00064 0.173 0.007 DBMET00065 0.115 0.015 DBMET00066 0.115 0.015 DBMET00067 0.186 0.006 DBMET01106 0.187 0.006 DBMET01109 0.113 0.015 DBMET01110 0.098 0.019 DBMET01107 0.187 0.006 DBMET01108 | DBMET01015 | |
| 0.263 | 0.077 | 0.693 | Antioxidant | 0.326 0.053 DBMET00060 0.261 0.078 DBMET00061 0.242 0.088 DBMET00062 0.244 0.087 DBMET00063 0.693 0.006 DBMET00064 0.591 0.012 DBMET00065 0.34 0.049 DBMET00066 0.34 0.049 DBMET00067 0.498 0.02 DBMET01106 0.285 0.068 DBMET01109 0.185 0.127 DBMET01110 0.291 0.065 DBMET01107 0.27 0.074 DBMET01108 | DBMET00064 | |
| 0.202 | 0.018 | 0.361 | Cyclooxygenase 3 inhibitor | 0.166 0.036 DBMET00060 0.205 0.017 DBMET00061 0.169 0.034 DBMET00062 0.172 0.032 DBMET00063 0.361 0.004 DBMET00064 0.2 0.018 DBMET00065 0.154 0.045 DBMET00066 0.154 0.045 DBMET00067 0.176 0.029 DBMET01106 0.192 0.022 DBMET01109 0.163 0.038 DBMET01110 0.148 0.049 DBMET01107 0.174 0.031 DBMET01108 | DBMET00064 | |
| 0.188 | 0.003 | 0.212 | Neutral endopeptidase inhibitor | 0.051 0.007 DBMET00060 0.106 0.004 DBMET00061 0.074 0.005 DBMET00062 0.112 0.004 DBMET00063 0.05 0.007 DBMET00066 0.05 0.007 DBMET00067 0.185 0.003 DBMET01109 0.12 0.004 DBMET01110 0.167 0.004 DBMET01107 0.212 0.003 DBMET01108 | DBMET01108 | |
| 0.203 | 0.02 | 0.369 | Expectorant | 0.271 0.01 DBMET01015 0.146 0.037 DBMET00060 0.223 0.016 DBMET00061 0.24 0.014 DBMET00062 0.26 0.012 DBMET00063 0.369 0.005 DBMET00064 0.129 0.045 DBMET00065 0.168 0.029 DBMET00066 0.168 0.029 DBMET00067 0.123 0.049 DBMET01106 0.225 0.016 DBMET01109 0.161 0.031 DBMET01110 0.139 0.04 DBMET01107 0.188 0.023 DBMET01108 | DBMET00064 | |
| 0.193 | 0.009 | 0.209 | Keratolytic | 0.105 0.028 DBMET00060 0.209 0.008 DBMET00061 0.146 0.015 DBMET00062 0.124 0.02 DBMET00063 0.119 0.022 DBMET00065 0.126 0.02 DBMET00066 0.126 0.02 DBMET00067 0.114 0.023 DBMET01106 0.168 0.012 DBMET01109 0.15 0.014 DBMET01110 0.127 0.019 DBMET01107 0.168 0.012 DBMET01108 | DBMET00061 | |
| 0.207 | 0.023 | 0.207 | Cystathionine beta-synthase inhibitor | 0.117 0.061 DBMET00060 0.133 0.049 DBMET00061 0.122 0.056 DBMET00062 0.106 0.07 DBMET00063 0.109 0.067 DBMET00064 0.204 0.024 DBMET00065 0.153 0.039 DBMET00066 0.153 0.039 DBMET00067 0.138 0.047 DBMET01106 0.16 0.036 DBMET01109 0.148 0.042 DBMET01110 0.129 0.052 DBMET01107 0.16 0.036 DBMET01108 | ||
| 0.196 | 0.013 | 0.196 | HIV-1 integrase (Overall Integration) inhibitor | 0.163 0.021 DBMET00060 0.138 0.03 DBMET00061 0.106 0.049 DBMET00062 0.09 0.065 DBMET00063 0.17 0.019 DBMET00065 0.145 0.027 DBMET00066 0.145 0.027 DBMET00067 0.165 0.02 DBMET01106 0.151 0.025 DBMET01109 0.178 0.017 DBMET01110 0.156 0.023 DBMET01107 0.151 0.025 DBMET01108 | ||
| 0.19 | 0.007 | 0.29 | Prostaglandin EP2 antagonist | 0.161 0.009 DBMET00060 0.121 0.014 DBMET00061 0.29 0.004 DBMET00062 0.245 0.005 DBMET00063 0.063 0.038 DBMET00064 0.084 0.024 DBMET00065 0.119 0.015 DBMET00066 0.119 0.015 DBMET00067 0.076 0.029 DBMET01106 0.277 0.005 DBMET01109 0.096 0.02 DBMET01110 0.077 0.028 DBMET01107 0.194 0.007 DBMET01108 | DBMET00062 | |
| 0.202 | 0.022 | 0.202 | Cathepsin H inhibitor | 0.138 0.056 DBMET00060 0.152 0.044 DBMET00061 0.185 0.027 DBMET00062 0.196 0.024 DBMET00063 0.172 0.033 DBMET00065 0.167 0.036 DBMET00066 0.167 0.036 DBMET00067 0.129 0.065 DBMET01106 0.186 0.027 DBMET01109 0.185 0.027 DBMET01110 0.171 0.034 DBMET01107 0.179 0.03 DBMET01108 | ||
| 0.296 | 0.117 | 0.334 | Calpain 2 inhibitor | 0.269 0.135 DBMET00061 0.216 0.174 DBMET01109 0.334 0.095 DBMET01110 0.254 0.147 DBMET01107 | DBMET01110 | |
| 0.184 | 0.005 | 0.207 | Glutamate release inhibitor | 0.094 0.053 DBMET00060 0.125 0.019 DBMET00061 0.151 0.01 DBMET00062 0.162 0.008 DBMET00063 0.207 0.005 DBMET00064 0.123 0.02 DBMET00065 0.114 0.026 DBMET00066 0.114 0.026 DBMET00067 0.091 0.059 DBMET01106 0.2 0.005 DBMET01109 0.16 0.008 DBMET01110 0.142 0.012 DBMET01107 0.172 0.006 DBMET01108 | DBMET00064 | |
| 0.184 | 0.007 | 0.287 | Interferon agonist | 0.092 0.037 DBMET00060 0.255 0.004 DBMET00061 0.15 0.01 DBMET00062 0.162 0.009 DBMET00063 0.287 0.004 DBMET00064 0.097 0.031 DBMET00065 0.167 0.008 DBMET00066 0.167 0.008 DBMET00067 0.09 0.038 DBMET01106 0.197 0.006 DBMET01109 0.16 0.009 DBMET01110 0.107 0.024 DBMET01107 0.153 0.01 DBMET01108 | DBMET00064 | |
| 0.18 | 0.003 | 0.18 | Glutamate (mGluR group III) antagonist | 0.075 0.008 DBMET00060 0.116 0.005 DBMET00061 0.058 0.014 DBMET00062 0.068 0.01 DBMET00063 0.095 0.005 DBMET00065 0.062 0.012 DBMET00066 0.062 0.012 DBMET00067 0.063 0.012 DBMET01106 0.17 0.003 DBMET01109 0.072 0.009 DBMET01110 0.087 0.006 DBMET01107 0.151 0.004 DBMET01108 | ||
| 0.236 | 0.062 | 0.409 | Peptidyltransferase inhibitor | 0.245 0.054 DBMET00060 0.261 0.043 DBMET00061 0.229 0.067 DBMET00062 0.241 0.057 DBMET00063 0.409 0.006 DBMET00064 0.223 0.074 DBMET00065 0.191 0.111 DBMET00066 0.191 0.111 DBMET00067 0.257 0.046 DBMET01106 0.199 0.1 DBMET01109 0.178 0.132 DBMET01110 0.163 0.162 DBMET01107 0.199 0.1 DBMET01108 | DBMET00064 | |
| 0.226 | 0.053 | 0.226 | Nitric-oxide synthase stimulant | 0.187 0.113 DBMET00061 0.214 0.067 DBMET00062 0.225 0.054 DBMET00063 0.212 0.071 DBMET00064 0.188 0.11 DBMET00065 0.172 0.149 DBMET00066 0.172 0.149 DBMET00067 0.198 0.093 DBMET01109 0.185 0.118 DBMET01110 0.172 0.148 DBMET01107 0.198 0.093 DBMET01108 | ||
| 0.172 | 0.002 | 0.172 | Glutamate (mGluR7) antagonist | 0.118 0.005 DBMET00060 0.128 0.004 DBMET00061 0.122 0.004 DBMET00062 0.13 0.004 DBMET00063 0.095 0.014 DBMET00065 0.119 0.005 DBMET00066 0.119 0.005 DBMET00067 0.071 0.041 DBMET01106 0.152 0.003 DBMET01109 0.128 0.004 DBMET01110 0.137 0.004 DBMET01107 0.152 0.003 DBMET01108 | ||
| 0.174 | 0.005 | 0.191 | Peroxisome proliferator-activated receptor alpha agonist | 0.143 0.007 DBMET00060 0.177 0.005 DBMET00061 0.136 0.007 DBMET00062 0.141 0.007 DBMET00063 0.154 0.006 DBMET00065 0.134 0.008 DBMET00066 0.134 0.008 DBMET00067 0.095 0.013 DBMET01106 0.191 0.004 DBMET01109 0.115 0.01 DBMET01110 0.098 0.013 DBMET01107 0.155 0.005 DBMET01108 | DBMET01109 | |
| 0.287 | 0.119 | 0.747 | Toll-Like receptor 7 agonist | 0.353 0.08 DBMET00061 0.747 0.006 DBMET00062 0.326 0.095 DBMET01109 0.359 0.078 DBMET01108 | DBMET00062 | |
| 0.171 | 0.003 | 0.177 | Glutamate (mGluR4) antagonist | 0.08 0.008 DBMET00060 0.118 0.005 DBMET00061 0.051 0.02 DBMET00062 0.06 0.014 DBMET00063 0.097 0.006 DBMET00065 0.063 0.013 DBMET00066 0.063 0.013 DBMET00067 0.065 0.012 DBMET01106 0.177 0.003 DBMET01109 0.072 0.01 DBMET01110 0.088 0.007 DBMET01107 0.15 0.004 DBMET01108 | DBMET01109 | |
| 0.173 | 0.005 | 0.203 | Sphingosine 1-phosphate receptor 4 agonist | 0.126 0.014 DBMET00060 0.196 0.004 DBMET00061 0.126 0.015 DBMET00062 0.132 0.013 DBMET00063 0.118 0.017 DBMET00065 0.119 0.017 DBMET00066 0.119 0.017 DBMET00067 0.108 0.021 DBMET01106 0.203 0.004 DBMET01109 0.121 0.016 DBMET01110 0.104 0.023 DBMET01107 0.168 0.006 DBMET01108 | DBMET01109 | |
| 0.18 | 0.012 | 0.575 | NADH dehydrogenase inhibitor | 0.575 0.002 DBMET01015 0.1 0.044 DBMET00060 0.152 0.017 DBMET00061 0.172 0.013 DBMET00062 0.156 0.016 DBMET00063 0.411 0.004 DBMET00064 0.153 0.017 DBMET00065 0.12 0.029 DBMET00066 0.12 0.029 DBMET00067 0.115 0.031 DBMET01106 0.147 0.018 DBMET01109 0.127 0.025 DBMET01110 0.116 0.031 DBMET01107 0.147 0.018 DBMET01108 | DBMET01015 | |
| 0.177 | 0.011 | 0.177 | DOPA decarboxylase inhibitor | 0.115 0.052 DBMET00060 0.145 0.024 DBMET00061 0.123 0.042 DBMET00062 0.114 0.052 DBMET00063 0.151 0.021 DBMET00065 0.133 0.032 DBMET00066 0.133 0.032 DBMET00067 0.121 0.044 DBMET01106 0.153 0.02 DBMET01109 0.166 0.014 DBMET01110 0.177 0.011 DBMET01107 0.153 0.02 DBMET01108 | ||
| 0.187 | 0.021 | 0.212 | GABA receptor agonist | 0.176 0.025 DBMET00061 0.173 0.026 DBMET00065 0.207 0.016 DBMET01109 0.212 0.015 DBMET01108 | DBMET01108 | |
| 0.239 | 0.075 | 0.253 | Calpain inhibitor | 0.198 0.115 DBMET00061 0.162 0.161 DBMET00062 0.186 0.127 DBMET00065 0.207 0.107 DBMET01109 0.248 0.067 DBMET01110 0.253 0.062 DBMET01107 0.219 0.095 DBMET01108 | DBMET01107 | |
| 0.185 | 0.024 | 0.251 | Microtubule formation inhibitor | 0.238 0.012 DBMET00060 0.182 0.025 DBMET00061 0.223 0.015 DBMET00062 0.178 0.026 DBMET00063 0.251 0.009 DBMET00064 0.196 0.021 DBMET00065 0.225 0.015 DBMET00066 0.225 0.015 DBMET00067 0.247 0.009 DBMET01106 0.176 0.027 DBMET01109 0.147 0.039 DBMET01110 0.14 0.043 DBMET01107 0.176 0.027 DBMET01108 | DBMET00064 | |
| 0.174 | 0.014 | 0.175 | Glutamate receptor agonist | 0.099 0.038 DBMET00060 0.125 0.025 DBMET00061 0.082 0.051 DBMET00065 0.085 0.049 DBMET00066 0.085 0.049 DBMET00067 0.152 0.017 DBMET01109 0.175 0.014 DBMET01108 | DBMET01108 | |
| 0.172 | 0.012 | 0.212 | Toll-Like receptor 4 antagonist | 0.163 0.015 DBMET01015 0.168 0.013 DBMET00060 0.169 0.013 DBMET00061 0.162 0.015 DBMET00062 0.16 0.016 DBMET00063 0.205 0.005 DBMET00064 0.212 0.005 DBMET00065 0.142 0.026 DBMET00066 0.142 0.026 DBMET00067 0.208 0.005 DBMET01106 0.176 0.011 DBMET01109 0.155 0.018 DBMET01110 0.145 0.024 DBMET01107 0.158 0.017 DBMET01108 | DBMET00065 | |
| 0.198 | 0.038 | 0.269 | ATPase inhibitor | 0.203 0.034 DBMET00060 0.194 0.043 DBMET00061 0.26 0.011 DBMET00062 0.179 0.059 DBMET00063 0.269 0.01 DBMET00064 0.183 0.055 DBMET00065 0.259 0.011 DBMET00066 0.259 0.011 DBMET00067 0.185 0.052 DBMET01106 0.179 0.059 DBMET01109 0.201 0.036 DBMET01110 0.141 0.117 DBMET01107 0.162 0.082 DBMET01108 | DBMET00064 | |
| 0.167 | 0.008 | 0.214 | Leukotriene antagonist | 0.173 0.008 DBMET00060 0.2 0.006 DBMET00061 0.137 0.012 DBMET00062 0.155 0.009 DBMET00063 0.103 0.021 DBMET00064 0.171 0.008 DBMET00065 0.129 0.014 DBMET00066 0.129 0.014 DBMET00067 0.141 0.011 DBMET01106 0.214 0.005 DBMET01109 0.1 0.022 DBMET01110 0.131 0.013 DBMET01107 0.213 0.005 DBMET01108 | DBMET01109 | |
| 0.224 | 0.065 | 0.41 | Platelet aggregation inhibitor | 0.272 0.043 DBMET00061 0.162 0.115 DBMET00062 0.203 0.079 DBMET00063 0.143 0.138 DBMET00065 0.41 0.017 DBMET01109 0.234 0.06 DBMET01107 0.293 0.037 DBMET01108 | DBMET01109 | |
| 0.236 | 0.078 | 0.398 | Antiamyloidogenic | 0.233 0.079 DBMET00060 0.231 0.08 DBMET00061 0.182 0.113 DBMET00062 0.176 0.117 DBMET00063 0.398 0.029 DBMET00064 0.235 0.078 DBMET01109 0.151 0.146 DBMET01110 0.169 0.123 DBMET01108 | DBMET00064 | |
| 0.163 | 0.005 | 0.196 | Glycine receptor antagonist | 0.146 0.008 DBMET00060 0.118 0.019 DBMET00061 0.124 0.016 DBMET00062 0.113 0.022 DBMET00063 0.196 0.004 DBMET00064 0.164 0.005 DBMET00065 0.128 0.014 DBMET00066 0.128 0.014 DBMET00067 0.152 0.007 DBMET01106 0.163 0.005 DBMET01109 0.124 0.016 DBMET01110 0.113 0.023 DBMET01107 0.151 0.007 DBMET01108 | DBMET00064 | |
| 0.173 | 0.015 | 0.285 | Alcohol dehydrogenase inhibitor | 0.285 0.005 DBMET01015 0.087 0.069 DBMET00060 0.228 0.009 DBMET00061 0.121 0.034 DBMET00062 0.16 0.018 DBMET00063 0.112 0.041 DBMET00064 0.126 0.031 DBMET00065 0.098 0.055 DBMET00066 0.098 0.055 DBMET00067 0.097 0.055 DBMET01106 0.214 0.011 DBMET01109 0.129 0.029 DBMET01110 0.145 0.022 DBMET01107 0.16 0.018 DBMET01108 | DBMET01015 | |
| 0.171 | 0.014 | 0.2 | Metalloproteinase-2 inhibitor | 0.188 0.011 DBMET00060 0.143 0.021 DBMET00061 0.097 0.04 DBMET00062 0.13 0.025 DBMET00063 0.105 0.036 DBMET00066 0.105 0.036 DBMET00067 0.184 0.012 DBMET01109 0.127 0.026 DBMET01110 0.13 0.025 DBMET01107 0.2 0.01 DBMET01108 | DBMET01108 | |
| 0.242 | 0.085 | 0.443 | DNA damaging | 0.176 0.138 DBMET00060 0.267 0.071 DBMET00061 0.443 0.02 DBMET00064 0.185 0.129 DBMET00065 0.167 0.148 DBMET00066 0.167 0.148 DBMET00067 0.164 0.153 DBMET01106 0.269 0.071 DBMET01109 0.195 0.12 DBMET01108 | DBMET00064 | |
| 0.16 | 0.005 | 0.249 | Sphingosine 1-phosphate receptor 5 agonist | 0.064 0.021 DBMET00060 0.129 0.005 DBMET00061 0.123 0.006 DBMET00062 0.12 0.006 DBMET00063 0.058 0.028 DBMET00065 0.083 0.012 DBMET00066 0.083 0.012 DBMET00067 0.249 0.004 DBMET01109 0.09 0.01 DBMET01110 0.076 0.014 DBMET01107 0.186 0.004 DBMET01108 | DBMET01109 | |
| 0.172 | 0.018 | 0.172 | Sphingosine 1-phosphate receptor 4 antagonist | 0.119 0.074 DBMET00060 0.172 0.018 DBMET00061 0.137 0.047 DBMET00062 0.132 0.053 DBMET00063 0.146 0.037 DBMET00065 0.126 0.062 DBMET00066 0.126 0.062 DBMET00067 0.124 0.066 DBMET01106 0.153 0.031 DBMET01109 0.15 0.034 DBMET01110 0.157 0.028 DBMET01107 0.153 0.031 DBMET01108 | ||
| 0.174 | 0.022 | 0.443 | UDP-glucose 4-epimerase inhibitor | 0.363 0.007 DBMET01015 0.087 0.078 DBMET00060 0.16 0.026 DBMET00061 0.165 0.024 DBMET00062 0.146 0.03 DBMET00063 0.443 0.004 DBMET00064 0.149 0.029 DBMET00065 0.109 0.052 DBMET00066 0.109 0.052 DBMET00067 0.106 0.054 DBMET01106 0.137 0.034 DBMET01109 0.156 0.027 DBMET01110 0.175 0.022 DBMET01107 0.137 0.034 DBMET01108 | DBMET00064 | |
| 0.171 | 0.019 | 0.227 | TRPA1 agonist | 0.191 0.013 DBMET00060 0.13 0.048 DBMET00061 0.135 0.043 DBMET00062 0.134 0.044 DBMET00063 0.213 0.008 DBMET00065 0.193 0.012 DBMET00066 0.193 0.012 DBMET00067 0.227 0.007 DBMET01106 0.17 0.019 DBMET01109 0.153 0.029 DBMET01110 0.168 0.02 DBMET01107 0.152 0.029 DBMET01108 | DBMET01106 | |
| 0.186 | 0.036 | 0.228 | Anesthetic local | 0.218 0.027 DBMET00060 0.224 0.026 DBMET00061 0.201 0.032 DBMET00062 0.228 0.025 DBMET00063 0.187 0.036 DBMET00066 0.187 0.036 DBMET00067 0.121 0.066 DBMET01106 0.124 0.064 DBMET01109 0.112 0.073 DBMET01110 0.151 0.048 DBMET01107 0.124 0.064 DBMET01108 | DBMET00063 | |
| 0.162 | 0.012 | 0.171 | Anabolic | 0.165 0.011 DBMET00060 0.147 0.019 DBMET00061 0.149 0.018 DBMET00062 0.145 0.021 DBMET00063 0.118 0.042 DBMET00064 0.171 0.009 DBMET00065 0.143 0.022 DBMET00066 0.143 0.022 DBMET00067 0.158 0.014 DBMET01106 0.163 0.012 DBMET01109 0.153 0.017 DBMET01110 0.166 0.011 DBMET01107 0.153 0.016 DBMET01108 | DBMET00065 | |
| 0.186 | 0.037 | 0.189 | Histone deacetylase SIRT1 inhibitor | 0.116 0.096 DBMET00060 0.145 0.066 DBMET00061 0.137 0.073 DBMET00063 0.11 0.104 DBMET00065 0.189 0.035 DBMET01109 0.169 0.047 DBMET01108 | DBMET01109 | |
| 0.157 | 0.009 | 0.165 | Lanosterol 14 alpha demethylase inhibitor | 0.129 0.023 DBMET00060 0.13 0.022 DBMET00061 0.135 0.019 DBMET00062 0.132 0.02 DBMET00063 0.109 0.043 DBMET00065 0.165 0.007 DBMET00066 0.165 0.007 DBMET00067 0.107 0.046 DBMET01106 0.154 0.01 DBMET01109 0.161 0.008 DBMET01110 0.142 0.014 DBMET01107 0.141 0.015 DBMET01108 | DBMET00067 | |
| 0.18 | 0.033 | 0.391 | Alkylator | 0.166 0.039 DBMET00060 0.208 0.024 DBMET00061 0.125 0.064 DBMET00062 0.185 0.031 DBMET00063 0.391 0.008 DBMET00064 0.199 0.027 DBMET00065 0.117 0.071 DBMET00066 0.117 0.071 DBMET00067 0.157 0.043 DBMET01106 0.206 0.024 DBMET01109 0.139 0.053 DBMET01107 0.16 0.042 DBMET01108 | DBMET00064 | |
| 0.166 | 0.019 | 0.186 | Caspase 3 inhibitor | 0.142 0.034 DBMET00060 0.154 0.025 DBMET00061 0.133 0.043 DBMET00062 0.136 0.039 DBMET00063 0.139 0.037 DBMET00065 0.151 0.027 DBMET00066 0.151 0.027 DBMET00067 0.106 0.083 DBMET01106 0.186 0.012 DBMET01109 0.152 0.027 DBMET01110 0.147 0.03 DBMET01107 0.164 0.02 DBMET01108 | DBMET01109 | |
| 0.149 | 0.004 | 0.214 | Kainate receptor 5 antagonist | 0.044 0.006 DBMET00060 0.047 0.005 DBMET00061 0.033 0.009 DBMET00063 0.214 0.003 DBMET00065 0.021 0.014 DBMET00066 0.021 0.014 DBMET00067 0.139 0.004 DBMET01106 0.123 0.004 DBMET01109 0.021 0.014 DBMET01110 0.041 0.007 DBMET01107 0.1 0.004 DBMET01108 | DBMET00065 | |
| 0.151 | 0.006 | 0.389 | CDC25B inhibitor | 0.093 0.019 DBMET00060 0.127 0.01 DBMET00061 0.081 0.027 DBMET00062 0.071 0.037 DBMET00063 0.074 0.033 DBMET00064 0.389 0.003 DBMET00065 0.093 0.019 DBMET00066 0.093 0.019 DBMET00067 0.247 0.004 DBMET01106 0.13 0.009 DBMET01109 0.102 0.015 DBMET01110 0.145 0.007 DBMET01107 0.163 0.005 DBMET01108 | DBMET00065 | |
| 0.161 | 0.016 | 0.462 | Selectin antagonist | 0.09 0.032 DBMET00060 0.164 0.016 DBMET00061 0.139 0.019 DBMET00062 0.148 0.018 DBMET00063 0.462 0.003 DBMET00064 0.083 0.035 DBMET00066 0.083 0.035 DBMET00067 0.192 0.012 DBMET01109 0.09 0.032 DBMET01110 0.075 0.039 DBMET01107 0.148 0.018 DBMET01108 | DBMET00064 | |
| 0.308 | 0.167 | 0.74 | Apoptosis agonist | 0.442 0.095 DBMET00060 0.298 0.174 DBMET00061 0.243 0.223 DBMET00063 0.74 0.024 DBMET00064 0.682 0.034 DBMET00065 0.421 0.104 DBMET00066 0.421 0.104 DBMET00067 0.664 0.037 DBMET01106 0.333 0.15 DBMET01109 0.415 0.107 DBMET01107 0.331 0.151 DBMET01108 | DBMET00064 | |
| 0.145 | 0.004 | 0.204 | Thromboxane synthase inhibitor | 0.123 0.005 DBMET00060 0.169 0.004 DBMET00061 0.077 0.013 DBMET00062 0.095 0.007 DBMET00063 0.093 0.008 DBMET00065 0.087 0.009 DBMET00066 0.087 0.009 DBMET00067 0.073 0.016 DBMET01106 0.204 0.003 DBMET01109 0.072 0.016 DBMET01110 0.078 0.013 DBMET01107 0.173 0.004 DBMET01108 | DBMET01109 | |
| 0.141 | 0.002 | 0.175 | Membrane dipeptidase inhibitor | 0.175 0.001 DBMET00060 0.134 0.002 DBMET00061 0.119 0.003 DBMET00062 0.11 0.003 DBMET00063 0.036 0.034 DBMET00064 0.133 0.002 DBMET00065 0.14 0.002 DBMET00066 0.14 0.002 DBMET00067 0.102 0.004 DBMET01106 0.152 0.002 DBMET01109 0.112 0.003 DBMET01110 0.103 0.004 DBMET01107 0.156 0.002 DBMET01108 | DBMET00060 | |
| 0.14 | 0.003 | 0.18 | Lysine carboxypeptidase inhibitor | 0.056 0.007 DBMET00060 0.106 0.004 DBMET00061 0.072 0.005 DBMET00062 0.085 0.004 DBMET00063 0.032 0.015 DBMET00065 0.056 0.007 DBMET00066 0.056 0.007 DBMET00067 0.17 0.002 DBMET01109 0.055 0.007 DBMET01110 0.064 0.005 DBMET01107 0.18 0.002 DBMET01108 | DBMET01108 | |
| 0.146 | 0.012 | 0.165 | Phenylalanine 4-hydroxylase inhibitor | 0.095 0.028 DBMET00060 0.132 0.015 DBMET00061 0.148 0.012 DBMET00062 0.165 0.01 DBMET00063 0.128 0.016 DBMET00065 0.081 0.037 DBMET00066 0.081 0.037 DBMET00067 0.129 0.016 DBMET01106 0.14 0.014 DBMET01109 0.093 0.029 DBMET01110 0.08 0.038 DBMET01107 0.14 0.014 DBMET01108 | DBMET00063 | |
| 0.137 | 0.004 | 0.168 | Peroxisome proliferator-activated receptor delta agonist | 0.087 0.007 DBMET00060 0.14 0.004 DBMET00061 0.096 0.006 DBMET00062 0.103 0.005 DBMET00063 0.049 0.013 DBMET00065 0.054 0.011 DBMET00066 0.054 0.011 DBMET00067 0.04 0.017 DBMET01106 0.15 0.004 DBMET01109 0.058 0.01 DBMET01110 0.069 0.009 DBMET01107 0.168 0.004 DBMET01108 | DBMET01108 | |
| 0.152 | 0.019 | 0.152 | Histidine decarboxylase inhibitor | 0.074 0.047 DBMET00061 0.123 0.025 DBMET00062 0.099 0.032 DBMET00063 0.138 0.021 DBMET00065 0.075 0.046 DBMET00066 0.075 0.046 DBMET00067 0.073 0.048 DBMET01106 0.097 0.033 DBMET01109 0.116 0.026 DBMET01110 0.145 0.02 DBMET01107 0.097 0.033 DBMET01108 | ||
| 0.149 | 0.018 | 0.203 | ABCA1 expression enhancer | 0.097 0.054 DBMET00060 0.143 0.019 DBMET00061 0.179 0.012 DBMET00062 0.095 0.057 DBMET00063 0.086 0.073 DBMET00065 0.1 0.05 DBMET00066 0.1 0.05 DBMET00067 0.169 0.014 DBMET01106 0.13 0.024 DBMET01109 0.102 0.048 DBMET01110 0.105 0.045 DBMET01107 0.203 0.009 DBMET01108 | DBMET01108 | |
| 0.145 | 0.014 | 0.171 | Matrix metalloproteinase inhibitor | 0.154 0.013 DBMET00060 0.136 0.016 DBMET00061 0.134 0.016 DBMET00062 0.117 0.021 DBMET00063 0.084 0.034 DBMET00066 0.084 0.034 DBMET00067 0.147 0.014 DBMET01109 0.096 0.028 DBMET01110 0.121 0.019 DBMET01107 0.171 0.011 DBMET01108 | DBMET01108 | |
| 0.148 | 0.018 | 0.164 | Interleukin 1 beta converting enzyme inhibitor | 0.126 0.03 DBMET00060 0.121 0.034 DBMET00061 0.098 0.06 DBMET00062 0.091 0.071 DBMET00065 0.125 0.031 DBMET00066 0.125 0.031 DBMET00067 0.088 0.075 DBMET01106 0.164 0.013 DBMET01109 0.152 0.016 DBMET01110 0.145 0.019 DBMET01107 0.147 0.019 DBMET01108 | DBMET01109 | |
| 0.144 | 0.013 | 0.188 | Glutathione S-transferase inhibitor | 0.173 0.008 DBMET00060 0.181 0.007 DBMET00061 0.104 0.034 DBMET00062 0.112 0.028 DBMET00063 0.129 0.018 DBMET00065 0.128 0.019 DBMET00066 0.128 0.019 DBMET00067 0.188 0.006 DBMET01106 0.152 0.012 DBMET01109 0.112 0.028 DBMET01110 0.152 0.012 DBMET01107 0.129 0.018 DBMET01108 | DBMET01106 | |
| 0.219 | 0.09 | 0.541 | Vasodilator | 0.343 0.035 DBMET01015 0.273 0.058 DBMET00060 0.25 0.069 DBMET00061 0.226 0.085 DBMET00062 0.35 0.033 DBMET00063 0.517 0.011 DBMET00064 0.541 0.009 DBMET00065 0.197 0.107 DBMET00066 0.197 0.107 DBMET00067 0.409 0.022 DBMET01106 0.259 0.064 DBMET01109 0.26 0.064 DBMET01107 0.161 0.141 DBMET01108 | DBMET00065 | |
| 0.237 | 0.109 | 0.519 | Lipoxygenase inhibitor | 0.276 0.084 DBMET00060 0.234 0.111 DBMET00061 0.519 0.016 DBMET00065 0.255 0.097 DBMET00066 0.255 0.097 DBMET00067 0.421 0.032 DBMET01106 0.255 0.097 DBMET01109 0.189 0.152 DBMET01107 0.208 0.132 DBMET01108 | DBMET00065 | |
| 0.132 | 0.004 | 0.164 | Squalene synthetase inhibitor | 0.15 0.004 DBMET00060 0.113 0.005 DBMET00061 0.139 0.004 DBMET00062 0.093 0.007 DBMET00063 0.112 0.005 DBMET00064 0.164 0.003 DBMET00065 0.154 0.003 DBMET00066 0.154 0.003 DBMET00067 0.149 0.004 DBMET01106 0.131 0.005 DBMET01109 0.085 0.008 DBMET01110 0.117 0.005 DBMET01107 0.141 0.004 DBMET01108 | DBMET00065 | |
| 0.133 | 0.006 | 0.176 | Leukotriene B4 antagonist | 0.151 0.005 DBMET00060 0.176 0.004 DBMET00061 0.106 0.009 DBMET00062 0.126 0.007 DBMET00063 0.102 0.01 DBMET00064 0.125 0.007 DBMET00065 0.094 0.012 DBMET00066 0.094 0.012 DBMET00067 0.111 0.008 DBMET01106 0.171 0.004 DBMET01109 0.077 0.016 DBMET01110 0.113 0.008 DBMET01107 0.129 0.006 DBMET01108 | DBMET00061 | |
| 0.132 | 0.005 | 0.21 | Interferon inducer | 0.074 0.03 DBMET00060 0.178 0.004 DBMET00061 0.114 0.009 DBMET00062 0.12 0.007 DBMET00063 0.21 0.003 DBMET00064 0.078 0.026 DBMET00065 0.086 0.019 DBMET00066 0.086 0.019 DBMET00067 0.061 0.052 DBMET01106 0.128 0.006 DBMET01109 0.089 0.017 DBMET01110 0.08 0.024 DBMET01107 0.109 0.01 DBMET01108 | DBMET00064 | |
| 0.131 | 0.006 | 0.162 | Estrogen-related receptor beta agonist | 0.093 0.034 DBMET00060 0.162 0.004 DBMET00061 0.101 0.023 DBMET00062 0.096 0.03 DBMET00063 0.104 0.02 DBMET00065 0.104 0.02 DBMET00066 0.104 0.02 DBMET00067 0.088 0.044 DBMET01106 0.13 0.007 DBMET01109 0.113 0.014 DBMET01110 0.106 0.018 DBMET01107 0.117 0.011 DBMET01108 | DBMET00061 | |
| 0.229 | 0.103 | 0.232 | Transcription factor STAT inhibitor | 0.197 0.143 DBMET00060 0.232 0.1 DBMET00063 0.177 0.173 DBMET00064 0.184 0.161 DBMET00065 0.229 0.103 DBMET00066 0.229 0.103 DBMET00067 0.2 0.138 DBMET01109 0.211 0.123 DBMET01108 | DBMET00063 | |
| 0.134 | 0.009 | 0.134 | Granulocyte macrophage colony stimulating factor agonist | 0.087 0.057 DBMET00060 0.115 0.019 DBMET00061 0.093 0.045 DBMET00062 0.087 0.058 DBMET00063 0.111 0.023 DBMET00065 0.101 0.033 DBMET00066 0.101 0.033 DBMET00067 0.089 0.053 DBMET01106 0.116 0.018 DBMET01109 0.109 0.024 DBMET01110 0.102 0.033 DBMET01107 0.116 0.018 DBMET01108 | ||
| 0.164 | 0.039 | 0.404 | Farnesoid X receptor antagonist | 0.151 0.051 DBMET00060 0.242 0.013 DBMET00061 0.404 0.004 DBMET00065 0.346 0.004 DBMET01106 0.174 0.032 DBMET01109 0.129 0.085 DBMET01110 0.201 0.021 DBMET01107 0.149 0.054 DBMET01108 | DBMET00065 | |
| 0.128 | 0.004 | 0.128 | Kainate receptor 4 antagonist | 0.058 0.005 DBMET00060 0.062 0.005 DBMET00061 0.026 0.016 DBMET00062 0.048 0.007 DBMET00063 0.032 0.013 DBMET00066 0.032 0.013 DBMET00067 0.115 0.004 DBMET01109 0.032 0.013 DBMET01110 0.055 0.006 DBMET01107 0.1 0.004 DBMET01108 | ||
| 0.158 | 0.035 | 0.2 | Beta amyloid protein antagonist | 0.108 0.079 DBMET00060 0.119 0.068 DBMET00061 0.096 0.095 DBMET00063 0.2 0.017 DBMET00064 0.16 0.034 DBMET01109 0.126 0.061 DBMET01108 | DBMET00064 | |
| 0.124 | 0.002 | 0.147 | Glutamate (mGluR3) agonist | 0.064 0.003 DBMET00060 0.121 0.002 DBMET00061 0.06 0.004 DBMET00062 0.066 0.003 DBMET00063 0.051 0.005 DBMET00064 0.042 0.008 DBMET00065 0.06 0.004 DBMET00066 0.06 0.004 DBMET00067 0.035 0.015 DBMET01106 0.143 0.002 DBMET01109 0.068 0.003 DBMET01110 0.075 0.003 DBMET01107 0.147 0.001 DBMET01108 | DBMET01108 | |
| 0.125 | 0.002 | 0.125 | Glutamate (mGluR8) antagonist | 0.079 0.004 DBMET00060 0.088 0.003 DBMET00061 0.063 0.005 DBMET00062 0.083 0.003 DBMET00063 0.053 0.007 DBMET00064 0.047 0.01 DBMET00065 0.064 0.005 DBMET00066 0.064 0.005 DBMET00067 0.039 0.019 DBMET01106 0.12 0.002 DBMET01109 0.068 0.004 DBMET01110 0.089 0.003 DBMET01107 0.113 0.002 DBMET01108 | ||
| 0.174 | 0.052 | 0.224 | Thiol protease inhibitor | 0.142 0.078 DBMET00060 0.19 0.043 DBMET00061 0.125 0.107 DBMET00062 0.132 0.093 DBMET00063 0.16 0.061 DBMET00065 0.127 0.102 DBMET00066 0.127 0.102 DBMET00067 0.147 0.072 DBMET01106 0.176 0.05 DBMET01109 0.224 0.032 DBMET01110 0.165 0.057 DBMET01107 0.156 0.063 DBMET01108 | DBMET01110 | |
| 0.126 | 0.004 | 0.126 | AMPA 4 receptor antagonist | 0.052 0.014 DBMET00060 0.054 0.013 DBMET00061 0.047 0.018 DBMET00062 0.041 0.025 DBMET00063 0.075 0.007 DBMET00065 0.055 0.012 DBMET00066 0.055 0.012 DBMET00067 0.057 0.011 DBMET01106 0.112 0.004 DBMET01109 0.059 0.01 DBMET01110 0.05 0.015 DBMET01107 0.095 0.005 DBMET01108 | ||
| 0.164 | 0.042 | 0.554 | Monophenol monooxygenase inhibitor | 0.24 0.025 DBMET00060 0.146 0.049 DBMET00061 0.134 0.054 DBMET00062 0.151 0.047 DBMET00063 0.554 0.006 DBMET00064 0.234 0.026 DBMET00065 0.218 0.029 DBMET00066 0.218 0.029 DBMET00067 0.152 0.046 DBMET01106 0.172 0.04 DBMET01109 0.131 0.055 DBMET01110 0.207 0.031 DBMET01107 0.135 0.053 DBMET01108 | DBMET00064 | |
| 0.147 | 0.026 | 0.152 | Sphingomyelinase inhibitor | 0.152 0.024 DBMET00061 0.141 0.029 DBMET00062 0.124 0.038 DBMET00063 0.14 0.029 DBMET00064 0.121 0.04 DBMET00065 0.137 0.03 DBMET00066 0.137 0.03 DBMET00067 0.114 0.046 DBMET01109 0.101 0.058 DBMET01110 0.088 0.075 DBMET01107 0.114 0.046 DBMET01108 | DBMET00061 | |
| 0.126 | 0.006 | 0.137 | Angiotensin-converting enzyme inhibitor | 0.066 0.023 DBMET00060 0.079 0.014 DBMET00061 0.07 0.02 DBMET00062 0.089 0.011 DBMET00063 0.074 0.016 DBMET00066 0.074 0.016 DBMET00067 0.112 0.007 DBMET01109 0.08 0.014 DBMET01110 0.103 0.008 DBMET01107 0.137 0.005 DBMET01108 | DBMET01108 | |
| 0.155 | 0.035 | 0.157 | Heat shock protein 70 antagonist | 0.156 0.033 DBMET01015 0.15 0.045 DBMET00060 0.138 0.083 DBMET00061 0.131 0.118 DBMET00062 0.142 0.066 DBMET00064 0.142 0.067 DBMET00065 0.136 0.093 DBMET00066 0.136 0.093 DBMET00067 0.15 0.046 DBMET01106 0.157 0.033 DBMET01109 0.133 0.107 DBMET01110 0.149 0.048 DBMET01108 | DBMET01109 | |
| 0.159 | 0.039 | 0.163 | Pregnane X receptor agonist | 0.16 0.037 DBMET00061 0.163 0.034 DBMET00065 0.145 0.063 DBMET00066 0.145 0.063 DBMET00067 0.136 0.084 DBMET01106 0.161 0.036 DBMET01109 0.137 0.08 DBMET01110 0.127 0.108 DBMET01107 0.149 0.054 DBMET01108 | DBMET00065 | |
| 0.127 | 0.01 | 0.157 | Matrix metalloproteinase (membrane-type) inhibitor | 0.141 0.009 DBMET00060 0.108 0.013 DBMET00061 0.066 0.027 DBMET00062 0.106 0.013 DBMET00063 0.066 0.027 DBMET00066 0.066 0.027 DBMET00067 0.138 0.009 DBMET01109 0.087 0.018 DBMET01110 0.109 0.013 DBMET01107 0.157 0.008 DBMET01108 | DBMET01108 | |
| 0.123 | 0.007 | 0.148 | GABA B receptor agonist | 0.071 0.064 DBMET00060 0.142 0.005 DBMET00061 0.106 0.013 DBMET00062 0.097 0.019 DBMET00063 0.094 0.022 DBMET00065 0.085 0.033 DBMET00066 0.085 0.033 DBMET00067 0.072 0.061 DBMET01106 0.148 0.004 DBMET01109 0.105 0.013 DBMET01110 0.096 0.02 DBMET01107 0.121 0.007 DBMET01108 | DBMET01109 | |
| 0.146 | 0.03 | 0.164 | Carbonic anhydrase III inhibitor | 0.138 0.033 DBMET00061 0.109 0.053 DBMET00062 0.092 0.072 DBMET00064 0.119 0.045 DBMET00065 0.097 0.066 DBMET00066 0.097 0.066 DBMET00067 0.164 0.024 DBMET01109 0.113 0.05 DBMET01110 0.098 0.065 DBMET01107 0.127 0.04 DBMET01108 | DBMET01109 | |
| 0.127 | 0.012 | 0.127 | Aminopeptidase microsomal inhibitor | 0.054 0.044 DBMET00060 0.077 0.026 DBMET00061 0.083 0.023 DBMET00062 0.075 0.028 DBMET00063 0.07 0.031 DBMET00066 0.07 0.031 DBMET00067 0.121 0.013 DBMET01109 0.084 0.023 DBMET01110 0.101 0.017 DBMET01107 0.125 0.012 DBMET01108 | ||
| 0.12 | 0.007 | 0.128 | Vanilloid 4 agonist | 0.101 0.016 DBMET00060 0.098 0.018 DBMET00061 0.113 0.009 DBMET00062 0.106 0.013 DBMET00063 0.109 0.011 DBMET00065 0.098 0.018 DBMET00066 0.098 0.018 DBMET00067 0.091 0.025 DBMET01106 0.128 0.005 DBMET01109 0.096 0.02 DBMET01110 0.089 0.027 DBMET01107 0.116 0.008 DBMET01108 | DBMET01109 | |
| 0.133 | 0.02 | 0.164 | Metalloproteinase-9 inhibitor | 0.135 0.019 DBMET00060 0.105 0.03 DBMET00061 0.164 0.013 DBMET00062 0.121 0.024 DBMET00063 0.104 0.03 DBMET00066 0.104 0.03 DBMET00067 0.13 0.021 DBMET01109 0.105 0.03 DBMET01110 0.121 0.024 DBMET01107 0.146 0.016 DBMET01108 | DBMET00062 | |
| 0.14 | 0.027 | 0.3 | Electron transport complex I inhibitor | 0.116 0.053 DBMET00060 0.138 0.028 DBMET00061 0.138 0.028 DBMET00062 0.134 0.031 DBMET00063 0.177 0.012 DBMET00065 0.213 0.007 DBMET00066 0.213 0.007 DBMET00067 0.201 0.008 DBMET01106 0.115 0.054 DBMET01109 0.3 0.005 DBMET01110 0.153 0.019 DBMET01107 0.115 0.054 DBMET01108 | DBMET01110 | |
| 0.116 | 0.003 | 0.122 | Glutamate (mGluR1) agonist | 0.074 0.004 DBMET00060 0.122 0.003 DBMET00061 0.042 0.005 DBMET00062 0.041 0.005 DBMET00063 0.049 0.005 DBMET00065 0.039 0.006 DBMET00066 0.039 0.006 DBMET00067 0.072 0.004 DBMET01106 0.114 0.003 DBMET01109 0.044 0.005 DBMET01110 0.035 0.007 DBMET01107 0.088 0.004 DBMET01108 | DBMET00061 | |
| 0.125 | 0.013 | 0.216 | Prostaglandin antagonist | 0.063 0.03 DBMET00061 0.075 0.024 DBMET00062 0.062 0.03 DBMET00063 0.216 0.006 DBMET01109 0.141 0.011 DBMET01108 | DBMET01109 | |
| 0.17 | 0.059 | 0.17 | Acetylcholine M1 receptor antagonist | 0.149 0.076 DBMET00060 0.167 0.061 DBMET00061 0.141 0.084 DBMET01109 0.165 0.062 DBMET01107 0.128 0.098 DBMET01108 | ||
| 0.116 | 0.005 | 0.116 | Glutamate (mGluR group II) agonist | 0.082 0.009 DBMET00061 0.095 0.007 DBMET01109 0.107 0.006 DBMET01108 | ||
| 0.114 | 0.004 | 0.114 | Carbonic anhydrase II stimulant | 0.069 0.015 DBMET00060 0.08 0.009 DBMET00061 0.054 0.032 DBMET00062 0.077 0.01 DBMET00063 0.047 0.046 DBMET00064 0.051 0.037 DBMET00066 0.051 0.037 DBMET00067 0.104 0.005 DBMET01109 0.053 0.033 DBMET01110 0.078 0.01 DBMET01107 0.104 0.005 DBMET01108 | ||
| 0.133 | 0.024 | 0.171 | Cathepsin G inhibitor | 0.07 0.054 DBMET00060 0.082 0.042 DBMET00061 0.093 0.036 DBMET00062 0.101 0.033 DBMET00063 0.106 0.031 DBMET00065 0.074 0.049 DBMET00066 0.074 0.049 DBMET00067 0.064 0.061 DBMET01106 0.161 0.019 DBMET01109 0.104 0.032 DBMET01110 0.087 0.039 DBMET01107 0.171 0.018 DBMET01108 | DBMET01108 | |
| 0.196 | 0.087 | 0.369 | Interleukin antagonist | 0.147 0.12 DBMET00060 0.209 0.079 DBMET00061 0.214 0.077 DBMET00062 0.369 0.036 DBMET00063 0.189 0.09 DBMET00065 0.346 0.039 DBMET00066 0.346 0.039 DBMET00067 0.354 0.038 DBMET01109 0.143 0.123 DBMET01107 0.241 0.065 DBMET01108 | DBMET00063 | |
| 0.118 | 0.01 | 0.13 | Androgen agonist | 0.13 0.009 DBMET00060 0.098 0.015 DBMET00061 0.061 0.04 DBMET00062 0.077 0.026 DBMET00063 0.077 0.026 DBMET00066 0.077 0.026 DBMET00067 0.107 0.013 DBMET01109 0.091 0.018 DBMET01110 0.092 0.018 DBMET01107 0.112 0.011 DBMET01108 | DBMET00060 | |
| 0.119 | 0.014 | 0.348 | Antimetabolite | 0.348 0.004 DBMET01015 0.117 0.014 DBMET00060 0.123 0.014 DBMET00061 0.072 0.021 DBMET00062 0.084 0.019 DBMET00063 0.106 0.015 DBMET00064 0.105 0.016 DBMET00065 0.071 0.021 DBMET00066 0.071 0.021 DBMET00067 0.09 0.018 DBMET01106 0.161 0.011 DBMET01109 0.059 0.026 DBMET01110 0.079 0.019 DBMET01107 0.116 0.014 DBMET01108 | DBMET01015 | |
| 0.118 | 0.013 | 0.149 | Toll-Like receptor 2 agonist | 0.041 0.028 DBMET00060 0.147 0.011 DBMET00061 0.111 0.014 DBMET00062 0.128 0.013 DBMET00063 0.115 0.013 DBMET00064 0.093 0.015 DBMET00065 0.055 0.022 DBMET00066 0.055 0.022 DBMET00067 0.04 0.029 DBMET01106 0.149 0.011 DBMET01109 0.057 0.021 DBMET01110 0.049 0.024 DBMET01107 0.109 0.014 DBMET01108 | DBMET01109 | |
| 0.142 | 0.037 | 0.17 | Xanthine oxidase inhibitor | 0.109 0.054 DBMET00060 0.119 0.048 DBMET00061 0.109 0.053 DBMET00062 0.12 0.047 DBMET00063 0.17 0.027 DBMET00064 0.097 0.063 DBMET00065 0.132 0.042 DBMET00066 0.132 0.042 DBMET00067 0.131 0.042 DBMET01106 0.131 0.042 DBMET01109 0.095 0.065 DBMET01110 0.084 0.083 DBMET01107 0.106 0.055 DBMET01108 | DBMET00064 | |
| 0.149 | 0.045 | 0.66 | Adenylate cyclase inhibitor | 0.66 0.002 DBMET01015 0.127 0.061 DBMET00060 0.152 0.044 DBMET00061 0.123 0.065 DBMET00062 0.136 0.055 DBMET00063 0.094 0.09 DBMET00064 0.105 0.08 DBMET01106 0.148 0.047 DBMET01109 0.103 0.082 DBMET01110 0.14 0.052 DBMET01108 | DBMET01015 | |
| 0.143 | 0.04 | 0.143 | Falcipain 3 inhibitor | 0.126 0.05 DBMET00061 0.091 0.08 DBMET00062 0.094 0.077 DBMET00065 0.093 0.078 DBMET00066 0.093 0.078 DBMET00067 0.104 0.067 DBMET01109 0.117 0.056 DBMET01110 0.098 0.072 DBMET01107 0.104 0.067 DBMET01108 | ||
| 0.198 | 0.095 | 0.266 | Cyclic AMP phosphodiesterase inhibitor | 0.186 0.105 DBMET00061 0.155 0.144 DBMET00062 0.225 0.077 DBMET00063 0.266 0.056 DBMET00064 0.151 0.15 DBMET00065 0.17 0.122 DBMET01109 0.209 0.087 DBMET01107 | DBMET00064 | |
| 0.104 | 0.003 | 0.12 | Glutamate (mGluR8) agonist | 0.067 0.005 DBMET00060 0.07 0.005 DBMET00061 0.068 0.005 DBMET00062 0.062 0.006 DBMET00063 0.067 0.005 DBMET00065 0.073 0.004 DBMET00066 0.073 0.004 DBMET00067 0.056 0.009 DBMET01106 0.115 0.003 DBMET01109 0.076 0.004 DBMET01110 0.069 0.005 DBMET01107 0.12 0.002 DBMET01108 | DBMET01108 | |
| 0.132 | 0.031 | 0.193 | Uric acid excretion stimulant | 0.12 0.038 DBMET00061 0.088 0.069 DBMET00062 0.135 0.029 DBMET00064 0.193 0.014 DBMET00066 0.193 0.014 DBMET00067 0.127 0.034 DBMET01109 0.082 0.078 DBMET01110 0.122 0.037 DBMET01107 0.107 0.047 DBMET01108 | DBMET00067 | |
| 0.118 | 0.017 | 0.133 | Na+ K+ transporting ATPase inhibitor | 0.111 0.022 DBMET00060 0.116 0.019 DBMET00061 0.112 0.021 DBMET00062 0.114 0.02 DBMET00063 0.133 0.01 DBMET00064 0.111 0.022 DBMET00065 0.114 0.02 DBMET00066 0.114 0.02 DBMET00067 0.104 0.028 DBMET01106 0.118 0.018 DBMET01109 0.107 0.025 DBMET01110 0.103 0.029 DBMET01107 0.114 0.02 DBMET01108 | DBMET00064 | |
| 0.161 | 0.061 | 0.389 | Lipid peroxidase inhibitor | 0.18 0.05 DBMET00061 0.112 0.103 DBMET00062 0.199 0.042 DBMET00063 0.389 0.01 DBMET00064 0.383 0.01 DBMET00065 0.167 0.057 DBMET00066 0.167 0.057 DBMET00067 0.193 0.045 DBMET01106 0.166 0.058 DBMET01109 0.109 0.106 DBMET01110 0.213 0.036 DBMET01107 0.122 0.091 DBMET01108 | DBMET00064 | |
| 0.12 | 0.02 | 0.175 | Bile acid receptor antagonist | 0.097 0.055 DBMET00060 0.128 0.014 DBMET00061 0.098 0.055 DBMET00062 0.096 0.058 DBMET00063 0.175 0.005 DBMET00065 0.098 0.055 DBMET00066 0.098 0.055 DBMET00067 0.133 0.012 DBMET01106 0.129 0.014 DBMET01109 0.105 0.039 DBMET01110 0.121 0.019 DBMET01107 0.116 0.023 DBMET01108 | DBMET00065 | |
| 0.108 | 0.009 | 0.125 | Metalloproteinase-3 inhibitor | 0.078 0.016 DBMET00060 0.105 0.009 DBMET00061 0.057 0.026 DBMET00062 0.079 0.016 DBMET00063 0.052 0.03 DBMET00066 0.052 0.03 DBMET00067 0.113 0.008 DBMET01109 0.057 0.026 DBMET01110 0.065 0.021 DBMET01107 0.125 0.007 DBMET01108 | DBMET01108 | |
| 0.105 | 0.006 | 0.248 | Alpha-mannosidase inhibitor | 0.059 0.029 DBMET00060 0.121 0.005 DBMET00061 0.103 0.006 DBMET00062 0.108 0.005 DBMET00063 0.248 0.003 DBMET00064 0.077 0.013 DBMET00065 0.07 0.017 DBMET00066 0.07 0.017 DBMET00067 0.06 0.027 DBMET01106 0.086 0.009 DBMET01109 0.074 0.014 DBMET01110 0.068 0.018 DBMET01107 0.086 0.009 DBMET01108 | DBMET00064 | |
| 0.231 | 0.131 | 0.622 | Immunomodulator | 0.622 0.01 DBMET01015 0.315 0.074 DBMET00060 0.355 0.058 DBMET00061 0.454 0.03 DBMET00062 0.335 0.065 DBMET00063 0.56 0.016 DBMET00064 0.202 0.162 DBMET00065 0.559 0.016 DBMET00066 0.559 0.016 DBMET00067 0.283 0.092 DBMET01106 0.29 0.088 DBMET01109 0.235 0.127 DBMET01108 | DBMET01015 | |
| 0.115 | 0.016 | 0.115 | D-Ala-D-Ala ligase inhibitor | 0.079 0.072 DBMET00060 0.085 0.054 DBMET00061 0.09 0.044 DBMET00062 0.085 0.056 DBMET00063 0.089 0.047 DBMET00065 0.089 0.046 DBMET00066 0.089 0.046 DBMET00067 0.101 0.028 DBMET01109 0.097 0.033 DBMET01110 0.091 0.043 DBMET01107 0.101 0.028 DBMET01108 | ||
| 0.111 | 0.013 | 0.155 | Endothelin-converting enzyme inhibitor | 0.061 0.024 DBMET00061 0.069 0.021 DBMET00062 0.155 0.008 DBMET00063 0.045 0.034 DBMET00066 0.045 0.034 DBMET00067 0.097 0.015 DBMET01109 0.053 0.028 DBMET01110 0.063 0.023 DBMET01107 0.114 0.013 DBMET01108 | DBMET00063 | |
| 0.116 | 0.018 | 0.15 | Leukotriene synthesis inhibitor | 0.094 0.03 DBMET00060 0.093 0.03 DBMET00061 0.076 0.04 DBMET00062 0.06 0.055 DBMET00063 0.15 0.009 DBMET00065 0.067 0.047 DBMET00066 0.067 0.047 DBMET00067 0.104 0.024 DBMET01106 0.134 0.013 DBMET01109 0.079 0.038 DBMET01110 0.072 0.043 DBMET01107 0.103 0.024 DBMET01108 | DBMET00065 | |
| 0.102 | 0.005 | 0.102 | Glutamate (mGluR group II) antagonist | 0.08 0.007 DBMET00061 0.04 0.025 DBMET00062 0.048 0.017 DBMET00063 0.08 0.007 DBMET01109 0.034 0.033 DBMET01110 0.042 0.023 DBMET01107 0.073 0.008 DBMET01108 | ||
| 0.101 | 0.005 | 0.111 | Retinoid X receptor agonist | 0.104 0.004 DBMET00060 0.083 0.007 DBMET00061 0.066 0.012 DBMET00062 0.066 0.012 DBMET00063 0.096 0.005 DBMET00065 0.08 0.008 DBMET00066 0.08 0.008 DBMET00067 0.111 0.004 DBMET01106 0.099 0.005 DBMET01109 0.071 0.01 DBMET01110 0.061 0.013 DBMET01107 0.11 0.004 DBMET01108 | DBMET01106 | |
| 0.174 | 0.077 | 0.196 | Amyloid beta precursor protein antagonist | 0.196 0.06 DBMET00061 0.16 0.091 DBMET00066 0.16 0.091 DBMET00067 0.145 0.107 DBMET01109 | DBMET00061 | |
| 0.107 | 0.012 | 0.107 | Aminopeptidase N inhibitor | 0.055 0.027 DBMET00061 0.062 0.023 DBMET00062 0.055 0.027 DBMET00063 0.05 0.031 DBMET00066 0.05 0.031 DBMET00067 0.102 0.013 DBMET01109 0.063 0.023 DBMET01110 0.07 0.02 DBMET01107 0.106 0.012 DBMET01108 | ||
| 0.099 | 0.005 | 0.119 | Lysophosphatidic acid 3 receptor antagonist | 0.119 0.004 DBMET00060 0.099 0.005 DBMET00061 0.096 0.005 DBMET00062 0.088 0.007 DBMET00063 0.117 0.004 DBMET00065 0.082 0.009 DBMET00066 0.082 0.009 DBMET00067 0.112 0.004 DBMET01106 0.107 0.004 DBMET01109 0.077 0.011 DBMET01110 0.071 0.014 DBMET01107 0.092 0.006 DBMET01108 | DBMET00060 | |
| 0.133 | 0.039 | 0.197 | Protease inhibitor | 0.127 0.043 DBMET00060 0.11 0.056 DBMET00061 0.138 0.036 DBMET00062 0.197 0.015 DBMET00063 0.083 0.082 DBMET00064 0.092 0.072 DBMET00065 0.089 0.076 DBMET00066 0.089 0.076 DBMET00067 0.135 0.038 DBMET01109 0.127 0.043 DBMET01110 0.182 0.019 DBMET01107 0.134 0.039 DBMET01108 | DBMET00063 | |
| 0.099 | 0.005 | 0.123 | Retinoid X alpha receptor agonist | 0.096 0.005 DBMET00060 0.071 0.009 DBMET00061 0.042 0.018 DBMET00062 0.039 0.021 DBMET00063 0.11 0.004 DBMET00065 0.069 0.009 DBMET00066 0.069 0.009 DBMET00067 0.123 0.004 DBMET01106 0.095 0.005 DBMET01109 0.057 0.012 DBMET01110 0.046 0.016 DBMET01107 0.085 0.007 DBMET01108 | DBMET01106 | |
| 0.112 | 0.018 | 0.134 | Neutrophil collagenase inhibitor | 0.074 0.036 DBMET00060 0.102 0.021 DBMET00061 0.067 0.042 DBMET00062 0.082 0.03 DBMET00063 0.056 0.055 DBMET00066 0.056 0.055 DBMET00067 0.131 0.015 DBMET01109 0.066 0.044 DBMET01110 0.075 0.035 DBMET01107 0.134 0.014 DBMET01108 | DBMET01108 | |
| 0.103 | 0.01 | 0.141 | 5-Alpha-reductase inhibitor | 0.095 0.01 DBMET00060 0.088 0.011 DBMET00061 0.04 0.024 DBMET00062 0.035 0.028 DBMET00063 0.04 0.024 DBMET00065 0.092 0.011 DBMET00066 0.092 0.011 DBMET00067 0.039 0.025 DBMET01106 0.141 0.007 DBMET01109 0.089 0.011 DBMET01110 0.084 0.012 DBMET01107 0.096 0.01 DBMET01108 | DBMET01109 | |
| 0.114 | 0.022 | 0.412 | Vanilloid agonist | 0.121 0.018 DBMET00060 0.129 0.015 DBMET00061 0.088 0.05 DBMET00062 0.08 0.069 DBMET00063 0.081 0.067 DBMET00064 0.143 0.012 DBMET00065 0.412 0.004 DBMET00066 0.412 0.004 DBMET00067 0.112 0.023 DBMET01106 0.12 0.018 DBMET01109 0.098 0.035 DBMET01110 0.089 0.05 DBMET01107 0.099 0.035 DBMET01108 | DBMET00067 | |
| 0.099 | 0.008 | 0.1 | Diacylglycerol O-acyltransferase inhibitor | 0.091 0.01 DBMET00061 0.059 0.027 DBMET00063 0.1 0.007 DBMET01109 0.052 0.034 DBMET01107 0.088 0.011 DBMET01108 | DBMET01109 | |
| 0.167 | 0.076 | 0.222 | Antipruritic | 0.169 0.075 DBMET00061 0.142 0.104 DBMET00062 0.222 0.036 DBMET00066 0.222 0.036 DBMET00067 0.185 0.06 DBMET01109 0.132 0.119 DBMET01110 0.171 0.073 DBMET01108 | DBMET00067 | |
| 0.096 | 0.005 | 0.134 | Peroxisome proliferator-activated receptor delta antagonist | 0.064 0.007 DBMET00061 0.05 0.01 DBMET00062 0.049 0.01 DBMET00063 0.033 0.023 DBMET00065 0.036 0.019 DBMET00066 0.036 0.019 DBMET00067 0.109 0.005 DBMET01109 0.04 0.014 DBMET01110 0.035 0.019 DBMET01107 0.134 0.005 DBMET01108 | DBMET01108 | |
| 0.203 | 0.114 | 0.207 | Neuropeptide Y2 antagonist | 0.202 0.115 DBMET00062 0.186 0.148 DBMET00063 0.179 0.162 DBMET00066 0.179 0.162 DBMET00067 0.207 0.107 DBMET01109 0.189 0.14 DBMET01107 0.185 0.149 DBMET01108 | DBMET01109 | |
| 0.098 | 0.01 | 0.109 | Leukocyte elastase inhibitor | 0.05 0.023 DBMET00060 0.068 0.015 DBMET00061 0.04 0.033 DBMET00063 0.108 0.009 DBMET01109 0.068 0.015 DBMET01110 0.073 0.014 DBMET01107 0.109 0.009 DBMET01108 | DBMET01108 | |
| 0.105 | 0.018 | 0.164 | Ribonucleoside-diphosphate reductase inhibitor | 0.164 0.009 DBMET01015 0.1 0.019 DBMET00060 0.105 0.018 DBMET00061 0.11 0.017 DBMET00062 0.1 0.019 DBMET00063 0.096 0.02 DBMET00065 0.069 0.029 DBMET00066 0.069 0.029 DBMET00067 0.069 0.029 DBMET01106 0.123 0.015 DBMET01109 0.084 0.023 DBMET01110 0.131 0.014 DBMET01107 0.103 0.018 DBMET01108 | DBMET01015 | |
| 0.09 | 0.004 | 0.134 | ATP citrate lysase inhibitor | 0.061 0.005 DBMET00060 0.046 0.009 DBMET00061 0.094 0.004 DBMET00062 0.078 0.004 DBMET00063 0.047 0.009 DBMET00065 0.054 0.006 DBMET00066 0.054 0.006 DBMET00067 0.045 0.009 DBMET01106 0.116 0.003 DBMET01109 0.068 0.004 DBMET01110 0.058 0.005 DBMET01107 0.134 0.003 DBMET01108 | DBMET01108 | |
| 0.092 | 0.005 | 0.216 | Prostaglandin agonist | 0.079 0.007 DBMET00060 0.111 0.005 DBMET00061 0.182 0.003 DBMET00062 0.216 0.003 DBMET00063 0.028 0.026 DBMET00064 0.134 0.004 DBMET00065 0.058 0.009 DBMET00066 0.058 0.009 DBMET00067 0.079 0.007 DBMET01106 0.14 0.004 DBMET01109 0.055 0.009 DBMET01110 0.049 0.01 DBMET01107 0.089 0.006 DBMET01108 | DBMET00063 | |
| 0.139 | 0.053 | 0.139 | Proteasome inhibitor | 0.133 0.056 DBMET00060 0.111 0.074 DBMET00061 0.104 0.081 DBMET00062 0.129 0.059 DBMET00063 0.104 0.082 DBMET00065 0.122 0.064 DBMET00066 0.122 0.064 DBMET00067 0.096 0.093 DBMET01106 0.133 0.057 DBMET01109 0.11 0.075 DBMET01110 0.108 0.077 DBMET01107 0.112 0.072 DBMET01108 | ||
| 0.097 | 0.012 | 0.12 | Thromboxane antagonist | 0.07 0.026 DBMET00060 0.102 0.01 DBMET00061 0.086 0.017 DBMET00062 0.07 0.026 DBMET00063 0.096 0.013 DBMET00065 0.082 0.019 DBMET00066 0.082 0.019 DBMET00067 0.057 0.034 DBMET01106 0.12 0.007 DBMET01109 0.065 0.029 DBMET01110 0.053 0.039 DBMET01107 0.107 0.009 DBMET01108 | DBMET01109 | |
| 0.104 | 0.02 | 0.204 | Ribonucleotide reductase inhibitor | 0.204 0.007 DBMET01015 0.098 0.021 DBMET00060 0.105 0.02 DBMET00061 0.109 0.019 DBMET00062 0.101 0.021 DBMET00063 0.095 0.022 DBMET00065 0.07 0.031 DBMET00066 0.07 0.031 DBMET00067 0.069 0.031 DBMET01106 0.12 0.017 DBMET01109 0.085 0.025 DBMET01110 0.127 0.016 DBMET01107 0.103 0.02 DBMET01108 | DBMET01015 | |
| 0.1 | 0.016 | 0.249 | Purinergic P2X1 antagonist | 0.249 0.002 DBMET01015 0.06 0.044 DBMET00061 0.07 0.032 DBMET00062 0.062 0.041 DBMET00063 0.055 0.052 DBMET00064 0.086 0.022 DBMET00065 0.058 0.046 DBMET00066 0.058 0.046 DBMET00067 0.058 0.047 DBMET01106 0.094 0.018 DBMET01109 0.068 0.034 DBMET01110 0.06 0.043 DBMET01107 0.094 0.018 DBMET01108 | DBMET01015 | |
| 0.1 | 0.017 | 0.1 | NMDA receptor glycine site agonist | 0.073 0.034 DBMET00061 0.087 0.024 DBMET00065 0.061 0.045 DBMET00066 0.061 0.045 DBMET00067 0.084 0.026 DBMET01109 0.06 0.045 DBMET01110 0.084 0.026 DBMET01108 | ||
| 0.127 | 0.043 | 0.431 | AMP-activated protein kinase stimulant | 0.13 0.041 DBMET00061 0.094 0.078 DBMET00063 0.431 0.004 DBMET00064 0.116 0.052 DBMET00065 0.122 0.047 DBMET01109 0.136 0.037 DBMET01108 | DBMET00064 | |
| 0.099 | 0.016 | 0.138 | Peroxisome proliferator-activated receptor gamma antagonist | 0.08 0.034 DBMET00060 0.094 0.019 DBMET00061 0.093 0.02 DBMET00062 0.097 0.017 DBMET00063 0.138 0.007 DBMET00065 0.099 0.016 DBMET00066 0.099 0.016 DBMET00067 0.092 0.021 DBMET01106 0.103 0.014 DBMET01109 0.082 0.031 DBMET01110 0.089 0.023 DBMET01107 0.094 0.019 DBMET01108 | DBMET00065 | |
| 0.126 | 0.043 | 0.26 | Mediator release inhibitor | 0.095 0.076 DBMET00060 0.145 0.031 DBMET00061 0.127 0.042 DBMET00062 0.11 0.059 DBMET00063 0.193 0.016 DBMET00064 0.26 0.009 DBMET00065 0.131 0.039 DBMET01106 0.142 0.032 DBMET01109 0.096 0.075 DBMET01110 0.145 0.031 DBMET01107 0.113 0.055 DBMET01108 | DBMET00065 | |
| 0.098 | 0.016 | 0.112 | Phospholipase D inhibitor | 0.086 0.027 DBMET00061 0.075 0.043 DBMET00062 0.068 0.059 DBMET00063 0.112 0.009 DBMET00065 0.07 0.053 DBMET00066 0.07 0.053 DBMET00067 0.081 0.032 DBMET01106 0.108 0.011 DBMET01109 0.069 0.056 DBMET01110 0.093 0.019 DBMET01108 | DBMET00065 | |
| 0.089 | 0.007 | 0.228 | Mannosidase inhibitor | 0.043 0.035 DBMET00060 0.101 0.005 DBMET00061 0.088 0.007 DBMET00062 0.091 0.007 DBMET00063 0.228 0.003 DBMET00064 0.063 0.015 DBMET00065 0.054 0.021 DBMET00066 0.054 0.021 DBMET00067 0.045 0.032 DBMET01106 0.084 0.008 DBMET01109 0.059 0.017 DBMET01110 0.053 0.023 DBMET01107 0.076 0.01 DBMET01108 | DBMET00064 | |
| 0.096 | 0.015 | 0.379 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.379 0.002 DBMET01015 0.07 0.025 DBMET00060 0.092 0.016 DBMET00061 0.098 0.015 DBMET00062 0.088 0.017 DBMET00063 0.101 0.014 DBMET00064 0.081 0.02 DBMET00065 0.06 0.034 DBMET00066 0.06 0.034 DBMET00067 0.084 0.019 DBMET01106 0.077 0.022 DBMET01109 0.064 0.03 DBMET01110 0.057 0.037 DBMET01107 0.077 0.022 DBMET01108 | DBMET01015 | |
| 0.149 | 0.069 | 0.382 | Hemostatic | 0.148 0.071 DBMET00061 0.136 0.087 DBMET00062 0.14 0.081 DBMET00063 0.382 0.009 DBMET00064 0.165 0.052 DBMET00066 0.165 0.052 DBMET00067 0.167 0.051 DBMET01109 0.168 0.05 DBMET01108 | DBMET00064 | |
| 0.084 | 0.004 | 0.084 | Geranyltranstransferase inhibitor | 0.056 0.017 DBMET00060 0.07 0.008 DBMET00061 0.061 0.013 DBMET00062 0.061 0.013 DBMET00063 0.082 0.004 DBMET00065 0.063 0.011 DBMET00066 0.063 0.011 DBMET00067 0.057 0.016 DBMET01106 0.077 0.005 DBMET01109 0.065 0.01 DBMET01110 0.059 0.014 DBMET01107 0.072 0.007 DBMET01108 | ||
| 0.083 | 0.004 | 0.083 | Free fatty acid receptor 1 antagonist | 0.039 0.017 DBMET00060 0.069 0.004 DBMET00061 0.048 0.01 DBMET00062 0.042 0.014 DBMET00063 0.046 0.011 DBMET00065 0.051 0.008 DBMET00066 0.051 0.008 DBMET00067 0.082 0.004 DBMET01109 0.06 0.005 DBMET01110 0.053 0.008 DBMET01107 0.082 0.004 DBMET01108 | ||
| 0.083 | 0.005 | 0.103 | Glucagon receptor antagonist | 0.041 0.013 DBMET00061 0.047 0.011 DBMET00062 0.047 0.011 DBMET00063 0.028 0.022 DBMET00066 0.028 0.022 DBMET00067 0.094 0.004 DBMET01109 0.034 0.017 DBMET01110 0.103 0.004 DBMET01108 | DBMET01108 | |
| 0.088 | 0.011 | 0.867 | Purinergic P2Y antagonist | 0.867 0.001 DBMET01015 0.04 0.036 DBMET00060 0.117 0.007 DBMET00061 0.042 0.034 DBMET00062 0.069 0.016 DBMET00063 0.047 0.029 DBMET00064 0.118 0.007 DBMET01109 0.062 0.018 DBMET01107 0.082 0.012 DBMET01108 | DBMET01015 | |
| 0.117 | 0.041 | 0.209 | Folate antagonist | 0.091 0.084 DBMET00061 0.096 0.073 DBMET00062 0.102 0.061 DBMET00065 0.209 0.009 DBMET01109 0.144 0.024 DBMET01108 | DBMET01109 | |
| 0.083 | 0.008 | 0.132 | Adenine nucleotide translocase inhibitor | 0.063 0.023 DBMET01015 0.058 0.033 DBMET00060 0.073 0.013 DBMET00061 0.066 0.019 DBMET00062 0.063 0.024 DBMET00063 0.132 0.003 DBMET00064 0.055 0.04 DBMET00065 0.065 0.021 DBMET00066 0.065 0.021 DBMET00067 0.059 0.03 DBMET01106 0.078 0.01 DBMET01109 0.068 0.017 DBMET01110 0.064 0.022 DBMET01107 0.124 0.004 DBMET01108 | DBMET00064 | |
| 0.091 | 0.015 | 0.138 | Prostaglandin F2 alpha antagonist | 0.068 0.034 DBMET00060 0.084 0.019 DBMET00061 0.103 0.01 DBMET00062 0.104 0.01 DBMET00063 0.07 0.033 DBMET00065 0.07 0.032 DBMET00066 0.07 0.032 DBMET00067 0.059 0.049 DBMET01106 0.138 0.005 DBMET01109 0.058 0.05 DBMET01110 0.102 0.011 DBMET01108 | DBMET01109 | |
| 0.087 | 0.011 | 0.105 | Thromboxane A2 antagonist | 0.065 0.024 DBMET00060 0.091 0.01 DBMET00061 0.078 0.016 DBMET00062 0.065 0.025 DBMET00063 0.084 0.013 DBMET00065 0.075 0.018 DBMET00066 0.075 0.018 DBMET00067 0.051 0.036 DBMET01106 0.105 0.006 DBMET01109 0.061 0.027 DBMET01110 0.049 0.037 DBMET01107 0.096 0.009 DBMET01108 | DBMET01109 | |
| 0.114 | 0.039 | 0.114 | Calcium antagonist | 0.113 0.039 DBMET00061 0.096 0.05 DBMET00062 0.11 0.041 DBMET00063 0.088 0.057 DBMET01109 0.082 0.062 DBMET01107 0.075 0.068 DBMET01108 | ||
| 0.08 | 0.006 | 0.093 | Arginase inhibitor | 0.038 0.024 DBMET00060 0.081 0.005 DBMET00061 0.058 0.011 DBMET00062 0.054 0.013 DBMET00063 0.093 0.004 DBMET00064 0.05 0.015 DBMET00065 0.05 0.015 DBMET00066 0.05 0.015 DBMET00067 0.031 0.03 DBMET01106 0.083 0.005 DBMET01109 0.054 0.013 DBMET01110 0.048 0.016 DBMET01107 0.074 0.007 DBMET01108 | DBMET00064 | |
| 0.101 | 0.027 | 0.113 | Prostaglandin-E synthase inhibitor | 0.07 0.049 DBMET00061 0.113 0.022 DBMET00065 0.063 0.059 DBMET00066 0.063 0.059 DBMET00067 0.086 0.035 DBMET01109 0.064 0.058 DBMET01110 0.082 0.037 DBMET01108 | DBMET00065 | |
| 0.089 | 0.015 | 0.108 | Exportin-1 inhibitor | 0.108 0.006 DBMET00060 0.066 0.053 DBMET00061 0.085 0.02 DBMET00062 0.091 0.014 DBMET00063 0.081 0.024 DBMET00065 0.088 0.017 DBMET00066 0.088 0.017 DBMET00067 0.108 0.006 DBMET01106 0.074 0.034 DBMET01109 0.077 0.03 DBMET01110 0.07 0.043 DBMET01107 0.088 0.016 DBMET01108 | DBMET01106 | |
| 0.081 | 0.008 | 0.092 | Leukotriene C antagonist | 0.079 0.008 DBMET00060 0.081 0.007 DBMET00061 0.07 0.014 DBMET00062 0.067 0.017 DBMET00063 0.079 0.008 DBMET00065 0.068 0.016 DBMET00066 0.068 0.016 DBMET00067 0.069 0.015 DBMET01106 0.092 0.005 DBMET01109 0.071 0.013 DBMET01110 0.072 0.013 DBMET01107 0.08 0.008 DBMET01108 | DBMET01109 | |
| 0.122 | 0.049 | 0.317 | 5-Lipoxygenase inhibitor | 0.107 0.058 DBMET00060 0.107 0.058 DBMET00061 0.317 0.009 DBMET00065 0.126 0.047 DBMET00066 0.126 0.047 DBMET00067 0.179 0.029 DBMET01106 0.119 0.051 DBMET01109 0.103 0.061 DBMET01108 | DBMET00065 | |
| 0.082 | 0.01 | 0.092 | HCV NS3/NS4A protease inhibitor | 0.092 0.006 DBMET00060 0.062 0.019 DBMET00061 0.056 0.025 DBMET00062 0.063 0.019 DBMET00063 0.046 0.04 DBMET00065 0.058 0.023 DBMET00066 0.058 0.023 DBMET00067 0.05 0.032 DBMET01106 0.088 0.008 DBMET01109 0.065 0.018 DBMET01110 0.076 0.012 DBMET01107 0.084 0.009 DBMET01108 | DBMET00060 | |
| 0.078 | 0.01 | 0.108 | Adenosine deaminase inhibitor | 0.108 0.005 DBMET01015 0.07 0.014 DBMET00060 0.09 0.007 DBMET00061 0.08 0.009 DBMET00062 0.095 0.006 DBMET00063 0.069 0.014 DBMET00064 0.06 0.02 DBMET00065 0.06 0.021 DBMET00066 0.06 0.021 DBMET00067 0.058 0.023 DBMET01106 0.076 0.011 DBMET01109 0.061 0.02 DBMET01110 0.056 0.025 DBMET01107 0.071 0.013 DBMET01108 | DBMET01015 | |
| 0.073 | 0.005 | 0.087 | Peptide deformylase inhibitor | 0.066 0.005 DBMET00060 0.053 0.009 DBMET00061 0.04 0.014 DBMET00062 0.035 0.017 DBMET00063 0.043 0.013 DBMET00066 0.043 0.013 DBMET00067 0.081 0.004 DBMET01109 0.076 0.005 DBMET01110 0.064 0.006 DBMET01107 0.087 0.004 DBMET01108 | DBMET01108 | |
| 0.084 | 0.016 | 0.09 | MDM2 inhibitor | 0.089 0.012 DBMET00061 0.07 0.04 DBMET00062 0.083 0.016 DBMET00063 0.067 0.047 DBMET00065 0.09 0.011 DBMET01109 0.067 0.049 DBMET01110 0.072 0.033 DBMET01107 0.079 0.021 DBMET01108 | DBMET01109 | |
| 0.071 | 0.003 | 0.082 | Prostaglandin F2 alpha agonist | 0.077 0.003 DBMET00060 0.081 0.002 DBMET00061 0.074 0.003 DBMET00062 0.079 0.002 DBMET00063 0.029 0.009 DBMET00064 0.046 0.005 DBMET00065 0.057 0.004 DBMET00066 0.057 0.004 DBMET00067 0.049 0.004 DBMET01106 0.082 0.002 DBMET01109 0.062 0.003 DBMET01110 0.056 0.004 DBMET01107 0.071 0.003 DBMET01108 | DBMET01109 | |
| 0.148 | 0.08 | 0.155 | CF transmembrane conductance regulator agonist | 0.155 0.068 DBMET00064 0.139 0.097 DBMET01106 0.137 0.102 DBMET01109 | DBMET00064 | |
| 0.094 | 0.026 | 0.108 | Sphingosine 1-phosphate receptor antagonist | 0.095 0.025 DBMET00061 0.078 0.05 DBMET00062 0.073 0.062 DBMET00063 0.108 0.017 DBMET01109 0.079 0.049 DBMET01110 0.075 0.056 DBMET01107 0.087 0.034 DBMET01108 | DBMET01109 | |
| 0.134 | 0.067 | 0.334 | Interleukin 4 antagonist | 0.19 0.025 DBMET00060 0.175 0.032 DBMET00061 0.18 0.029 DBMET00064 0.183 0.028 DBMET00065 0.334 0.007 DBMET00066 0.334 0.007 DBMET00067 0.132 0.069 DBMET01106 0.122 0.083 DBMET01109 | DBMET00067 | |
| 0.102 | 0.035 | 0.144 | Inducible nitric-oxide synthase inhibitor | 0.089 0.049 DBMET00060 0.105 0.033 DBMET00065 0.132 0.021 DBMET00066 0.132 0.021 DBMET00067 0.093 0.044 DBMET01106 0.088 0.05 DBMET01109 0.144 0.018 DBMET01107 0.078 0.066 DBMET01108 | DBMET01107 | |
| 0.075 | 0.009 | 0.083 | Pregnane X receptor antagonist | 0.055 0.045 DBMET00060 0.064 0.023 DBMET00061 0.057 0.039 DBMET00062 0.083 0.005 DBMET00065 0.064 0.023 DBMET00066 0.064 0.023 DBMET00067 0.068 0.017 DBMET01106 0.077 0.008 DBMET01109 0.061 0.028 DBMET01110 0.057 0.039 DBMET01107 0.071 0.013 DBMET01108 | DBMET00065 | |
| 0.087 | 0.021 | 0.105 | NMDA 2C receptor antagonist | 0.055 0.052 DBMET00060 0.074 0.029 DBMET00061 0.105 0.014 DBMET01109 0.08 0.025 DBMET01108 | DBMET01109 | |
| 0.156 | 0.09 | 0.524 | Nitric oxide antagonist | 0.25 0.051 DBMET00060 0.165 0.084 DBMET00061 0.165 0.085 DBMET00062 0.181 0.076 DBMET00063 0.524 0.014 DBMET00064 0.418 0.023 DBMET00065 0.328 0.035 DBMET00066 0.328 0.035 DBMET00067 0.336 0.034 DBMET01106 0.152 0.093 DBMET01109 0.166 0.084 DBMET01110 0.243 0.053 DBMET01107 0.18 0.077 DBMET01108 | DBMET00064 | |
| 0.08 | 0.015 | 0.14 | Plasminogen activator inhibitor antagonist | 0.069 0.019 DBMET00061 0.14 0.005 DBMET01109 0.044 0.042 DBMET01110 0.081 0.015 DBMET01108 | DBMET01109 | |
| 0.081 | 0.016 | 0.094 | Sphingosine 1-phosphate receptor 3 antagonist | 0.056 0.044 DBMET00060 0.094 0.01 DBMET00061 0.06 0.037 DBMET00062 0.065 0.032 DBMET00063 0.055 0.046 DBMET00065 0.08 0.017 DBMET01109 0.06 0.037 DBMET01110 0.072 0.023 DBMET01108 | DBMET00061 | |
| 0.087 | 0.022 | 0.112 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.05 DBMET00060 0.075 0.032 DBMET00061 0.066 0.042 DBMET00062 0.069 0.038 DBMET00063 0.078 0.029 DBMET00065 0.082 0.026 DBMET00066 0.082 0.026 DBMET00067 0.061 0.051 DBMET01106 0.084 0.024 DBMET01109 0.078 0.029 DBMET01110 0.112 0.012 DBMET01107 0.077 0.029 DBMET01108 | DBMET01107 | |
| 0.074 | 0.01 | 0.098 | Sphingosine 1-phosphate receptor agonist | 0.098 0.006 DBMET00061 0.087 0.007 DBMET00062 0.078 0.009 DBMET00063 0.043 0.032 DBMET00066 0.043 0.032 DBMET00067 0.093 0.006 DBMET01109 0.044 0.031 DBMET01110 0.079 0.009 DBMET01108 | DBMET00061 | |
| 0.084 | 0.021 | 0.17 | GP IIb/IIIa receptor antagonist | 0.051 0.032 DBMET00061 0.047 0.035 DBMET00062 0.045 0.037 DBMET00066 0.045 0.037 DBMET00067 0.137 0.012 DBMET01109 0.062 0.027 DBMET01110 0.17 0.009 DBMET01108 | DBMET01108 | |
| 0.159 | 0.095 | 0.338 | DNA methyltransferase I inhibitor | 0.187 0.076 DBMET00064 0.338 0.016 DBMET00065 0.183 0.078 DBMET00066 0.183 0.078 DBMET00067 0.24 0.051 DBMET01106 0.188 0.075 DBMET01109 0.133 0.125 DBMET01107 0.139 0.117 DBMET01108 | DBMET00065 | |
| 0.067 | 0.004 | 0.079 | Retinoid X receptor antagonist | 0.063 0.005 DBMET00060 0.063 0.005 DBMET00061 0.046 0.017 DBMET00062 0.041 0.022 DBMET00063 0.074 0.004 DBMET00065 0.07 0.004 DBMET00066 0.07 0.004 DBMET00067 0.079 0.003 DBMET01106 0.064 0.005 DBMET01109 0.054 0.009 DBMET01110 0.05 0.013 DBMET01107 0.062 0.005 DBMET01108 | DBMET01106 | |
| 0.082 | 0.02 | 0.091 | Matrix metalloproteinase 1 inhibitor | 0.091 0.016 DBMET00060 0.08 0.021 DBMET00061 0.049 0.04 DBMET00062 0.063 0.029 DBMET00063 0.056 0.035 DBMET00066 0.056 0.035 DBMET00067 0.068 0.027 DBMET01109 0.059 0.032 DBMET01110 0.063 0.03 DBMET01107 0.084 0.019 DBMET01108 | DBMET00060 | |
| 0.112 | 0.05 | 0.143 | Gastric antisecretory | 0.097 0.07 DBMET00060 0.143 0.03 DBMET00061 0.09 0.079 DBMET00062 0.113 0.05 DBMET00065 0.087 0.083 DBMET01106 0.128 0.037 DBMET01109 0.087 0.083 DBMET01107 0.12 0.043 DBMET01108 | DBMET00061 | |
| 0.084 | 0.022 | 0.09 | Collagenase 3 inhibitor | 0.076 0.027 DBMET00061 0.057 0.046 DBMET00063 0.089 0.019 DBMET01109 0.06 0.04 DBMET01107 0.09 0.019 DBMET01108 | DBMET01108 | |
| 0.069 | 0.007 | 0.082 | GABA uptake inhibitor | 0.066 0.008 DBMET00060 0.082 0.005 DBMET00061 0.046 0.019 DBMET00062 0.04 0.026 DBMET00063 0.065 0.008 DBMET00065 0.048 0.017 DBMET00066 0.048 0.017 DBMET00067 0.045 0.02 DBMET01106 0.076 0.005 DBMET01109 0.043 0.022 DBMET01110 0.038 0.029 DBMET01107 0.062 0.009 DBMET01108 | DBMET00061 | |
| 0.07 | 0.009 | 0.07 | Glutamate (mGluR2) agonist | 0.048 0.014 DBMET00061 0.047 0.015 DBMET01109 0.06 0.011 DBMET01108 | ||
| 0.065 | 0.005 | 0.09 | Leukotriene B4 receptor 1 antagonist | 0.056 0.005 DBMET00060 0.079 0.004 DBMET00061 0.05 0.007 DBMET00062 0.042 0.01 DBMET00063 0.025 0.022 DBMET00064 0.049 0.007 DBMET00065 0.051 0.007 DBMET00066 0.051 0.007 DBMET00067 0.039 0.012 DBMET01106 0.09 0.004 DBMET01109 0.043 0.01 DBMET01110 0.048 0.008 DBMET01107 0.066 0.005 DBMET01108 | DBMET01109 | |
| 0.212 | 0.152 | 0.219 | Thyroid hormone antagonist | 0.216 0.148 DBMET00061 0.219 0.146 DBMET00066 0.219 0.146 DBMET00067 0.196 0.165 DBMET01109 0.216 0.148 DBMET01107 | DBMET00067 | |
| 0.075 | 0.015 | 0.099 | Sphingosine 1-phosphate receptor 1 antagonist | 0.083 0.013 DBMET00061 0.064 0.023 DBMET00062 0.059 0.031 DBMET00063 0.099 0.009 DBMET01109 0.061 0.028 DBMET01110 0.054 0.042 DBMET01107 0.07 0.018 DBMET01108 | DBMET01109 | |
| 0.077 | 0.018 | 0.106 | Elastase inhibitor | 0.061 0.029 DBMET00061 0.075 0.019 DBMET01109 0.106 0.009 DBMET01110 0.105 0.009 DBMET01107 0.078 0.017 DBMET01108 | DBMET01110 | |
| 0.12 | 0.061 | 0.133 | Interleukin 8 antagonist | 0.121 0.06 DBMET00061 0.133 0.047 DBMET00065 0.113 0.071 DBMET00066 0.113 0.071 DBMET00067 0.124 0.056 DBMET01109 0.115 0.069 DBMET01107 0.102 0.091 DBMET01108 | DBMET00065 | |
| 0.077 | 0.018 | 0.105 | Sphingosine kinase inhibitor | 0.105 0.006 DBMET00061 0.087 0.012 DBMET00062 0.077 0.019 DBMET00063 0.055 0.05 DBMET00065 0.07 0.024 DBMET01109 0.059 0.042 DBMET01110 0.062 0.035 DBMET01108 | DBMET00061 | |
| 0.063 | 0.005 | 0.063 | Angiotensin AT1 receptor antagonist | 0.051 0.017 DBMET00060 0.057 0.009 DBMET00061 0.05 0.017 DBMET00062 0.055 0.011 DBMET00063 0.06 0.006 DBMET00065 0.056 0.01 DBMET00066 0.056 0.01 DBMET00067 0.05 0.018 DBMET01106 0.059 0.007 DBMET01109 0.056 0.011 DBMET01110 0.048 0.02 DBMET01107 0.059 0.007 DBMET01108 | ||
| 0.065 | 0.008 | 0.065 | Guanylate cyclase inhibitor | 0.058 0.013 DBMET00061 0.052 0.019 DBMET00062 0.045 0.027 DBMET00063 0.061 0.011 DBMET00064 0.05 0.021 DBMET00065 0.041 0.031 DBMET00066 0.041 0.031 DBMET00067 0.059 0.013 DBMET01109 0.057 0.014 DBMET01110 0.061 0.011 DBMET01107 0.059 0.013 DBMET01108 | ||
| 0.066 | 0.01 | 0.084 | Sphingosine 1-phosphate receptor 1 agonist | 0.084 0.005 DBMET00061 0.076 0.007 DBMET00062 0.071 0.008 DBMET00063 0.038 0.036 DBMET00065 0.039 0.035 DBMET00066 0.039 0.035 DBMET00067 0.078 0.006 DBMET01109 0.044 0.027 DBMET01110 0.07 0.008 DBMET01108 | DBMET00061 | |
| 0.066 | 0.009 | 0.081 | Nicotinic acid receptor agonist | 0.037 0.023 DBMET00060 0.052 0.014 DBMET00061 0.081 0.006 DBMET00065 0.04 0.02 DBMET00066 0.04 0.02 DBMET00067 0.052 0.014 DBMET01106 0.049 0.015 DBMET01109 0.034 0.028 DBMET01110 0.061 0.011 DBMET01107 0.043 0.019 DBMET01108 | DBMET00065 | |
| 0.066 | 0.01 | 0.066 | Dopamine D5 agonist | 0.05 0.018 DBMET00065 0.041 0.026 DBMET00066 0.041 0.026 DBMET00067 0.051 0.017 DBMET01109 0.048 0.019 DBMET01110 0.043 0.024 DBMET01107 0.051 0.017 DBMET01108 | ||
| 0.117 | 0.061 | 0.121 | Estrogen antagonist | 0.102 0.093 DBMET00060 0.121 0.053 DBMET00061 0.107 0.081 DBMET00065 0.112 0.071 DBMET01109 0.102 0.095 DBMET01108 | DBMET00061 | |
| 0.069 | 0.013 | 0.178 | Heparanase inhibitor | 0.05 0.044 DBMET00060 0.062 0.02 DBMET00061 0.056 0.031 DBMET00062 0.053 0.038 DBMET00063 0.178 0.002 DBMET00064 0.055 0.033 DBMET00065 0.057 0.028 DBMET00066 0.057 0.028 DBMET00067 0.068 0.013 DBMET01109 0.057 0.027 DBMET01110 0.058 0.027 DBMET01107 0.063 0.018 DBMET01108 | DBMET00064 | |
| 0.08 | 0.024 | 0.287 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.287 0.003 DBMET01015 0.062 0.037 DBMET00060 0.059 0.04 DBMET00062 0.066 0.033 DBMET00063 0.063 0.036 DBMET00064 0.1 0.017 DBMET00065 0.095 0.018 DBMET00066 0.095 0.018 DBMET00067 0.078 0.026 DBMET01106 0.086 0.022 DBMET01109 0.052 0.05 DBMET01110 0.07 0.03 DBMET01108 | DBMET01015 | |
| 0.062 | 0.007 | 0.098 | Prostaglandin EP4 antagonist | 0.032 0.014 DBMET00060 0.039 0.011 DBMET00061 0.098 0.004 DBMET00062 0.078 0.005 DBMET00063 0.046 0.009 DBMET00066 0.046 0.009 DBMET00067 0.094 0.005 DBMET01109 0.026 0.018 DBMET01110 0.058 0.007 DBMET01108 | DBMET00062 | |
| 0.062 | 0.006 | 0.113 | Lysophosphatidic acid 2 receptor antagonist | 0.106 0.004 DBMET00060 0.113 0.004 DBMET00061 0.045 0.01 DBMET00062 0.037 0.014 DBMET00063 0.106 0.004 DBMET00065 0.037 0.015 DBMET00066 0.037 0.015 DBMET00067 0.092 0.005 DBMET01106 0.068 0.005 DBMET01109 0.032 0.019 DBMET01110 0.045 0.01 DBMET01108 | DBMET00061 | |
| 0.059 | 0.003 | 0.07 | Lysophosphatidic acid receptor 1 agonist | 0.038 0.006 DBMET00060 0.07 0.003 DBMET00061 0.06 0.003 DBMET00062 0.061 0.003 DBMET00063 0.055 0.004 DBMET00065 0.046 0.004 DBMET00066 0.046 0.004 DBMET00067 0.04 0.005 DBMET01106 0.058 0.003 DBMET01109 0.04 0.005 DBMET01110 0.036 0.007 DBMET01107 0.047 0.004 DBMET01108 | DBMET00061 | |
| 0.059 | 0.004 | 0.066 | Carboxypeptidase B inhibitor | 0.039 0.013 DBMET00060 0.05 0.007 DBMET00061 0.047 0.008 DBMET00062 0.048 0.008 DBMET00063 0.048 0.007 DBMET00065 0.045 0.009 DBMET00066 0.045 0.009 DBMET00067 0.035 0.018 DBMET01106 0.059 0.004 DBMET01109 0.045 0.009 DBMET01110 0.042 0.011 DBMET01107 0.066 0.004 DBMET01108 | DBMET01108 | |
| 0.069 | 0.015 | 0.092 | Squalene epoxidase inhibitor | 0.047 0.041 DBMET00060 0.092 0.007 DBMET00061 0.051 0.032 DBMET00062 0.046 0.042 DBMET00063 0.077 0.011 DBMET00064 0.078 0.01 DBMET00065 0.053 0.029 DBMET00066 0.053 0.029 DBMET00067 0.048 0.038 DBMET01106 0.056 0.024 DBMET01109 0.05 0.035 DBMET01110 0.056 0.024 DBMET01108 | DBMET00061 | |
| 0.155 | 0.101 | 0.515 | Platelet adhesion inhibitor | 0.181 0.081 DBMET00061 0.436 0.009 DBMET00064 0.473 0.006 DBMET00065 0.164 0.092 DBMET00066 0.164 0.092 DBMET00067 0.145 0.111 DBMET01106 0.196 0.073 DBMET01109 0.515 0.005 DBMET01107 0.132 0.128 DBMET01108 | DBMET01107 | |
| 0.058 | 0.004 | 0.069 | Retinoid X alpha receptor antagonist | 0.055 0.005 DBMET00060 0.054 0.005 DBMET00061 0.04 0.015 DBMET00062 0.036 0.02 DBMET00063 0.064 0.003 DBMET00065 0.061 0.004 DBMET00066 0.061 0.004 DBMET00067 0.069 0.003 DBMET01106 0.053 0.005 DBMET01109 0.047 0.008 DBMET01110 0.044 0.011 DBMET01107 0.053 0.005 DBMET01108 | DBMET01106 | |
| 0.058 | 0.005 | 0.058 | Angiotensin II receptor antagonist | 0.038 0.017 DBMET00060 0.047 0.008 DBMET00061 0.043 0.011 DBMET00062 0.044 0.01 DBMET00063 0.052 0.006 DBMET00065 0.043 0.011 DBMET00066 0.043 0.011 DBMET00067 0.037 0.019 DBMET01106 0.051 0.006 DBMET01109 0.044 0.01 DBMET01110 0.037 0.019 DBMET01107 0.051 0.006 DBMET01108 | ||
| 0.078 | 0.025 | 0.113 | Caspase 9 inhibitor | 0.062 0.043 DBMET00061 0.06 0.048 DBMET00062 0.058 0.051 DBMET00063 0.059 0.05 DBMET00065 0.061 0.045 DBMET00066 0.061 0.045 DBMET00067 0.113 0.011 DBMET01109 0.094 0.016 DBMET01110 0.086 0.02 DBMET01107 0.097 0.015 DBMET01108 | DBMET01109 | |
| 0.097 | 0.044 | 0.162 | ATPase (Vacuolar H+) inhibitor | 0.092 0.052 DBMET00061 0.162 0.005 DBMET00062 0.109 0.029 DBMET00063 0.118 0.021 DBMET00064 0.129 0.014 DBMET00065 0.146 0.008 DBMET00066 0.146 0.008 DBMET00067 0.096 0.045 DBMET01106 0.091 0.055 DBMET01109 0.133 0.013 DBMET01110 0.083 0.071 DBMET01107 0.085 0.067 DBMET01108 | DBMET00062 | |
| 0.058 | 0.005 | 0.077 | Prostaglandin D2 agonist | 0.052 0.007 DBMET00060 0.057 0.006 DBMET00061 0.056 0.006 DBMET00062 0.077 0.004 DBMET00063 0.029 0.024 DBMET00064 0.057 0.006 DBMET00065 0.046 0.009 DBMET00066 0.046 0.009 DBMET00067 0.039 0.013 DBMET01106 0.074 0.004 DBMET01109 0.046 0.009 DBMET01110 0.042 0.011 DBMET01107 0.06 0.005 DBMET01108 | DBMET00063 | |
| 0.066 | 0.014 | 0.079 | Thymidylate synthase inhibitor | 0.048 0.031 DBMET00060 0.055 0.022 DBMET00061 0.041 0.04 DBMET00065 0.079 0.008 DBMET01109 0.041 0.04 DBMET01107 0.072 0.01 DBMET01108 | DBMET01109 | |
| 0.081 | 0.03 | 0.081 | Glutamate (mGluR) agonist | 0.056 0.049 DBMET01109 0.073 0.034 DBMET01108 | ||
| 0.064 | 0.013 | 0.069 | Urate transporter 1 inhibitor | 0.069 0.011 DBMET01109 0.058 0.015 DBMET01108 | DBMET01109 | |
| 0.064 | 0.013 | 0.066 | Collagenase inhibitor | 0.064 0.013 DBMET00060 0.052 0.028 DBMET00061 0.052 0.027 DBMET00063 0.061 0.015 DBMET01109 0.058 0.018 DBMET01110 0.066 0.011 DBMET01107 0.063 0.013 DBMET01108 | DBMET01107 | |
| 0.071 | 0.021 | 0.09 | Sphingosine kinase 2 inhibitor | 0.09 0.011 DBMET00061 0.063 0.028 DBMET00062 0.059 0.033 DBMET00063 0.053 0.041 DBMET01109 0.051 0.046 DBMET01110 0.053 0.041 DBMET01108 | DBMET00061 | |
| 0.077 | 0.028 | 0.259 | Neuraminidase inhibitor | 0.079 0.026 DBMET00060 0.094 0.018 DBMET00061 0.259 0.003 DBMET00062 0.101 0.015 DBMET00063 0.121 0.01 DBMET00064 0.056 0.048 DBMET00065 0.092 0.018 DBMET00066 0.092 0.018 DBMET00067 0.063 0.04 DBMET01109 | DBMET00062 | |
| 0.052 | 0.003 | 0.072 | Vanilloid 2 agonist | 0.044 0.004 DBMET00060 0.037 0.005 DBMET00061 0.038 0.004 DBMET00062 0.035 0.005 DBMET00063 0.072 0.002 DBMET00064 0.039 0.004 DBMET00065 0.038 0.004 DBMET00066 0.038 0.004 DBMET00067 0.042 0.004 DBMET01106 0.045 0.003 DBMET01109 0.042 0.004 DBMET01110 0.039 0.004 DBMET01107 0.045 0.003 DBMET01108 | DBMET00064 | |
| 0.054 | 0.005 | 0.118 | Integrin alpha1beta1 antagonist | 0.059 0.005 DBMET00060 0.041 0.019 DBMET00061 0.039 0.024 DBMET00062 0.037 0.031 DBMET00063 0.039 0.023 DBMET00065 0.047 0.009 DBMET00066 0.047 0.009 DBMET00067 0.039 0.023 DBMET01106 0.061 0.004 DBMET01109 0.043 0.015 DBMET01110 0.04 0.021 DBMET01107 0.118 0.002 DBMET01108 | DBMET01108 | |
| 0.054 | 0.005 | 0.068 | HMG CoA reductase inhibitor | 0.045 0.01 DBMET00060 0.046 0.009 DBMET00061 0.061 0.005 DBMET00062 0.068 0.004 DBMET00063 0.052 0.006 DBMET00064 0.068 0.004 DBMET00065 0.047 0.009 DBMET00066 0.047 0.009 DBMET00067 0.053 0.006 DBMET01106 0.06 0.005 DBMET01109 0.042 0.012 DBMET01110 0.041 0.014 DBMET01107 0.064 0.004 DBMET01108 | DBMET00065 | |
| 0.056 | 0.007 | 0.102 | 5-Alpha-reductase 2 inhibitor | 0.021 0.012 DBMET00060 0.04 0.008 DBMET00061 0.019 0.014 DBMET00066 0.019 0.014 DBMET00067 0.102 0.005 DBMET01109 0.02 0.013 DBMET01110 0.048 0.007 DBMET01108 | DBMET01109 | |
| 0.07 | 0.021 | 0.081 | Lipocortins synthesis agonist | 0.056 0.045 DBMET00060 0.071 0.02 DBMET00061 0.062 0.033 DBMET00062 0.059 0.037 DBMET00063 0.081 0.013 DBMET00064 0.067 0.025 DBMET00065 0.065 0.027 DBMET00066 0.065 0.027 DBMET00067 0.055 0.048 DBMET01106 0.075 0.017 DBMET01109 0.078 0.015 DBMET01110 0.068 0.023 DBMET01107 0.067 0.024 DBMET01108 | DBMET00064 | |
| 0.053 | 0.004 | 0.053 | Nicotinic acid receptor 2 antagonist | 0.046 0.004 DBMET00060 0.033 0.009 DBMET00061 0.031 0.012 DBMET00062 0.027 0.018 DBMET00063 0.038 0.006 DBMET00065 0.047 0.004 DBMET00066 0.047 0.004 DBMET00067 0.04 0.005 DBMET01106 0.042 0.005 DBMET01109 0.037 0.006 DBMET01110 0.033 0.009 DBMET01107 0.042 0.005 DBMET01108 | ||
| 0.056 | 0.007 | 0.079 | Peroxisome proliferator-activated receptor alpha antagonist | 0.043 0.009 DBMET00061 0.038 0.01 DBMET00062 0.028 0.012 DBMET00063 0.079 0.005 DBMET00065 0.019 0.016 DBMET00066 0.019 0.016 DBMET00067 0.064 0.007 DBMET01109 0.02 0.015 DBMET01110 0.045 0.009 DBMET01108 | DBMET00065 | |
| 0.062 | 0.013 | 0.075 | AICAR transformylase inhibitor | 0.044 0.03 DBMET00062 0.04 0.039 DBMET00063 0.042 0.034 DBMET00065 0.041 0.035 DBMET00066 0.041 0.035 DBMET00067 0.075 0.008 DBMET01109 0.046 0.027 DBMET01110 0.042 0.035 DBMET01107 0.061 0.013 DBMET01108 | DBMET01109 | |
| 0.056 | 0.007 | 0.066 | Leukotriene C4 antagonist | 0.055 0.008 DBMET00060 0.056 0.007 DBMET00061 0.046 0.014 DBMET00062 0.044 0.017 DBMET00063 0.055 0.007 DBMET00065 0.045 0.015 DBMET00066 0.045 0.015 DBMET00067 0.046 0.014 DBMET01106 0.066 0.005 DBMET01109 0.048 0.012 DBMET01110 0.048 0.012 DBMET01107 0.055 0.007 DBMET01108 | DBMET01109 | |
| 0.053 | 0.005 | 0.073 | Glutamate (mGluR1a) agonist | 0.053 0.005 DBMET00061 0.028 0.01 DBMET00065 0.021 0.017 DBMET00066 0.021 0.017 DBMET00067 0.073 0.004 DBMET01109 0.025 0.012 DBMET01110 0.021 0.017 DBMET01107 0.044 0.005 DBMET01108 | DBMET01109 | |
| 0.124 | 0.075 | 0.148 | Antibacterial (Helicobacter pylori) | 0.133 0.064 DBMET00061 0.132 0.065 DBMET00063 0.146 0.05 DBMET00064 0.148 0.047 DBMET00065 0.12 0.081 DBMET01109 0.13 0.067 DBMET01107 0.133 0.064 DBMET01108 | DBMET00065 | |
| 0.078 | 0.03 | 0.109 | Cannabinoid CB1 receptor agonist | 0.109 0.017 DBMET00061 0.066 0.038 DBMET01109 0.052 0.05 DBMET01108 | DBMET00061 | |
| 0.052 | 0.004 | 0.064 | Prostaglandin H2 antagonist | 0.043 0.005 DBMET00060 0.05 0.004 DBMET00061 0.033 0.01 DBMET00062 0.035 0.009 DBMET00063 0.026 0.017 DBMET00065 0.042 0.005 DBMET00066 0.042 0.005 DBMET00067 0.064 0.003 DBMET01109 0.034 0.01 DBMET01110 0.036 0.008 DBMET01107 0.061 0.003 DBMET01108 | DBMET01109 | |
| 0.068 | 0.02 | 0.068 | Ryanodine receptor antagonist | 0.058 0.045 DBMET00060 0.056 0.052 DBMET00062 0.061 0.034 DBMET00065 0.063 0.031 DBMET01106 0.067 0.022 DBMET01109 0.056 0.052 DBMET01110 0.062 0.031 DBMET01108 | ||
| 0.111 | 0.063 | 0.128 | Acetylcholine release stimulant | 0.122 0.045 DBMET00061 0.128 0.037 DBMET00064 0.116 0.056 DBMET00065 0.101 0.085 DBMET01106 0.104 0.079 DBMET01109 | DBMET00064 | |
| 0.053 | 0.005 | 0.09 | Prostaglandin EP2 agonist | 0.027 0.014 DBMET00060 0.057 0.005 DBMET00061 0.068 0.004 DBMET00062 0.09 0.003 DBMET00063 0.034 0.011 DBMET00064 0.054 0.005 DBMET00065 0.037 0.009 DBMET00066 0.037 0.009 DBMET00067 0.043 0.007 DBMET01106 0.069 0.004 DBMET01109 0.032 0.011 DBMET01110 0.024 0.015 DBMET01107 0.051 0.005 DBMET01108 | DBMET00063 | |
| 0.055 | 0.007 | 0.056 | AMPA 3 receptor antagonist | 0.039 0.014 DBMET00065 0.029 0.021 DBMET01106 0.056 0.007 DBMET01109 0.046 0.01 DBMET01108 | DBMET01109 | |
| 0.056 | 0.009 | 0.141 | Leukotriene D4 antagonist | 0.024 0.02 DBMET00060 0.046 0.011 DBMET00061 0.026 0.018 DBMET00062 0.024 0.02 DBMET00063 0.023 0.021 DBMET00066 0.023 0.021 DBMET00067 0.117 0.005 DBMET01109 0.023 0.021 DBMET01107 0.141 0.005 DBMET01108 | DBMET01108 | |
| 0.064 | 0.017 | 0.064 | Immunoglobulin Fc receptor antagonist | 0.053 0.048 DBMET00061 0.062 0.021 DBMET00062 0.064 0.017 DBMET00063 0.056 0.034 DBMET01109 0.052 0.051 DBMET01110 0.056 0.034 DBMET01108 | ||
| 0.064 | 0.018 | 0.065 | NMDA receptor subunit 3B antagonist | 0.045 0.029 DBMET00061 0.065 0.017 DBMET01109 0.051 0.024 DBMET01108 | DBMET01109 | |
| 0.048 | 0.003 | 0.06 | Carbonic anhydrase X inhibitor | 0.021 0.008 DBMET00060 0.042 0.003 DBMET00061 0.043 0.003 DBMET00062 0.037 0.004 DBMET00063 0.036 0.004 DBMET00065 0.027 0.005 DBMET00066 0.027 0.005 DBMET00067 0.025 0.005 DBMET01106 0.06 0.002 DBMET01109 0.029 0.004 DBMET01110 0.026 0.005 DBMET01107 0.047 0.003 DBMET01108 | DBMET01109 | |
| 0.048 | 0.003 | 0.06 | Carbonic anhydrase VIII inhibitor | 0.021 0.008 DBMET00060 0.042 0.003 DBMET00061 0.043 0.003 DBMET00062 0.037 0.004 DBMET00063 0.036 0.004 DBMET00065 0.027 0.005 DBMET00066 0.027 0.005 DBMET00067 0.025 0.005 DBMET01106 0.06 0.002 DBMET01109 0.029 0.004 DBMET01110 0.026 0.005 DBMET01107 0.047 0.003 DBMET01108 | DBMET01109 | |
| 0.063 | 0.018 | 0.125 | Farnesyltransferase inhibitor | 0.065 0.018 DBMET00060 0.046 0.032 DBMET00061 0.062 0.019 DBMET00062 0.125 0.005 DBMET00065 0.058 0.021 DBMET00066 0.058 0.021 DBMET00067 0.07 0.016 DBMET01106 0.055 0.023 DBMET01109 0.049 0.028 DBMET01107 0.074 0.014 DBMET01108 | DBMET00065 | |
| 0.084 | 0.038 | 0.092 | Epoxide hydrolase inhibitor | 0.083 0.039 DBMET00061 0.066 0.06 DBMET00065 0.092 0.031 DBMET01109 0.073 0.05 DBMET01108 | DBMET01109 | |
| 0.075 | 0.03 | 0.238 | Neuraminidase (influenza) inhibitor | 0.068 0.038 DBMET00060 0.095 0.018 DBMET00061 0.238 0.004 DBMET00062 0.097 0.017 DBMET00063 0.145 0.008 DBMET00064 0.061 0.051 DBMET00065 0.088 0.021 DBMET00066 0.088 0.021 DBMET00067 0.066 0.041 DBMET01109 0.059 0.055 DBMET01107 0.059 0.057 DBMET01108 | DBMET00062 | |
| 0.066 | 0.022 | 0.126 | Carbonic anhydrase XIV inhibitor | 0.061 0.024 DBMET00061 0.049 0.034 DBMET00062 0.126 0.006 DBMET00064 0.07 0.02 DBMET01109 0.044 0.04 DBMET01110 0.075 0.018 DBMET01108 | DBMET00064 | |
| 0.049 | 0.005 | 0.1 | Free fatty acid receptor 1 agonist | 0.027 0.007 DBMET00061 0.017 0.012 DBMET00062 0.027 0.007 DBMET00063 0.022 0.009 DBMET00066 0.022 0.009 DBMET00067 0.1 0.004 DBMET01109 0.018 0.012 DBMET01110 0.082 0.004 DBMET01108 | DBMET01109 | |
| 0.048 | 0.004 | 0.088 | Prostacyclin agonist | 0.033 0.005 DBMET00060 0.034 0.005 DBMET00061 0.053 0.004 DBMET00062 0.078 0.004 DBMET00063 0.026 0.007 DBMET00065 0.035 0.005 DBMET00066 0.035 0.005 DBMET00067 0.088 0.003 DBMET01109 0.025 0.007 DBMET01110 0.02 0.008 DBMET01107 0.052 0.004 DBMET01108 | DBMET01109 | |
| 0.054 | 0.011 | 0.054 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.036 DBMET00061 0.052 0.013 DBMET00065 0.04 0.033 DBMET00066 0.04 0.033 DBMET00067 0.041 0.031 DBMET01106 0.046 0.02 DBMET01109 0.044 0.024 DBMET01110 0.041 0.031 DBMET01107 0.046 0.02 DBMET01108 | ||
| 0.064 | 0.02 | 0.098 | Glucose-6-phosphate translocase inhibitor | 0.05 0.038 DBMET00060 0.098 0.006 DBMET00064 0.055 0.03 DBMET00065 0.053 0.033 DBMET00066 0.053 0.033 DBMET00067 0.066 0.018 DBMET01106 0.058 0.026 DBMET01109 0.073 0.014 DBMET01110 0.066 0.018 DBMET01107 0.05 0.038 DBMET01108 | DBMET00064 | |
| 0.065 | 0.023 | 0.168 | Integrin antagonist | 0.126 0.013 DBMET01109 0.168 0.009 DBMET01108 | DBMET01108 | |
| 0.057 | 0.016 | 0.097 | Cytokine production stimulant | 0.065 0.009 DBMET00061 0.048 0.036 DBMET00062 0.055 0.019 DBMET00063 0.097 0.004 DBMET00064 0.05 0.028 DBMET01109 0.047 0.039 DBMET01110 0.058 0.015 DBMET01107 0.049 0.032 DBMET01108 | DBMET00064 | |
| 0.051 | 0.009 | 0.051 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.044 0.011 DBMET01109 0.034 0.016 DBMET01108 | ||
| 0.1 | 0.059 | 0.107 | Glutamate (mGluR7) agonist | 0.107 0.048 DBMET01109 0.094 0.074 DBMET01108 | DBMET01109 | |
| 0.104 | 0.062 | 0.104 | Carbonic anhydrase XV inhibitor | 0.092 0.079 DBMET00061 0.089 0.085 DBMET00065 | ||
| 0.045 | 0.004 | 0.054 | Lysophosphatidic acid 1 receptor antagonist | 0.041 0.004 DBMET00060 0.034 0.005 DBMET00061 0.046 0.004 DBMET00062 0.033 0.005 DBMET00063 0.031 0.006 DBMET00065 0.027 0.008 DBMET00066 0.027 0.008 DBMET00067 0.021 0.014 DBMET01106 0.054 0.004 DBMET01109 0.027 0.008 DBMET01110 0.023 0.011 DBMET01107 0.041 0.004 DBMET01108 | DBMET01109 | |
| 0.114 | 0.074 | 0.114 | Acetylcholine muscarinic antagonist | 0.111 0.077 DBMET00061 0.102 0.089 DBMET01107 | ||
| 0.047 | 0.008 | 0.047 | Purinergic P2Y14 antagonist | 0.027 0.025 DBMET00061 0.033 0.017 DBMET01109 0.033 0.017 DBMET01108 | ||
| 0.199 | 0.159 | 0.348 | Nootropic | 0.348 0.055 DBMET00063 | DBMET00063 | |
| 0.153 | 0.114 | 0.375 | DNA methylase inhibitor | 0.375 0.013 DBMET01015 0.242 0.053 DBMET00064 0.316 0.023 DBMET00065 0.171 0.1 DBMET00066 0.171 0.1 DBMET00067 0.208 0.074 DBMET01106 0.178 0.095 DBMET01109 | DBMET01015 | |
| 0.118 | 0.08 | 0.164 | M17 leucyl aminopeptidase inhibitor | 0.106 0.093 DBMET01109 0.164 0.048 DBMET01108 | DBMET01108 | |
| 0.057 | 0.019 | 0.057 | Oxytocin agonist | 0.052 0.022 DBMET00061 0.057 0.019 DBMET01109 0.041 0.03 DBMET01110 0.052 0.022 DBMET01108 | ||
| 0.045 | 0.007 | 0.083 | 5-Alpha-reductase 1 inhibitor | 0.018 0.012 DBMET00060 0.03 0.009 DBMET00061 0.083 0.005 DBMET01109 0.037 0.008 DBMET01108 | DBMET01109 | |
| 0.05 | 0.013 | 0.068 | Prostacyclin antagonist | 0.039 0.019 DBMET00060 0.051 0.013 DBMET00061 0.042 0.017 DBMET00063 0.068 0.008 DBMET01109 0.047 0.014 DBMET01108 | DBMET01109 | |
| 0.062 | 0.025 | 0.062 | DNA helicase inhibitor | 0.056 0.035 DBMET00065 0.051 0.045 DBMET01109 0.051 0.045 DBMET01108 | ||
| 0.042 | 0.004 | 0.042 | Hedgehog signaling activator | 0.026 0.024 DBMET00060 0.036 0.006 DBMET00061 0.037 0.005 DBMET00062 0.04 0.004 DBMET00063 0.026 0.023 DBMET00065 0.03 0.013 DBMET00066 0.03 0.013 DBMET00067 0.039 0.005 DBMET01109 0.033 0.009 DBMET01110 0.03 0.012 DBMET01107 0.036 0.006 DBMET01108 | ||
| 0.041 | 0.004 | 0.052 | Aminopeptidase A inhibitor | 0.021 0.01 DBMET00060 0.024 0.008 DBMET00061 0.033 0.006 DBMET00062 0.033 0.006 DBMET00063 0.016 0.014 DBMET00065 0.025 0.008 DBMET00066 0.025 0.008 DBMET00067 0.052 0.003 DBMET01109 0.027 0.007 DBMET01110 0.024 0.008 DBMET01107 0.052 0.003 DBMET01108 | DBMET01108 | |
| 0.057 | 0.02 | 0.058 | Carbonic anhydrase IV inhibitor | 0.04 0.033 DBMET00061 0.058 0.02 DBMET01109 0.047 0.027 DBMET01107 0.045 0.028 DBMET01108 | DBMET01109 | |
| 0.059 | 0.022 | 0.073 | CD45 antagonist | 0.048 0.04 DBMET00060 0.066 0.017 DBMET00065 0.053 0.029 DBMET01106 0.073 0.014 DBMET01109 0.046 0.045 DBMET01110 0.057 0.024 DBMET01108 | DBMET01109 | |
| 0.044 | 0.008 | 0.058 | Kynurenine 3 monooxygenase inhibitor | 0.029 0.016 DBMET00062 0.029 0.016 DBMET00063 0.037 0.011 DBMET00065 0.026 0.019 DBMET00066 0.026 0.019 DBMET00067 0.058 0.005 DBMET01109 0.035 0.012 DBMET01110 0.028 0.017 DBMET01107 0.043 0.009 DBMET01108 | DBMET01109 | |
| 0.057 | 0.021 | 0.057 | Cholesterol esterase inhibitor | 0.047 0.034 DBMET00061 0.044 0.04 DBMET01109 | ||
| 0.112 | 0.077 | 0.146 | Histone deacetylase class III inhibitor | 0.146 0.047 DBMET01109 0.1 0.09 DBMET01108 | DBMET01109 | |
| 0.045 | 0.01 | 0.054 | Uridine phosphorylase inhibitor | 0.033 0.015 DBMET00060 0.054 0.007 DBMET00061 0.044 0.01 DBMET00062 0.035 0.014 DBMET00063 0.045 0.01 DBMET00064 0.034 0.015 DBMET00065 0.038 0.013 DBMET01106 0.044 0.01 DBMET01109 0.025 0.023 DBMET01110 0.037 0.013 DBMET01108 | DBMET00061 | |
| 0.074 | 0.039 | 0.146 | Glucagon-like peptide 1 agonist | 0.064 0.045 DBMET00061 0.081 0.034 DBMET00062 0.087 0.03 DBMET00063 0.096 0.024 DBMET01109 0.146 0.009 DBMET01110 0.078 0.036 DBMET01108 | DBMET01110 | |
| 0.038 | 0.003 | 0.054 | Retinoid X beta receptor antagonist | 0.039 0.003 DBMET00060 0.032 0.004 DBMET00061 0.024 0.008 DBMET00062 0.022 0.01 DBMET00063 0.036 0.004 DBMET00065 0.045 0.003 DBMET00066 0.045 0.003 DBMET00067 0.054 0.002 DBMET01106 0.037 0.003 DBMET01109 0.028 0.005 DBMET01110 0.026 0.006 DBMET01107 0.034 0.004 DBMET01108 | DBMET01106 | |
| 0.085 | 0.051 | 0.09 | Carbonic anhydrase VI inhibitor | 0.083 0.053 DBMET00061 0.078 0.06 DBMET00065 0.09 0.046 DBMET01109 0.071 0.07 DBMET01108 | DBMET01109 | |
| 0.053 | 0.019 | 0.053 | NMDA receptor subunit 3A antagonist | 0.033 0.031 DBMET00061 0.049 0.02 DBMET01109 0.039 0.026 DBMET01108 | ||
| 0.059 | 0.025 | 0.059 | Bombesin 2 receptor antagonist | 0.052 0.031 DBMET00061 0.058 0.026 DBMET00062 0.053 0.03 DBMET00063 0.059 0.025 DBMET01109 0.054 0.029 DBMET01108 | ||
| 0.061 | 0.028 | 0.082 | Dihydroorotate oxidase inhibitor | 0.082 0.009 DBMET00060 0.051 0.047 DBMET00065 0.067 0.02 DBMET00066 0.067 0.02 DBMET00067 0.057 0.033 DBMET01106 0.051 0.049 DBMET01109 0.051 0.048 DBMET01107 0.051 0.049 DBMET01108 | DBMET00060 | |
| 0.125 | 0.092 | 0.139 | Mannose-6-phosphate isomerase inhibitor | 0.139 0.075 DBMET00064 | DBMET00064 | |
| 0.043 | 0.011 | 0.043 | Liver X receptor beta antagonist | 0.03 0.019 DBMET00060 0.026 0.023 DBMET00061 0.04 0.013 DBMET01109 0.033 0.017 DBMET01108 | ||
| 0.103 | 0.071 | 0.133 | Nav1.4 sodium channel blocker | 0.133 0.042 DBMET01109 0.114 0.058 DBMET01108 | DBMET01109 | |
| 0.039 | 0.007 | 0.117 | Prostaglandin E2 agonist | 0.033 0.009 DBMET00060 0.04 0.007 DBMET00061 0.101 0.004 DBMET00062 0.117 0.004 DBMET00063 0.078 0.004 DBMET00065 0.027 0.013 DBMET00066 0.027 0.013 DBMET00067 0.046 0.006 DBMET01106 0.064 0.005 DBMET01109 0.025 0.014 DBMET01110 0.021 0.019 DBMET01107 0.038 0.008 DBMET01108 | DBMET00063 | |
| 0.035 | 0.003 | 0.047 | Lysophosphatidic acid receptor 3 agonist | 0.018 0.006 DBMET00060 0.047 0.003 DBMET00061 0.037 0.003 DBMET00062 0.032 0.003 DBMET00063 0.035 0.003 DBMET00065 0.024 0.004 DBMET00066 0.024 0.004 DBMET00067 0.022 0.005 DBMET01106 0.035 0.003 DBMET01109 0.02 0.005 DBMET01110 0.017 0.007 DBMET01107 0.026 0.004 DBMET01108 | DBMET00061 | |
| 0.035 | 0.004 | 0.043 | Neuraminidase (Influenza B) inhibitor | 0.043 0.003 DBMET00060 0.032 0.004 DBMET00061 0.04 0.003 DBMET00062 0.035 0.004 DBMET00063 0.024 0.009 DBMET00064 0.033 0.004 DBMET00065 0.032 0.004 DBMET00066 0.032 0.004 DBMET00067 0.039 0.003 DBMET01106 0.029 0.005 DBMET01109 0.026 0.007 DBMET01110 0.024 0.009 DBMET01107 0.029 0.005 DBMET01108 | DBMET00060 | |
| 0.039 | 0.007 | 0.039 | Purinergic P2Y15 antagonist | 0.028 0.02 DBMET00061 0.03 0.016 DBMET00062 0.028 0.021 DBMET00063 0.027 0.024 DBMET00064 0.028 0.02 DBMET00065 0.027 0.024 DBMET00066 0.027 0.024 DBMET00067 0.034 0.012 DBMET01109 0.029 0.019 DBMET01110 0.026 0.025 DBMET01107 0.034 0.012 DBMET01108 | ||
| 0.034 | 0.004 | 0.042 | Calcium-dependent phospholipase A2 inhibitor | 0.011 0.01 DBMET00060 0.024 0.004 DBMET00061 0.017 0.005 DBMET00062 0.016 0.005 DBMET00063 0.015 0.006 DBMET00066 0.015 0.006 DBMET00067 0.041 0.004 DBMET01109 0.041 0.004 DBMET01110 0.042 0.004 DBMET01107 0.028 0.004 DBMET01108 | DBMET01107 | |
| 0.052 | 0.022 | 0.052 | Dihydroorotase inhibitor | 0.04 0.039 DBMET00061 0.045 0.031 DBMET01110 | ||
| 0.036 | 0.006 | 0.081 | Prostaglandin EP4 agonist | 0.014 0.011 DBMET00061 0.074 0.004 DBMET00062 0.081 0.004 DBMET00063 0.049 0.005 DBMET00065 0.038 0.006 DBMET01106 0.064 0.004 DBMET01109 0.034 0.007 DBMET01108 | DBMET00063 | |
| 0.044 | 0.015 | 0.049 | VCAM-1 antagonist | 0.041 0.023 DBMET00060 0.041 0.021 DBMET00061 0.043 0.018 DBMET00065 0.041 0.023 DBMET00066 0.041 0.023 DBMET00067 0.038 0.034 DBMET01106 0.049 0.01 DBMET01109 0.04 0.026 DBMET01107 0.045 0.014 DBMET01108 | DBMET01109 | |
| 0.051 | 0.022 | 0.116 | Neuraminidase (Influenza A) inhibitor | 0.051 0.023 DBMET00060 0.06 0.013 DBMET00061 0.116 0.004 DBMET00062 0.054 0.019 DBMET00063 0.07 0.007 DBMET00064 0.044 0.034 DBMET00065 0.043 0.036 DBMET00066 0.043 0.036 DBMET00067 0.045 0.033 DBMET01106 0.046 0.03 DBMET01109 0.042 0.039 DBMET01108 | DBMET00062 | |
| 0.044 | 0.015 | 0.049 | VCAM antagonist | 0.041 0.023 DBMET00060 0.041 0.021 DBMET00061 0.043 0.018 DBMET00065 0.041 0.024 DBMET00066 0.041 0.024 DBMET00067 0.038 0.034 DBMET01106 0.049 0.01 DBMET01109 0.04 0.024 DBMET01107 0.045 0.014 DBMET01108 | DBMET01109 | |
| 0.055 | 0.026 | 0.067 | Neurotensin receptor antagonist | 0.05 0.028 DBMET01109 0.04 0.036 DBMET01110 0.067 0.022 DBMET01107 0.045 0.031 DBMET01108 | DBMET01107 | |
| 0.04 | 0.011 | 0.04 | Glutamate (mGluR2) antagonist | 0.03 0.019 DBMET00061 0.029 0.021 DBMET01109 0.028 0.024 DBMET01108 | ||
| 0.039 | 0.011 | 0.049 | Calcium-independent phospholipase A2 inhibitor | 0.036 0.019 DBMET00060 0.041 0.009 DBMET00061 0.035 0.02 DBMET00062 0.034 0.024 DBMET00063 0.037 0.015 DBMET00065 0.035 0.022 DBMET00066 0.035 0.022 DBMET00067 0.037 0.016 DBMET01106 0.041 0.009 DBMET01109 0.049 0.004 DBMET01110 0.047 0.005 DBMET01107 0.037 0.016 DBMET01108 | DBMET01110 | |
| 0.047 | 0.019 | 0.067 | Sphingosine kinase 1 inhibitor | 0.067 0.007 DBMET00061 0.054 0.013 DBMET00062 0.048 0.019 DBMET00063 0.04 0.032 DBMET01109 0.038 0.036 DBMET01108 | DBMET00061 | |
| 0.066 | 0.038 | 0.146 | HIV-1 integrase (Strand Transfer) inhibitor | 0.146 0.013 DBMET00065 0.108 0.02 DBMET01106 0.07 0.036 DBMET01110 0.09 0.027 DBMET01107 | DBMET00065 | |
| 0.032 | 0.004 | 0.038 | Isoleucine-tRNA ligase inhibitor | 0.024 0.013 DBMET00060 0.038 0.003 DBMET00061 0.03 0.005 DBMET00062 0.03 0.005 DBMET00063 0.028 0.007 DBMET00064 0.026 0.009 DBMET00065 0.03 0.005 DBMET00066 0.03 0.005 DBMET00067 0.025 0.01 DBMET01106 0.032 0.004 DBMET01109 0.026 0.009 DBMET01110 0.024 0.013 DBMET01107 0.033 0.004 DBMET01108 | DBMET00061 | |
| 0.049 | 0.021 | 0.058 | GABA B receptor antagonist | 0.042 0.031 DBMET00061 0.048 0.022 DBMET00062 0.058 0.014 DBMET01109 0.047 0.023 DBMET01107 0.045 0.026 DBMET01108 | DBMET01109 | |
| 0.031 | 0.003 | 0.038 | Thromboxane A2 agonist | 0.018 0.007 DBMET00060 0.035 0.003 DBMET00061 0.029 0.003 DBMET00062 0.026 0.004 DBMET00063 0.026 0.004 DBMET00065 0.022 0.005 DBMET00066 0.022 0.005 DBMET00067 0.019 0.007 DBMET01106 0.038 0.003 DBMET01109 0.02 0.005 DBMET01110 0.018 0.007 DBMET01107 0.03 0.003 DBMET01108 | DBMET01109 | |
| 0.044 | 0.017 | 0.052 | p53 inhibitor | 0.036 0.024 DBMET00061 0.052 0.013 DBMET00062 0.05 0.014 DBMET00063 0.04 0.02 DBMET01109 0.049 0.014 DBMET01107 0.033 0.027 DBMET01108 | DBMET00062 | |
| 0.075 | 0.048 | 0.076 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.076 0.045 DBMET00065 0.071 0.056 DBMET01106 | DBMET00065 | |
| 0.031 | 0.005 | 0.049 | Ileal bile acid transport inhibitor | 0.027 0.005 DBMET00061 0.023 0.007 DBMET00062 0.022 0.008 DBMET00063 0.049 0.004 DBMET00064 0.016 0.013 DBMET00065 0.035 0.004 DBMET01109 0.016 0.013 DBMET01110 0.027 0.005 DBMET01108 | DBMET00064 | |
| 0.034 | 0.008 | 0.059 | Retinoid X gamma receptor antagonist | 0.034 0.008 DBMET00060 0.03 0.012 DBMET00061 0.034 0.008 DBMET00065 0.038 0.005 DBMET00066 0.038 0.005 DBMET00067 0.059 0.002 DBMET01106 0.033 0.009 DBMET01109 0.028 0.016 DBMET01110 0.026 0.02 DBMET01107 0.032 0.01 DBMET01108 | DBMET01106 | |
| 0.029 | 0.003 | 0.04 | Telomerase stimulant | 0.018 0.01 DBMET00060 0.022 0.006 DBMET00061 0.023 0.005 DBMET00062 0.021 0.006 DBMET00063 0.04 0.002 DBMET00064 0.02 0.008 DBMET00065 0.021 0.007 DBMET00066 0.021 0.007 DBMET00067 0.016 0.014 DBMET01106 0.025 0.004 DBMET01109 0.023 0.005 DBMET01110 0.021 0.006 DBMET01107 0.025 0.004 DBMET01108 | DBMET00064 | |
| 0.039 | 0.013 | 0.06 | Methionyl aminopeptidase 1 inhibitor | 0.043 0.009 DBMET00060 0.037 0.015 DBMET00062 0.042 0.01 DBMET00063 0.06 0.005 DBMET00066 0.06 0.005 DBMET00067 0.037 0.015 DBMET01109 0.032 0.023 DBMET01108 | DBMET00067 | |
| 0.04 | 0.015 | 0.048 | AMPA 1 receptor antagonist | 0.048 0.012 DBMET00065 0.031 0.019 DBMET01106 0.037 0.016 DBMET01109 0.027 0.022 DBMET01108 | DBMET00065 | |
| 0.058 | 0.033 | 0.08 | Glucosylceramidase inhibitor | 0.08 0.016 DBMET00061 0.063 0.027 DBMET00064 | DBMET00061 | |
| 0.071 | 0.046 | 0.083 | Elastase 1 inhibitor | 0.083 0.033 DBMET01109 0.065 0.054 DBMET01110 0.066 0.053 DBMET01108 | DBMET01109 | |
| 0.093 | 0.068 | 0.127 | Phosphodiesterase 6D inhibitor | 0.095 0.063 DBMET00060 0.091 0.074 DBMET00061 0.101 0.05 DBMET00062 0.093 0.067 DBMET00063 0.127 0.02 DBMET00064 0.105 0.043 DBMET00065 0.096 0.059 DBMET00066 0.096 0.059 DBMET00067 0.09 0.076 DBMET01106 0.089 0.079 DBMET01109 | DBMET00064 | |
| 0.034 | 0.009 | 0.039 | Thyroid hormone agonist | 0.029 0.014 DBMET00061 0.024 0.023 DBMET00065 0.039 0.007 DBMET01109 0.025 0.02 DBMET01110 0.033 0.01 DBMET01108 | DBMET01109 | |
| 0.037 | 0.012 | 0.072 | Angiotensin AT2 receptor antagonist | 0.072 0.006 DBMET00065 0.049 0.01 DBMET01106 0.019 0.016 DBMET01109 | DBMET00065 | |
| 0.04 | 0.016 | 0.049 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.045 0.012 DBMET00061 0.043 0.013 DBMET00065 0.049 0.009 DBMET01109 0.034 0.025 DBMET01110 0.039 0.018 DBMET01108 | DBMET01109 | |
| 0.031 | 0.006 | 0.031 | ICAM 1 antagonist | 0.031 0.006 DBMET00061 0.021 0.02 DBMET00062 0.021 0.02 DBMET00063 0.025 0.012 DBMET00065 0.022 0.019 DBMET00066 0.022 0.019 DBMET00067 0.024 0.014 DBMET01109 0.024 0.014 DBMET01108 | ||
| 0.042 | 0.018 | 0.044 | Vanilloid 3 antagonist | 0.041 0.02 DBMET00061 0.039 0.023 DBMET00065 0.044 0.014 DBMET01109 0.038 0.026 DBMET01108 | DBMET01109 | |
| 0.141 | 0.117 | 0.141 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.081 | 0.057 | 0.308 | Antineoplastic antibiotic | 0.122 0.038 DBMET00060 0.071 0.064 DBMET00061 0.217 0.018 DBMET00062 0.138 0.034 DBMET00063 0.308 0.009 DBMET00064 0.161 0.029 DBMET00065 0.219 0.018 DBMET00066 0.219 0.018 DBMET00067 0.183 0.024 DBMET01106 0.072 0.063 DBMET01109 0.152 0.03 DBMET01110 0.129 0.036 DBMET01107 0.08 0.058 DBMET01108 | DBMET00064 | |
| 0.043 | 0.019 | 0.052 | Calcitonin receptor agonist | 0.044 0.018 DBMET00061 0.044 0.019 DBMET00062 0.048 0.017 DBMET00063 0.052 0.016 DBMET01109 0.03 0.027 DBMET01110 0.042 0.019 DBMET01108 | DBMET01109 | |
| 0.027 | 0.003 | 0.258 | Methylmalonyl-CoA mutase inhibitor | 0.258 0 DBMET01015 0.021 0.007 DBMET00060 0.024 0.004 DBMET00061 0.027 0.003 DBMET00062 0.026 0.003 DBMET00063 0.018 0.012 DBMET00064 0.021 0.008 DBMET00065 0.022 0.006 DBMET00066 0.022 0.006 DBMET00067 0.019 0.011 DBMET01106 0.029 0.003 DBMET01109 0.022 0.005 DBMET01110 0.021 0.007 DBMET01107 0.027 0.003 DBMET01108 | DBMET01015 | |
| 0.033 | 0.009 | 0.135 | Retinoid X gamma receptor agonist | 0.028 0.011 DBMET00060 0.033 0.009 DBMET00065 0.024 0.015 DBMET00066 0.024 0.015 DBMET00067 0.135 0.003 DBMET01106 0.031 0.01 DBMET01109 0.027 0.012 DBMET01108 | DBMET01106 | |
| 0.028 | 0.005 | 0.041 | G-protein-coupled receptor 120 agonist | 0.041 0.004 DBMET00061 0.018 0.011 DBMET00062 0.018 0.011 DBMET00063 0.021 0.009 DBMET00065 0.015 0.014 DBMET00066 0.015 0.014 DBMET00067 0.041 0.004 DBMET01109 0.017 0.012 DBMET01110 0.028 0.005 DBMET01108 | DBMET01109 | |
| 0.037 | 0.014 | 0.143 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.143 0.001 DBMET01015 0.046 0.01 DBMET00061 0.038 0.013 DBMET00062 0.03 0.018 DBMET00063 0.024 0.023 DBMET00064 0.037 0.014 DBMET01109 0.032 0.016 DBMET01108 | DBMET01015 | |
| 0.027 | 0.004 | 0.027 | Angiotensin AT1B receptor antagonist | 0.014 0.009 DBMET00060 0.019 0.006 DBMET00061 0.025 0.004 DBMET00065 0.014 0.01 DBMET00066 0.014 0.01 DBMET00067 0.013 0.01 DBMET01106 0.024 0.005 DBMET01109 0.015 0.009 DBMET01110 0.014 0.009 DBMET01107 0.023 0.005 DBMET01108 | ||
| 0.032 | 0.01 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.01 DBMET00061 0.037 0.005 DBMET00062 0.029 0.018 DBMET00063 0.035 0.006 DBMET00064 0.033 0.009 DBMET00066 0.033 0.009 DBMET00067 0.031 0.013 DBMET01109 0.028 0.02 DBMET01110 0.027 0.025 DBMET01107 0.03 0.015 DBMET01108 | DBMET00062 | |
| 0.039 | 0.016 | 0.043 | Growth factor receptor-bound protein 2 antagonist | 0.032 0.031 DBMET00061 0.04 0.014 DBMET01109 0.034 0.027 DBMET01110 0.032 0.031 DBMET01107 0.043 0.009 DBMET01108 | DBMET01108 | |
| 0.077 | 0.054 | 0.086 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.076 0.054 DBMET00061 0.068 0.063 DBMET00065 0.067 0.064 DBMET01109 0.086 0.046 DBMET01107 | DBMET01107 | |
| 0.048 | 0.025 | 0.059 | Glutamate (mGluR group III) agonist | 0.046 0.026 DBMET01109 0.059 0.019 DBMET01108 | DBMET01108 | |
| 0.027 | 0.005 | 0.032 | Thyroid hormone alpha antagonist | 0.023 0.006 DBMET00061 0.032 0.005 DBMET01109 0.027 0.005 DBMET01108 | DBMET01109 | |
| 0.025 | 0.003 | 0.038 | Thromboxane agonist | 0.012 0.006 DBMET00060 0.029 0.003 DBMET00061 0.027 0.003 DBMET00062 0.022 0.004 DBMET00063 0.019 0.004 DBMET00065 0.016 0.004 DBMET00066 0.016 0.004 DBMET00067 0.012 0.007 DBMET01106 0.038 0.003 DBMET01109 0.017 0.004 DBMET01110 0.014 0.005 DBMET01107 0.025 0.003 DBMET01108 | DBMET01109 | |
| 0.063 | 0.041 | 0.066 | Corticotropin releasing factor 2 receptor antagonist | 0.066 0.034 DBMET01109 0.057 0.054 DBMET01108 | DBMET01109 | |
| 0.081 | 0.06 | 0.081 | CC chemokine 5 receptor agonist | 0.078 0.071 DBMET01109 | ||
| 0.037 | 0.015 | 0.075 | Prostaglandin EP3 antagonist | 0.033 0.018 DBMET00062 0.04 0.014 DBMET00063 0.075 0.007 DBMET01109 0.042 0.013 DBMET01108 | DBMET01109 | |
| 0.051 | 0.03 | 0.073 | Glycine transporter 2 inhibitor | 0.053 0.028 DBMET00061 0.073 0.02 DBMET00065 0.06 0.025 DBMET01109 0.041 0.037 DBMET01108 | DBMET00065 | |
| 0.049 | 0.028 | 0.05 | Adenylate cyclase 1 inhibitor | 0.05 0.026 DBMET00060 0.048 0.029 DBMET00061 0.05 0.026 DBMET01106 | DBMET01106 | |
| 0.026 | 0.005 | 0.026 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 DBMET01109 0.016 0.014 DBMET01110 0.019 0.01 DBMET01108 | ||
| 0.033 | 0.013 | 0.038 | LFA antagonist | 0.038 0.009 DBMET00061 0.029 0.017 DBMET00065 0.033 0.013 DBMET01109 0.028 0.019 DBMET01108 | DBMET00061 | |
| 0.08 | 0.06 | 0.086 | Caspase 7 inhibitor | 0.086 0.048 DBMET01109 0.077 0.069 DBMET01108 | DBMET01109 | |
| 0.024 | 0.004 | 0.029 | Glutamate (mGluR6) agonist | 0.013 0.007 DBMET00061 0.013 0.008 DBMET00062 0.011 0.01 DBMET00063 0.016 0.005 DBMET00065 0.014 0.007 DBMET00066 0.014 0.007 DBMET00067 0.011 0.01 DBMET01106 0.029 0.003 DBMET01109 0.015 0.006 DBMET01110 0.013 0.008 DBMET01107 0.022 0.004 DBMET01108 | DBMET01109 | |
| 0.025 | 0.005 | 0.035 | Angiotensin-converting enzyme 2 inhibitor | 0.017 0.013 DBMET00061 0.016 0.015 DBMET00062 0.021 0.008 DBMET01109 0.022 0.008 DBMET01110 0.035 0.004 DBMET01107 0.02 0.009 DBMET01108 | DBMET01107 | |
| 0.047 | 0.028 | 0.048 | Fructose-1,6-bisphosphatase inhibitor | 0.046 0.029 DBMET00061 0.048 0.027 DBMET01109 0.043 0.033 DBMET01108 | DBMET01109 | |
| 0.023 | 0.005 | 0.039 | Vitamin D receptor agonist | 0.025 0.004 DBMET00060 0.033 0.003 DBMET00061 0.039 0.003 DBMET00062 0.028 0.004 DBMET00063 0.026 0.004 DBMET00064 0.017 0.011 DBMET00065 0.032 0.004 DBMET00066 0.032 0.004 DBMET00067 0.019 0.007 DBMET01106 0.027 0.004 DBMET01109 0.021 0.006 DBMET01110 0.019 0.007 DBMET01107 0.022 0.005 DBMET01108 | DBMET00062 | |
| 0.026 | 0.007 | 0.029 | Caspase 8 inhibitor | 0.02 0.012 DBMET00061 0.018 0.016 DBMET00062 0.018 0.017 DBMET00063 0.02 0.013 DBMET00066 0.02 0.013 DBMET00067 0.029 0.005 DBMET01109 0.023 0.009 DBMET01110 0.023 0.009 DBMET01107 0.025 0.007 DBMET01108 | DBMET01109 | |
| 0.022 | 0.004 | 0.022 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.007 DBMET00061 0.013 0.01 DBMET00065 0.015 0.007 DBMET00066 0.015 0.007 DBMET00067 0.017 0.005 DBMET01109 0.014 0.007 DBMET01110 0.013 0.01 DBMET01107 0.017 0.005 DBMET01108 | ||
| 0.043 | 0.026 | 0.043 | Liver X receptor alpha agonist | 0.042 0.027 DBMET00061 0.041 0.028 DBMET01110 | ||
| 0.038 | 0.02 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.042 0.014 DBMET00061 0.041 0.015 DBMET00064 0.038 0.02 DBMET00065 0.034 0.027 DBMET01109 | DBMET00061 | |
| 0.021 | 0.004 | 0.025 | Carboxypeptidase B2 inhibitor | 0.013 0.006 DBMET00061 0.013 0.006 DBMET00062 0.013 0.006 DBMET00063 0.011 0.008 DBMET00066 0.011 0.008 DBMET00067 0.02 0.004 DBMET01109 0.011 0.007 DBMET01110 0.01 0.009 DBMET01107 0.025 0.003 DBMET01108 | DBMET01108 | |
| 0.034 | 0.017 | 0.169 | AMPA 2 receptor antagonist | 0.169 0.004 DBMET00065 0.129 0.005 DBMET01106 0.032 0.019 DBMET01109 | DBMET00065 | |
| 0.092 | 0.075 | 0.106 | Nitric-oxide synthase inhibitor | 0.105 0.053 DBMET00065 0.106 0.05 DBMET00066 0.106 0.05 DBMET00067 0.102 0.057 DBMET01107 | DBMET00067 | |
| 0.025 | 0.009 | 0.028 | Angiotensin AT1A receptor antagonist | 0.022 0.015 DBMET00061 0.028 0.007 DBMET00065 0.024 0.011 DBMET01106 0.023 0.012 DBMET01109 0.023 0.013 DBMET01108 | DBMET00065 | |
| 0.033 | 0.017 | 0.038 | Epoxide hydrolase 1 inhibitor | 0.038 0.012 DBMET01109 0.031 0.021 DBMET01108 | DBMET01109 | |
| 0.048 | 0.032 | 0.068 | Potassium channel Kv1.3 blocker | 0.068 0.016 DBMET00060 0.058 0.022 DBMET00061 0.046 0.034 DBMET00066 0.046 0.034 DBMET00067 | DBMET00060 | |
| 0.038 | 0.023 | 0.053 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.045 0.015 DBMET00060 0.05 0.011 DBMET00061 0.033 0.032 DBMET00062 0.039 0.023 DBMET00065 0.053 0.01 DBMET01106 | DBMET01106 | |
| 0.056 | 0.041 | 0.118 | Acetyl-CoA transferase 2 inhibitor | 0.052 0.05 DBMET00064 0.073 0.015 DBMET00066 0.073 0.015 DBMET00067 0.118 0.004 DBMET01110 0.059 0.032 DBMET01108 | DBMET01110 | |
| 0.037 | 0.022 | 0.037 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.034 | 0.019 | 0.034 | HCV NS5B polymerase inhibitor | 0.028 0.027 DBMET01109 0.03 0.024 DBMET01108 | ||
| 0.071 | 0.057 | 0.087 | Carbonic anhydrase XIII inhibitor | 0.069 0.059 DBMET00061 0.087 0.045 DBMET00065 0.077 0.052 DBMET01109 | DBMET00065 | |
| 0.023 | 0.009 | 0.051 | Retinoic acid beta receptor agonist | 0.018 0.017 DBMET00060 0.032 0.005 DBMET00061 0.02 0.014 DBMET00065 0.051 0.004 DBMET01106 0.02 0.014 DBMET01109 0.018 0.017 DBMET01107 0.02 0.014 DBMET01108 | DBMET01106 | |
| 0.025 | 0.011 | 0.166 | Retinoid X beta receptor agonist | 0.023 0.013 DBMET00060 0.027 0.01 DBMET00065 0.019 0.018 DBMET00066 0.019 0.018 DBMET00067 0.166 0.003 DBMET01106 0.025 0.011 DBMET01109 0.022 0.014 DBMET01108 | DBMET01106 | |
| 0.036 | 0.023 | 0.296 | Phosphoglycerate kinase inhibitor | 0.296 0.002 DBMET01015 0.051 0.014 DBMET00061 0.033 0.027 DBMET00062 0.044 0.017 DBMET00063 0.038 0.021 DBMET01109 0.032 0.028 DBMET01108 | DBMET01015 | |
| 0.033 | 0.021 | 0.062 | Caspase 2 inhibitor | 0.033 0.021 DBMET00062 0.062 0.009 DBMET01109 0.028 0.025 DBMET01110 0.044 0.014 DBMET01108 | DBMET01109 | |
| 0.025 | 0.013 | 0.025 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.016 DBMET01109 0.024 0.016 DBMET01108 | ||
| 0.081 | 0.07 | 0.101 | Hematopoietic | 0.099 0.036 DBMET01015 0.079 0.076 DBMET00063 0.101 0.034 DBMET01109 0.081 0.069 DBMET01108 | DBMET01109 | |
| 0.037 | 0.026 | 0.037 | Delayed rectifier potassium channel blocker | 0.035 0.031 DBMET00061 | ||
| 0.034 | 0.023 | 0.039 | Glutamate (mGluR4) agonist | 0.035 0.022 DBMET01109 0.039 0.017 DBMET01108 | DBMET01108 | |
| 0.044 | 0.034 | 0.11 | Phosphorylase inhibitor | 0.046 0.033 DBMET00061 0.052 0.029 DBMET00063 0.11 0.012 DBMET00064 0.042 0.036 DBMET01109 0.057 0.027 DBMET01108 | DBMET00064 | |
| 0.029 | 0.019 | 0.031 | Endothelin receptor antagonist | 0.031 0.017 DBMET00065 0.025 0.023 DBMET00066 0.025 0.023 DBMET00067 0.031 0.017 DBMET01109 | DBMET01109 | |
| 0.036 | 0.026 | 0.045 | Histone deacetylase 7 inhibitor | 0.032 0.031 DBMET01109 0.043 0.021 DBMET01110 0.045 0.02 DBMET01107 | DBMET01107 | |
| 0.016 | 0.006 | 0.019 | Carbonic anhydrase XI inhibitor | 0.012 0.01 DBMET00061 0.013 0.009 DBMET00062 0.013 0.009 DBMET00065 0.019 0.004 DBMET01109 0.015 0.006 DBMET01108 | DBMET01109 | |
| 0.023 | 0.014 | 0.025 | Geranylgeranyltransferase inhibitor | 0.021 0.017 DBMET00061 0.025 0.012 DBMET00062 0.02 0.018 DBMET00065 0.025 0.012 DBMET01108 | DBMET01108 | |
| 0.037 | 0.028 | 0.041 | Farnesoid X receptor agonist | 0.041 0.023 DBMET01109 | DBMET01109 | |
| 0.077 | 0.069 | 0.077 | Antineoplastic alkaloid | 0.074 0.073 DBMET01109 | ||
| 0.039 | 0.031 | 0.084 | Thymidine kinase inhibitor | 0.084 0.008 DBMET01015 0.049 0.02 DBMET00061 0.037 0.035 DBMET01109 | DBMET01015 | |
| 0.058 | 0.049 | 0.1 | HIV-1 integrase (3'-Processing) inhibitor | 0.1 0.026 DBMET00065 0.062 0.045 DBMET01106 | DBMET00065 | |
| 0.019 | 0.011 | 0.027 | Estrogen-related receptor gamma agonist | 0.027 0.005 DBMET00061 0.018 0.013 DBMET01109 | DBMET00061 | |
| 0.016 | 0.01 | 0.144 | Purinergic P2Y1 agonist | 0.144 0.001 DBMET01015 0.015 0.011 DBMET00061 0.014 0.013 DBMET01109 0.014 0.013 DBMET01108 | DBMET01015 | |
| 0.025 | 0.019 | 0.025 | Acid ceramidase inhibitor | |||
| 0.025 | 0.018 | 0.044 | Integrin alpha4 antagonist | 0.044 0.012 DBMET01109 0.043 0.013 DBMET01108 | DBMET01109 | |
| 0.036 | 0.029 | 0.055 | Cholecystokinin B agonist | 0.055 0.014 DBMET01109 0.041 0.022 DBMET01108 | DBMET01109 | |
| 0.027 | 0.02 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.028 | 0.021 | 0.039 | Estrogen-related receptor gamma antagonist | 0.039 0.005 DBMET00061 | DBMET00061 | |
| 0.021 | 0.014 | 0.021 | Integrin alpha4beta7 antagonist | 0.018 0.017 DBMET01109 | ||
| 0.047 | 0.041 | 0.047 | Potassium channel (Inward rectifier) activator | |||
| 0.022 | 0.016 | 0.028 | Vitamin D receptor antagonist | 0.024 0.012 DBMET00060 0.025 0.01 DBMET00061 0.027 0.009 DBMET00062 0.028 0.008 DBMET00063 0.025 0.01 DBMET00064 0.024 0.012 DBMET00066 0.024 0.012 DBMET00067 0.021 0.018 DBMET01109 | DBMET00063 | |
| 0.037 | 0.031 | 0.04 | Histone deacetylase 9 inhibitor | 0.04 0.025 DBMET01110 0.038 0.03 DBMET01107 | DBMET01110 | |
| 0.024 | 0.019 | 0.024 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.045 | 0.04 | 0.045 | Potassium channel (ATP-sensitive) activator | |||
| 0.047 | 0.041 | 0.047 | Prolyl endopeptidase inhibitor | 0.045 0.044 DBMET01109 0.046 0.043 DBMET01110 | ||
| 0.039 | 0.034 | 0.039 | Complement C3a chemotactic receptor antagonist | |||
| 0.056 | 0.051 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.018 | 0.013 | 0.018 | CXC chemokine 5 receptor antagonist | |||
| 0.022 | 0.017 | 0.044 | Retinoic acid gamma receptor agonist | 0.024 0.012 DBMET00061 0.022 0.016 DBMET00065 0.044 0.004 DBMET01106 | DBMET01106 | |
| 0.011 | 0.006 | 0.011 | Angiotensin AT2 receptor agonist | 0.011 0.007 DBMET00061 0.01 0.008 DBMET01109 0.01 0.008 DBMET01108 | ||
| 0.044 | 0.039 | 0.047 | Aldosterone antagonist | 0.045 0.037 DBMET00061 0.047 0.033 DBMET00063 | DBMET00063 | |
| 0.022 | 0.018 | 0.126 | Retinoic acid receptor agonist | 0.028 0.011 DBMET00061 0.036 0.008 DBMET00065 0.126 0.004 DBMET01106 | DBMET01106 | |
| 0.041 | 0.037 | 0.049 | Dihydrofolate reductase inhibitor | 0.049 0.02 DBMET01109 | DBMET01109 | |
| 0.012 | 0.008 | 0.036 | Immunosuppressant Cyclosporine-like | 0.032 0.002 DBMET00060 0.036 0.001 DBMET00066 0.036 0.001 DBMET00067 | DBMET00067 | |
| 0.069 | 0.065 | 0.069 | Potassium channel (Tandem pore domain) blocker | |||
| 0.02 | 0.016 | 0.025 | Toll-Like receptor 8 agonist | 0.025 0.007 DBMET00061 | DBMET00061 | |
| 0.032 | 0.028 | 0.032 | RNA-directed RNA polymerase inhibitor | |||
| 0.078 | 0.074 | 0.235 | Transcription factor NF kappa B stimulant | 0.11 0.031 DBMET01015 0.098 0.041 DBMET00060 0.079 0.071 DBMET00061 0.083 0.062 DBMET00063 0.18 0.011 DBMET00064 0.235 0.007 DBMET00065 0.098 0.041 DBMET01106 0.105 0.035 DBMET01109 0.113 0.029 DBMET01107 0.081 0.068 DBMET01108 | DBMET00065 | |
| 0.045 | 0.042 | 0.048 | Dopamine beta hydroxylase inhibitor | 0.046 0.039 DBMET00066 0.046 0.039 DBMET00067 0.048 0.034 DBMET01106 | DBMET01106 | |
| 0.049 | 0.046 | 0.055 | Nicotinic alpha3beta2 receptor antagonist | 0.055 0.033 DBMET00061 | DBMET00061 | |
| 0.011 | 0.008 | 0.028 | Calcineurin inhibitor | 0.028 0.002 DBMET00060 0.016 0.004 DBMET00066 0.016 0.004 DBMET00067 0.018 0.004 DBMET01106 0.012 0.007 DBMET01109 | DBMET00060 | |
| 0.108 | 0.105 | 0.142 | Toll-Like receptor antagonist | 0.142 0.061 DBMET00061 | DBMET00061 | |
| 0.231 | 0.228 | 0.231 | Calcium channel L-type activator | |||
| 0.021 | 0.018 | 0.067 | Purinergic P2Y12 antagonist | 0.067 0.005 DBMET01015 0.047 0.007 DBMET00061 0.06 0.005 DBMET01109 0.026 0.014 DBMET01108 | DBMET01015 | |
| 0.025 | 0.022 | 0.045 | Toll-Like receptor 4 agonist | 0.045 0.004 DBMET01015 0.026 0.019 DBMET00061 0.043 0.004 DBMET00064 0.028 0.014 DBMET01109 | DBMET01015 | |
| 0.049 | 0.046 | 0.098 | Vanilloid 2 antagonist | 0.051 0.04 DBMET00062 0.098 0.005 DBMET00065 0.056 0.028 DBMET00066 0.056 0.028 DBMET00067 0.051 0.039 DBMET01106 | DBMET00065 | |
| 0.061 | 0.058 | 0.067 | Potassium channel (ATP-sensitive) blocker | 0.067 0.047 DBMET00061 | DBMET00061 | |
| 0.02 | 0.018 | 0.038 | Integrin alphaVbeta3 antagonist | 0.03 0.008 DBMET01109 0.038 0.005 DBMET01108 | DBMET01108 | |
| 0.059 | 0.057 | 0.071 | Beta adrenoreceptor antagonist | 0.064 0.047 DBMET00061 0.063 0.049 DBMET00062 0.071 0.037 DBMET00063 0.062 0.051 DBMET00065 | DBMET00063 | |
| 0.048 | 0.046 | 0.048 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.057 | 0.055 | 0.09 | Nitric oxide donor | 0.079 0.023 DBMET00061 0.09 0.014 DBMET00064 0.069 0.034 DBMET01109 0.06 0.048 DBMET01108 | DBMET00064 | |
| 0.006 | 0.004 | 0.007 | Bone morphogenic protein 1 inhibitor | 0.007 0.004 DBMET01109 0.005 0.004 DBMET01108 | DBMET01109 | |
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET01109 0.006 0.005 DBMET01108 | ||
| 0.031 | 0.029 | 0.038 | Melatonin receptor 1A agonist | 0.038 0.016 DBMET00060 0.033 0.024 DBMET00061 0.034 0.022 DBMET01106 | DBMET00060 | |
| 0.032 | 0.031 | 0.032 | Nicotinic acid receptor 2 agonist | |||
| 0.05 | 0.049 | 0.05 | Glutamate (mGluR1) antagonist | |||
| 0.02 | 0.019 | 0.03 | Prostaglandin D2 antagonist | 0.03 0.011 DBMET01109 | DBMET01109 | |
| 0.038 | 0.037 | 0.038 | Plasmepsin II inhibitor | 0.038 0.035 DBMET00062 | ||
| 0.02 | 0.019 | 0.042 | Leukotriene B4 receptor 2 antagonist | 0.022 0.015 DBMET00061 0.021 0.017 DBMET00064 0.042 0.005 DBMET00065 0.022 0.015 DBMET01106 0.026 0.011 DBMET01109 0.02 0.019 DBMET01108 | DBMET00065 | |
| 0.018 | 0.017 | 0.036 | Antibiotic Anthracycline-like | 0.018 0.017 DBMET00063 0.036 0.003 DBMET00064 0.018 0.015 DBMET01107 | DBMET00064 | |
| 0.018 | 0.018 | 0.052 | Vitronectin receptor antagonist | 0.032 0.01 DBMET01109 0.052 0.006 DBMET01108 | DBMET01108 | |
| 0.035 | 0.035 | 0.106 | Retinoic acid alpha receptor agonist | 0.049 0.015 DBMET00061 0.052 0.013 DBMET00065 0.106 0.004 DBMET01106 | DBMET01106 | |
| 0.032 | 0.032 | 0.034 | HCV polyprotein inhibitor | 0.034 0.025 DBMET00060 0.032 0.029 DBMET01109 0.033 0.026 DBMET01110 | DBMET00060 | |
| 0.069 | 0.07 | 0.079 | Estrogen receptor alpha antagonist | 0.079 0.05 DBMET00065 0.076 0.055 DBMET01106 | DBMET00065 | |
| 0.059 | 0.059 | 0.063 | Beta 3 adrenoreceptor antagonist | 0.063 0.049 DBMET00061 0.061 0.053 DBMET00062 | DBMET00061 | |
| 0.049 | 0.05 | 0.059 | Cathepsin B inhibitor | 0.054 0.042 DBMET01110 0.059 0.037 DBMET01107 | DBMET01107 | |
| 0.044 | 0.045 | 0.052 | Beta 2 adrenoreceptor antagonist | 0.048 0.04 DBMET00062 0.052 0.034 DBMET00065 0.046 0.043 DBMET01106 | DBMET00065 | |
| 0.017 | 0.018 | 0.098 | Purinergic P2T antagonist | 0.098 0.005 DBMET01015 0.033 0.012 DBMET00061 0.053 0.009 DBMET01109 0.018 0.017 DBMET01108 | DBMET01015 | |
| 0.053 | 0.054 | 0.133 | Cathepsin E inhibitor | 0.081 0.022 DBMET00060 0.133 0.007 DBMET00062 0.092 0.016 DBMET00063 0.082 0.021 DBMET01110 | DBMET00062 | |
| 0.014 | 0.016 | 0.016 | Thyroid hormone alpha agonist | 0.016 0.011 DBMET01109 | DBMET01109 | |
| 0.029 | 0.03 | 0.082 | Histone deacetylase 2 inhibitor | 0.082 0.011 DBMET01110 0.038 0.019 DBMET01107 | DBMET01110 | |
| 0.029 | 0.03 | 0.031 | Liver X receptor beta agonist | 0.031 0.027 DBMET00061 | DBMET00061 | |
| 0.024 | 0.025 | 0.029 | NMDA 2D receptor antagonist | 0.029 0.016 DBMET01109 | DBMET01109 | |
| 0.013 | 0.014 | 0.022 | Integrin beta6 antagonist | 0.016 0.006 DBMET01109 0.022 0.004 DBMET01108 | DBMET01108 | |
| 0.047 | 0.049 | 0.064 | Xanthine dehydrogenase inhibitor | 0.064 0.035 DBMET00061 | DBMET00061 | |
| 0.046 | 0.048 | 0.066 | Factor III inhibitor | 0.049 0.036 DBMET00060 0.046 0.045 DBMET00061 0.053 0.028 DBMET00064 0.059 0.019 DBMET00066 0.059 0.019 DBMET00067 0.054 0.026 DBMET01106 0.066 0.013 DBMET01110 | DBMET01110 | |
| 0.018 | 0.019 | 0.019 | Endothelin A receptor antagonist | 0.019 0.017 DBMET01109 | DBMET01109 | |
| 0.027 | 0.029 | 0.06 | Sphingosine 1-phosphate receptor 3 agonist | 0.06 0.012 DBMET00061 0.046 0.018 DBMET00062 0.042 0.02 DBMET00063 0.042 0.02 DBMET01109 0.031 0.027 DBMET01108 | DBMET00061 | |
| 0.028 | 0.03 | 0.031 | Elastase 3B inhibitor | 0.031 0.02 DBMET01109 | DBMET01109 | |
| 0.028 | 0.03 | 0.031 | Elastase 2B inhibitor | 0.031 0.02 DBMET01109 | DBMET01109 | |
| 0.028 | 0.03 | 0.031 | Elastase 3A inhibitor | 0.031 0.02 DBMET01109 | DBMET01109 | |
| 0.035 | 0.037 | 0.038 | Aggrecanase 1 inhibitor | 0.038 0.03 DBMET01109 | DBMET01109 | |
| 0.036 | 0.038 | 0.052 | Glucagon-like peptide 1 receptor antagonist | 0.052 0.012 DBMET01109 0.041 0.025 DBMET01108 | DBMET01109 | |
| 0.097 | 0.1 | 0.099 | Cholinergic antagonist | 0.099 0.097 DBMET00061 | DBMET00061 | |
| 0.027 | 0.03 | 0.034 | Caspase 6 inhibitor | 0.034 0.014 DBMET01109 0.031 0.019 DBMET01110 0.029 0.024 DBMET01107 0.031 0.019 DBMET01108 | DBMET01109 | |
| 0.034 | 0.037 | 0.037 | Dihydropteroate synthase inhibitor | 0.037 0.031 DBMET01109 | DBMET01109 | |
| 0.118 | 0.122 | 0.176 | Hexokinase inhibitor | 0.133 0.1 DBMET01015 0.176 0.052 DBMET00064 0.16 0.067 DBMET00065 | DBMET00064 | |
| 0.059 | 0.063 | 0.061 | Calcium channel P-type blocker | 0.06 0.059 DBMET00062 0.061 0.053 DBMET00063 | DBMET00063 | |
| 0.045 | 0.049 | 0.054 | Maillard reaction inhibitor | 0.049 0.044 DBMET00061 0.054 0.039 DBMET01109 | DBMET01109 | |
| 0.069 | 0.074 | 0.149 | Chymotrypsin inhibitor | 0.082 0.052 DBMET01109 0.079 0.055 DBMET01110 0.149 0.017 DBMET01107 | DBMET01107 | |
| 0.011 | 0.016 | 0.014 | Integrin alphaVbeta6 antagonist | 0.014 0.01 DBMET01108 | DBMET01108 | |
| 0.015 | 0.019 | 0.051 | Retinoic acid receptor antagonist | 0.018 0.013 DBMET00065 0.017 0.014 DBMET00066 0.017 0.014 DBMET00067 0.051 0.004 DBMET01106 | DBMET01106 | |
| 0.032 | 0.037 | 0.034 | Adenosine uptake inhibitor | 0.034 0.026 DBMET01107 | DBMET01107 | |
| 0.015 | 0.022 | 0.031 | Integrin alphaVbeta1 antagonist | 0.02 0.012 DBMET01109 0.031 0.005 DBMET01108 | DBMET01108 | |
| 0.034 | 0.041 | 0.046 | Integrin alpha5beta1 antagonist | 0.037 0.034 DBMET00065 0.039 0.03 DBMET01109 0.046 0.022 DBMET01108 | DBMET01108 | |
| 0.015 | 0.023 | 0.042 | Retinoic acid alpha receptor antagonist | 0.02 0.014 DBMET00065 0.02 0.014 DBMET00066 0.02 0.014 DBMET00067 0.042 0.004 DBMET01106 | DBMET01106 | |
| 0.014 | 0.022 | 0.036 | Integrin beta3 antagonist | 0.023 0.012 DBMET01109 0.036 0.008 DBMET01108 | DBMET01108 | |
| 0.076 | 0.085 | 0.119 | Phosphodiesterase I inhibitor | 0.119 0.028 DBMET01015 | DBMET01015 | |
| 0.029 | 0.038 | 0.038 | G protein-coupled receptor agonist | 0.033 0.031 DBMET00061 0.038 0.026 DBMET01109 | DBMET01109 | |
| 0.026 | 0.036 | 0.069 | Leukotriene A4 hydrolase inhibitor | 0.034 0.029 DBMET00061 0.069 0.012 DBMET01109 0.06 0.015 DBMET01108 | DBMET01109 | |
| 0.015 | 0.025 | 0.03 | Integrin beta5 antagonist | 0.019 0.017 DBMET01109 0.03 0.009 DBMET01108 | DBMET01108 | |
| 0.044 | 0.055 | 0.06 | Beta 1 adrenoreceptor antagonist | 0.049 0.048 DBMET00062 0.06 0.035 DBMET00063 0.059 0.037 DBMET00065 | DBMET00063 | |
| 0.127 | 0.139 | 0.153 | Pyruvate kinase inhibitor | 0.144 0.121 DBMET01107 0.153 0.113 DBMET01108 | DBMET01108 | |
| 0.04 | 0.053 | 0.143 | Protein 50S ribosomal subunit inhibitor | 0.054 0.036 DBMET01015 0.052 0.037 DBMET00062 0.143 0.007 DBMET00064 0.07 0.024 DBMET00066 0.07 0.024 DBMET00067 0.064 0.028 DBMET01106 0.078 0.02 DBMET01110 0.068 0.025 DBMET01108 | DBMET00064 | |
| 0.07 | 0.083 | 0.076 | MAP kinase kinase 7 inhibitor | 0.076 0.06 DBMET00061 | DBMET00061 | |
| 0.064 | 0.078 | 0.076 | Macrophage migration inhibitory factor inhibitor | 0.076 0.057 DBMET00061 0.076 0.057 DBMET01108 | DBMET01108 | |
| 0.023 | 0.037 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.019 DBMET00061 | DBMET00061 | |
| 0.011 | 0.026 | 0.018 | Prostaglandin EP1 antagonist | 0.018 0.015 DBMET01109 | DBMET01109 | |
| 0.046 | 0.061 | 0.051 | Fatty acid synthase inhibitor | 0.051 0.05 DBMET00066 0.051 0.05 DBMET00067 | DBMET00067 | |
| 0.031 | 0.048 | 0.052 | Acetyl-CoA transferase 1 inhibitor | 0.042 0.026 DBMET00065 0.048 0.019 DBMET00066 0.048 0.019 DBMET00067 0.052 0.014 DBMET01110 | DBMET01110 | |
| 0.146 | 0.163 | 0.518 | Tumour necrosis factor alpha release inhibitor | 0.366 0.034 DBMET01015 0.464 0.018 DBMET00060 0.164 0.14 DBMET00061 0.189 0.119 DBMET00063 0.518 0.012 DBMET00064 0.252 0.074 DBMET00066 0.252 0.074 DBMET00067 | DBMET00064 | |
| 0.018 | 0.035 | 0.025 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.023 DBMET01107 | DBMET01107 | |
| 0.004 | 0.023 | 0.008 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.008 0.004 DBMET01109 | DBMET01109 | |
| 0.042 | 0.061 | 0.098 | Acetyl-CoA transferase inhibitor | 0.065 0.027 DBMET00065 0.054 0.036 DBMET00066 0.054 0.036 DBMET00067 0.098 0.014 DBMET01110 | DBMET01110 | |
| 0.014 | 0.033 | 0.025 | Corticosteroid-like | 0.025 0.01 DBMET00064 | DBMET00064 | |
| 0.058 | 0.078 | 0.081 | Secretase beta inhibitor | 0.081 0.035 DBMET00063 0.074 0.043 DBMET00065 | DBMET00063 | |
| 0.036 | 0.056 | 0.064 | Prostaglandin E2 antagonist | 0.048 0.038 DBMET00062 0.064 0.027 DBMET01109 | DBMET01109 | |
| 0.014 | 0.035 | 0.021 | Aminopeptidase P inhibitor | 0.021 0.019 DBMET00062 | DBMET00062 | |
| 0.072 | 0.094 | 0.134 | Interleukin 5 antagonist | 0.09 0.054 DBMET00060 0.134 0.016 DBMET00061 0.093 0.049 DBMET00066 0.093 0.049 DBMET00067 | DBMET00061 | |
| 0.056 | 0.077 | 0.06 | Prolactin release inhibitor | 0.06 0.053 DBMET00060 | DBMET00060 | |
| 0.139 | 0.161 | 0.576 | Free radical scavenger | 0.19 0.106 DBMET00060 0.576 0.01 DBMET00064 0.496 0.017 DBMET00065 0.202 0.096 DBMET00066 0.202 0.096 DBMET00067 0.456 0.021 DBMET01106 0.157 0.137 DBMET01109 0.213 0.088 DBMET01107 | DBMET00064 | |
| 0.027 | 0.049 | 0.037 | Histone deacetylase 8 inhibitor | 0.037 0.032 DBMET01107 | DBMET01107 | |
| 0.008 | 0.03 | 0.021 | Retinoic acid receptor gamma antagonist | 0.021 0.004 DBMET01106 | DBMET01106 | |
| 0.02 | 0.042 | 0.056 | Plasmepsin I inhibitor | 0.056 0.005 DBMET00062 0.039 0.013 DBMET00063 | DBMET00062 | |
| 0.034 | 0.057 | 0.067 | Microtubule stabilization | 0.051 0.027 DBMET00062 0.062 0.012 DBMET00064 0.055 0.022 DBMET00065 0.046 0.033 DBMET00066 0.046 0.033 DBMET00067 0.067 0.008 DBMET01106 | DBMET01106 | |
| 0.006 | 0.03 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 DBMET01015 0.01 0.008 DBMET00064 | DBMET01015 | |
| 0.082 | 0.107 | 0.125 | Chelator | 0.104 0.072 DBMET00061 0.125 0.049 DBMET01107 | DBMET01107 | |
| 0.03 | 0.056 | 0.079 | HIV-1 protease inhibitor | 0.064 0.01 DBMET00062 0.079 0.006 DBMET00063 | DBMET00063 | |
| 0.004 | 0.031 | 0.021 | Antibiotic Macrolide-like | 0.021 0.006 DBMET00064 | DBMET00064 | |
| 0.062 | 0.09 | 0.078 | Androgen antagonist | 0.078 0.068 DBMET00063 | DBMET00063 | |
| 0.038 | 0.066 | 0.129 | Cathepsin D inhibitor | 0.104 0.017 DBMET00062 0.129 0.01 DBMET00063 | DBMET00063 | |
| 0.034 | 0.062 | 0.055 | Carbonic anhydrase I inhibitor | 0.055 0.039 DBMET00064 | DBMET00064 | |
| 0.006 | 0.034 | 0.019 | Retinoic acid beta receptor antagonist | 0.019 0.005 DBMET01106 | DBMET01106 | |
| 0.037 | 0.065 | 0.085 | Human rhinovirus A protease inhibitor | 0.047 0.046 DBMET00063 0.085 0.021 DBMET01107 | DBMET01107 | |
| 0.019 | 0.047 | 0.07 | Sodium/glucose cotransporter inhibitor | 0.07 0.004 DBMET00064 | DBMET00064 | |
| 0.014 | 0.044 | 0.063 | Histone deacetylase 10 inhibitor | 0.063 0.008 DBMET01110 | DBMET01110 | |
| 0.069 | 0.102 | 0.391 | Aminoacyl-tRNA synthetase inhibitor | 0.391 0.004 DBMET01015 0.093 0.054 DBMET00061 | DBMET01015 | |
| 0.003 | 0.036 | 0.009 | Mannitol 2-dehydrogenase inhibitor | 0.009 0.005 DBMET00062 0.008 0.006 DBMET00063 | DBMET00062 | |
| 0.016 | 0.05 | 0.077 | Sodium/glucose cotransporter 2 inhibitor | 0.077 0.004 DBMET00064 | DBMET00064 | |
| 0.038 | 0.073 | 0.076 | Carbonic anhydrase inhibitor | 0.076 0.037 DBMET00064 | DBMET00064 | |
| 0.099 | 0.134 | 0.183 | DNA repair enzyme inhibitor | 0.183 0.012 DBMET00064 | DBMET00064 | |
| 0.032 | 0.067 | 0.059 | Carbonic anhydrase II inhibitor | 0.059 0.035 DBMET00064 | DBMET00064 | |
| 0.018 | 0.053 | 0.062 | Histone deacetylase class IV inhibitor | 0.062 0.01 DBMET01110 | DBMET01110 | |
| 0.018 | 0.053 | 0.062 | Histone deacetylase 11 inhibitor | 0.062 0.01 DBMET01110 | DBMET01110 | |
| 0.037 | 0.073 | 0.051 | Cathepsin L inhibitor | 0.051 0.049 DBMET01110 | DBMET01110 | |
| 0.018 | 0.055 | 0.054 | Cholecystokinin antagonist | 0.054 0.022 DBMET01109 0.041 0.029 DBMET01108 | DBMET01109 | |
| 0.004 | 0.045 | 0.076 | Glucagon agonist | 0.076 0.003 DBMET01110 | DBMET01110 | |
| 0.021 | 0.064 | 0.034 | Calpain 1 inhibitor | 0.032 0.028 DBMET01110 0.034 0.022 DBMET01107 | DBMET01107 | |
| 0.014 | 0.058 | 0.166 | Renin inhibitor | 0.078 0.009 DBMET00062 0.166 0.004 DBMET00063 | DBMET00063 | |
| 0.031 | 0.076 | 0.044 | Guanylate cyclase stimulant | 0.044 0.029 DBMET01109 | DBMET01109 | |
| 0.01 | 0.059 | 0.026 | Cholecystokinin B antagonist | 0.026 0.025 DBMET01109 | DBMET01109 | |
| 0.032 | 0.081 | 0.072 | Carnitine palmitoyltransferase 1B inhibitor | 0.072 0.01 DBMET01015 | DBMET01015 | |
| 0.126 | 0.178 | 0.218 | Catenin beta inhibitor | 0.168 0.07 DBMET00065 0.218 0.021 DBMET01109 0.148 0.11 DBMET01108 | DBMET01109 | |
| 0.002 | 0.058 | 0.006 | DNA polymerase III subunit alpha inhibitor | 0.006 0.005 DBMET00063 | DBMET00063 | |
| 0.026 | 0.084 | 0.087 | Neuropeptide agonist | 0.087 0.03 DBMET00063 | DBMET00063 | |
| 0.05 | 0.109 | 0.087 | HIV-1 integrase inhibitor | 0.087 0.033 DBMET00065 0.07 0.048 DBMET01110 | DBMET00065 | |
| 0.047 | 0.106 | 0.165 | Topoisomerase II alpha inhibitor | 0.165 0.02 DBMET00064 | DBMET00064 | |
| 0.19 | 0.25 | 0.247 | Analgesic | 0.247 0.185 DBMET01108 | DBMET01108 | |
| 0.035 | 0.096 | 0.067 | TRPA1 antagonist | 0.067 0.036 DBMET00065 | DBMET00065 | |
| 0.023 | 0.088 | 0.088 | Antibiotic Aminoglycoside-like | 0.088 0.004 DBMET00064 | DBMET00064 | |
| 0.009 | 0.076 | 0.023 | Geranylgeranyltransferase I inhibitor | 0.023 0.013 DBMET00062 0.019 0.017 DBMET00065 | DBMET00062 | |
| 0.046 | 0.117 | 0.076 | CYP2A6 inhibitor | 0.076 0.052 DBMET00065 | DBMET00065 | |
| 0.172 | 0.243 | 0.408 | 15-Lipoxygenase inhibitor | 0.408 0.071 DBMET00065 0.312 0.124 DBMET01106 | DBMET00065 | |
| 0.145 | 0.216 | 0.218 | 12-Lipoxygenase inhibitor | 0.218 0.133 DBMET00065 | DBMET00065 | |
| 0.034 | 0.115 | 0.146 | Lipase inhibitor | 0.065 0.059 DBMET00064 0.146 0.01 DBMET00065 0.124 0.016 DBMET01106 | DBMET00065 | |
| 0.036 | 0.124 | 0.065 | Transcription factor AP-1 inhibitor | 0.065 0.036 DBMET01106 | DBMET01106 | |
| 0.008 | 0.1 | 0.015 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.015 0.011 DBMET01110 | DBMET01110 | |
| 0.007 | 0.102 | 0.07 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.07 0.003 DBMET01015 | DBMET01015 | |
| 0.127 | 0.225 | 0.173 | 5 Hydroxytryptamine 1E antagonist | 0.173 0.162 DBMET01106 | DBMET01106 | |
| 0.009 | 0.109 | 0.025 | Dopamine D1 agonist | 0.025 0.013 DBMET00064 | DBMET00064 | |
| 0.01 | 0.125 | 0.04 | Histone deacetylase 4 inhibitor | 0.04 0.017 DBMET01110 | DBMET01110 | |
| 0.006 | 0.122 | 0.028 | Adenosine kinase inhibitor | 0.028 0.011 DBMET01015 | DBMET01015 | |
| 0.093 | 0.219 | 0.275 | P-glycoprotein inhibitor | 0.202 0.063 DBMET00060 0.155 0.11 DBMET00062 0.143 0.128 DBMET00063 0.202 0.062 DBMET00064 0.275 0.034 DBMET00065 0.259 0.039 DBMET00066 0.259 0.039 DBMET00067 | DBMET00065 | |
| 0.055 | 0.2 | 0.098 | Thioredoxin reductase inhibitor | 0.098 0.03 DBMET00065 0.083 0.054 DBMET00066 0.083 0.054 DBMET00067 | DBMET00065 | |
| 0.013 | 0.158 | 0.078 | Cyclophilin A inhibitor | 0.058 0.005 DBMET00060 0.078 0.004 DBMET00066 0.078 0.004 DBMET00067 0.049 0.007 DBMET01107 | DBMET00067 | |
| 0.141 | 0.288 | 0.347 | Antiobesity | 0.347 0.089 DBMET00065 | DBMET00065 | |
| 0.005 | 0.153 | 0.046 | Histone deacetylase 3 inhibitor | 0.046 0.011 DBMET01110 | DBMET01110 | |
| 0.052 | 0.205 | 0.177 | Beta glucuronidase inhibitor | 0.177 0.016 DBMET00064 | DBMET00064 | |
| 0.01 | 0.168 | 0.068 | Protein 30S ribosomal subunit inhibitor | 0.068 0.005 DBMET00064 | DBMET00064 | |
| 0.077 | 0.237 | 0.101 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.098 DBMET00063 | DBMET00063 | |
| 0.077 | 0.245 | 0.298 | NOS3 expression enhancer | 0.258 0.025 DBMET00060 0.298 0.018 DBMET00064 0.291 0.019 DBMET00066 0.291 0.019 DBMET00067 | DBMET00064 | |
| 0.002 | 0.179 | 0.066 | Purinergic P2Y agonist | 0.066 0.002 DBMET01015 | DBMET01015 | |
| 0.002 | 0.184 | 0.076 | Purinergic P2 agonist | 0.076 0.002 DBMET01015 | DBMET01015 | |
| 0.002 | 0.184 | 0.076 | Purinergic receptor agonist | 0.076 0.002 DBMET01015 | DBMET01015 | |
| 0.006 | 0.193 | 0.129 | Purinergic P2X agonist | 0.129 0.002 DBMET01015 | DBMET01015 | |
| 0.006 | 0.195 | 0.022 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.022 0.006 DBMET01015 | DBMET01015 | |
| 0.057 | 0.249 | 0.186 | Interleukin 1 antagonist | 0.186 0.039 DBMET00066 0.186 0.039 DBMET00067 | DBMET00067 | |
| 0.007 | 0.201 | 0.022 | Adenosine A3 receptor agonist | 0.022 0.007 DBMET01015 | DBMET01015 | |
| 0.082 | 0.279 | 0.217 | Papain-like protease (SARS coronavirus) inhibitor | 0.217 0.008 DBMET00065 0.172 0.019 DBMET01106 | DBMET00065 | |
| 0.035 | 0.257 | 0.091 | ErbB-3 antagonist | 0.091 0.049 DBMET00060 0.073 0.071 DBMET01106 0.073 0.071 DBMET01109 | DBMET00060 | |
| 0.049 | 0.274 | 0.335 | Ca(v)3.1 blocker | 0.085 0.046 DBMET00060 0.335 0.002 DBMET00065 0.289 0.003 DBMET01106 | DBMET00065 | |
| 0.084 | 0.309 | 0.252 | Cardiotonic | 0.252 0.081 DBMET00063 | DBMET00063 | |
| 0.039 | 0.269 | 0.116 | Cyclooxygenase 1 inhibitor | 0.116 0.084 DBMET00065 | DBMET00065 | |
| 0.124 | 0.357 | 0.507 | Caspase 3 stimulant | 0.338 0.063 DBMET00064 0.507 0.019 DBMET00065 0.379 0.051 DBMET01106 | DBMET00065 | |
| 0.013 | 0.25 | 0.061 | Estrogen-related receptor beta antagonist | 0.061 0.004 DBMET00061 | DBMET00061 | |
| 0.006 | 0.244 | 0.032 | Histone deacetylase 5 inhibitor | 0.032 0.023 DBMET01110 | DBMET01110 | |
| 0.006 | 0.257 | 0.34 | Beta tubulin antagonist | 0.225 0.006 DBMET00065 0.34 0.004 DBMET01106 | DBMET01106 | |
| 0.03 | 0.287 | 0.188 | Topoisomerase II inhibitor | 0.188 0.036 DBMET00064 0.128 0.061 DBMET00065 | DBMET00064 | |
| 0.008 | 0.266 | 0.033 | Melatonin 2 agonist | 0.033 0.023 DBMET00060 | DBMET00060 | |
| 0.013 | 0.274 | 0.093 | Purinergic P2Y2 antagonist | 0.093 0.004 DBMET01015 | DBMET01015 | |
| 0 | 0.263 | 0.007 | Purinergic P2Y4 agonist | 0.007 0.002 DBMET01015 | DBMET01015 | |
| 0.013 | 0.277 | 0.027 | DNA polymerase III inhibitor | 0.027 0.022 DBMET00061 | DBMET00061 | |
| 0.014 | 0.28 | 0.172 | Purinergic P2 antagonist | 0.172 0.008 DBMET01015 | DBMET01015 | |
| 0.04 | 0.32 | 0.21 | Cyclooxygenase inhibitor | 0.21 0.038 DBMET00065 | DBMET00065 | |
| 0.005 | 0.302 | 0.021 | Histone deacetylase 1 inhibitor | 0.021 0.02 DBMET01110 | DBMET01110 | |
| 0.074 | 0.375 | 0.423 | Alpha-glucosidase inhibitor | 0.423 0.105 DBMET00064 0.243 0.192 DBMET00065 | DBMET00064 | |
| 0.02 | 0.363 | 0.255 | Topoisomerase I inhibitor | 0.255 0.016 DBMET00064 0.095 0.074 DBMET00065 | DBMET00064 | |
| 0.086 | 0.457 | 0.147 | CC chemokine 6 receptor antagonist | 0.147 0.026 DBMET00064 | DBMET00064 | |
| 0.013 | 0.388 | 0.201 | Purinergic P2X2 antagonist | 0.201 0.005 DBMET01015 | DBMET01015 | |
| 0.022 | 0.424 | 0.166 | Cyclooxygenase 2 inhibitor | 0.166 0.044 DBMET00065 | DBMET00065 | |
| 0.02 | 0.424 | 0.058 | Antiviral (Hepatitis D) | 0.058 0.024 DBMET01015 | DBMET01015 | |
| 0.004 | 0.422 | 0.058 | Adenosine A1 receptor agonist | 0.058 0.005 DBMET01015 | DBMET01015 | |
| 0.005 | 0.435 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.014 DBMET00064 | DBMET00064 | |
| 0.023 | 0.456 | 0.134 | Multidrug resistance-associated protein 1 inhibitor | 0.134 0.035 DBMET00064 | DBMET00064 | |
| 0.042 | 0.533 | 0.274 | Angiogenesis inhibitor | 0.274 0.107 DBMET00064 | DBMET00064 | |
| 0.011 | 0.535 | 0.301 | Tubulin antagonist | 0.161 0.053 DBMET00065 0.301 0.019 DBMET01106 | DBMET01106 | |
| 0.015 | 0.581 | 0.081 | Factor IXa inhibitor | 0.081 0.015 DBMET00064 | DBMET00064 | |
| 0.003 | 0.584 | 0.125 | Purinergic P2Y1 antagonist | 0.125 0.002 DBMET01015 | DBMET01015 | |
| 0.024 | 0.612 | 0.164 | MAP3K9 inhibitor | 0.164 0.041 DBMET00061 | DBMET00061 | |
| 0.004 | 0.622 | 0.019 | Adenosine A2b receptor agonist | 0.019 0.006 DBMET01015 | DBMET01015 | |
| 0.011 | 0.666 | 0.091 | DNA intercalator | 0.091 0.084 DBMET00064 | DBMET00064 | |
| 0.023 | 0.698 | 0.15 | Interleukin 2 antagonist | 0.15 0.018 DBMET00066 0.15 0.018 DBMET00067 | DBMET00067 | |
| 0.049 | 0.78 | 0.16 | MAP kinase kinase 5 inhibitor | 0.16 0.116 DBMET00062 | DBMET00062 | |
| 0.009 | 0.762 | 0.317 | Antimitotic | 0.317 0.04 DBMET01106 | DBMET01106 | |
| 0.005 | 0.898 | 0.14 | DNA directed RNA polymerase inhibitor | 0.14 0.027 DBMET01015 | DBMET01015 | |
| 0.005 | 0.926 | 0.051 | Phosphodiesterase 7A inhibitor | 0.051 0.037 DBMET00065 | DBMET00065 | |
| 0.003 | 0.971 | 0.086 | Epidermal growth factor antagonist | 0.086 0.058 DBMET01106 | DBMET01106 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |